activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
Not Active	1650342	CHEMBL860775	Average Binding Constant for FRK; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL4223	Homo sapiens	Kd		
Not Active	1650342	CHEMBL860775	Average Binding Constant for FRK; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL4223	Homo sapiens	Kd		
	1650343	CHEMBL860775	Average Binding Constant for FRK; NA=Not Active at 10 uM	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	=	Kd	nM	190.0	CHEMBL4223	Homo sapiens	Kd	uM	0.19
Not Active	1650344	CHEMBL860775	Average Binding Constant for FRK; NA=Not Active at 10 uM	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253		Kd			CHEMBL4223	Homo sapiens	Kd		
Not Active	1650345	CHEMBL860775	Average Binding Constant for FRK; NA=Not Active at 10 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535		Kd			CHEMBL4223	Homo sapiens	Kd		
Not Active	1650346	CHEMBL860775	Average Binding Constant for FRK; NA=Not Active at 10 uM	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660		Kd			CHEMBL4223	Homo sapiens	Kd		
Not Active	1650347	CHEMBL860775	Average Binding Constant for FRK; NA=Not Active at 10 uM	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829		Kd			CHEMBL4223	Homo sapiens	Kd		
	1650348	CHEMBL860775	Average Binding Constant for FRK; NA=Not Active at 10 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	440.0	CHEMBL4223	Homo sapiens	Kd	uM	0.44
Not Active	1650349	CHEMBL860775	Average Binding Constant for FRK; NA=Not Active at 10 uM	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762		Kd			CHEMBL4223	Homo sapiens	Kd		
Not Active	1650350	CHEMBL860775	Average Binding Constant for FRK; NA=Not Active at 10 uM	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690		Kd			CHEMBL4223	Homo sapiens	Kd		
	1651071	CHEMBL860775	Average Binding Constant for FRK; NA=Not Active at 10 uM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	260.0	CHEMBL4223	Homo sapiens	Kd	uM	0.26
	1651072	CHEMBL860775	Average Binding Constant for FRK; NA=Not Active at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Kd	nM	6000.0	CHEMBL4223	Homo sapiens	Kd	uM	6.0
	1651073	CHEMBL860775	Average Binding Constant for FRK; NA=Not Active at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Kd	nM	4400.0	CHEMBL4223	Homo sapiens	Kd	uM	4.4
	1651074	CHEMBL860775	Average Binding Constant for FRK; NA=Not Active at 10 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	Kd	nM	3300.0	CHEMBL4223	Homo sapiens	Kd	uM	3.3
	1651075	CHEMBL860775	Average Binding Constant for FRK; NA=Not Active at 10 uM	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	360.0	CHEMBL4223	Homo sapiens	Kd	uM	0.36
Not Active	1651076	CHEMBL860775	Average Binding Constant for FRK; NA=Not Active at 10 uM	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279		Kd			CHEMBL4223	Homo sapiens	Kd		
	1651077	CHEMBL860775	Average Binding Constant for FRK; NA=Not Active at 10 uM	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Kd	nM	3500.0	CHEMBL4223	Homo sapiens	Kd	uM	3.5
Not Active	1651078	CHEMBL860775	Average Binding Constant for FRK; NA=Not Active at 10 uM	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939		Kd			CHEMBL4223	Homo sapiens	Kd		
Not Active	1651079	CHEMBL860775	Average Binding Constant for FRK; NA=Not Active at 10 uM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553		Kd			CHEMBL4223	Homo sapiens	Kd		
	1651080	CHEMBL860775	Average Binding Constant for FRK; NA=Not Active at 10 uM	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	480.0	CHEMBL4223	Homo sapiens	Kd	uM	0.48
	1651081	CHEMBL860775	Average Binding Constant for FRK; NA=Not Active at 10 uM	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	8100.0	CHEMBL4223	Homo sapiens	Kd	uM	8.1
	2147370	CHEMBL922155	Activity of human PTK5 kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	90.0	CHEMBL4223	Homo sapiens	Activity	%	90.0
	2206919	CHEMBL990554	Inhibition of Frk	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	440.0	CHEMBL4223	Homo sapiens	Kd	nM	440.0
	2395441	CHEMBL961268	Binding affinity to FRK at 10 uM by Ambit binding assay relative to control	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	=	Activity	%	0.0	CHEMBL4223	Homo sapiens	Activity	%	0.0
	2470233	CHEMBL984519	Inhibition of FRK at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL4223	Homo sapiens	INH	%	10.0
Not Evaluated	2476615	CHEMBL1035879	Binding affinity to human FRK at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167		Activity			CHEMBL4223	Homo sapiens	Activity		
Not Evaluated	2476818	CHEMBL1035879	Binding affinity to human FRK at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL4223	Homo sapiens	Activity		
Not Evaluated	2478657	CHEMBL1035879	Binding affinity to human FRK at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL4223	Homo sapiens	Activity		
Not Evaluated	2478860	CHEMBL1035879	Binding affinity to human FRK at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755		Activity			CHEMBL4223	Homo sapiens	Activity		
	2479571	CHEMBL988960	Binding affinity to human FRK	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519	=	Kd	nM	6.0	CHEMBL4223	Homo sapiens	Kd	nM	6.0
	2479573	CHEMBL988960	Binding affinity to human FRK	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466	=	Kd	nM	122.0	CHEMBL4223	Homo sapiens	Kd	nM	122.0
Not Evaluated	2479715	CHEMBL1035879	Binding affinity to human FRK at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312		Activity			CHEMBL4223	Homo sapiens	Activity		
	2480714	CHEMBL1035879	Binding affinity to human FRK at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409	=	Activity	%	0.5	CHEMBL4223	Homo sapiens	Activity	%	0.5
Not Evaluated	2577336	CHEMBL1035879	Binding affinity to human FRK at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL4223	Homo sapiens	Activity		
Not Evaluated	2577539	CHEMBL1035879	Binding affinity to human FRK at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL4223	Homo sapiens	Activity		
	2593541	CHEMBL1035879	Binding affinity to human FRK at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	38.7	CHEMBL4223	Homo sapiens	Activity	%	38.7
	2593744	CHEMBL1035879	Binding affinity to human FRK at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097	=	Activity	%	0.4	CHEMBL4223	Homo sapiens	Activity	%	0.4
	2594010	CHEMBL1035879	Binding affinity to human FRK at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519	=	Activity	%	1.3	CHEMBL4223	Homo sapiens	Activity	%	1.3
Not Evaluated	2594953	CHEMBL1035879	Binding affinity to human FRK at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL4223	Homo sapiens	Activity		
Not Evaluated	2595156	CHEMBL1035879	Binding affinity to human FRK at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL4223	Homo sapiens	Activity		
	2595222	CHEMBL1035879	Binding affinity to human FRK at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466	=	Activity	%	0.7	CHEMBL4223	Homo sapiens	Activity	%	0.7
	2596353	CHEMBL1035879	Binding affinity to human FRK at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342	=	Activity	%	16.5	CHEMBL4223	Homo sapiens	Activity	%	16.5
Not Evaluated	2597622	CHEMBL1035879	Binding affinity to human FRK at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019		Activity			CHEMBL4223	Homo sapiens	Activity		
Not Evaluated	2597825	CHEMBL1035879	Binding affinity to human FRK at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL4223	Homo sapiens	Activity		
	2603062	CHEMBL1023857	Inhibition of FRK	B	Cc1cccc(C(=O)Nc2cccc([C@H](C)Nc3cncc(Cl)n3)c2)c1		CHEMBL504075	=	Kd	nM	12.0	CHEMBL4223	Homo sapiens	Kd	nM	12.0
Active	2719543	CHEMBL1059993	Inhibition of Frk at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(NC(=O)c4cncc(-c5cccs5)c4)c3)cc2C(F)(F)F)CC1		CHEMBL556140		Inhibition	%		CHEMBL4223	Homo sapiens	INH		
	2721705	CHEMBL1055107	Inhibition of PTK5 at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL4223	Homo sapiens	INH	%	50.0
	2890919	CHEMBL1060247	Binding constant for FRK kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	400.0	CHEMBL4223	Homo sapiens	Kd	nM	400.0
	2890920	CHEMBL1060247	Binding constant for FRK kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	=	Kd	nM	99.0	CHEMBL4223	Homo sapiens	Kd	nM	99.0
	2890921	CHEMBL1060247	Binding constant for FRK kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	26.0	CHEMBL4223	Homo sapiens	Kd	nM	26.0
	2890922	CHEMBL1060247	Binding constant for FRK kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL4223	Homo sapiens	Kd	uM	10.0
	2890923	CHEMBL1060247	Binding constant for FRK kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	1200.0	CHEMBL4223	Homo sapiens	Kd	nM	1200.0
	2890924	CHEMBL1060247	Binding constant for FRK kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL4223	Homo sapiens	Kd	uM	10.0
	2890925	CHEMBL1060247	Binding constant for FRK kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	2300.0	CHEMBL4223	Homo sapiens	Kd	nM	2300.0
	2890926	CHEMBL1060247	Binding constant for FRK kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	=	Kd	nM	590.0	CHEMBL4223	Homo sapiens	Kd	nM	590.0
	2890927	CHEMBL1060247	Binding constant for FRK kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	3400.0	CHEMBL4223	Homo sapiens	Kd	nM	3400.0
	2890928	CHEMBL1060247	Binding constant for FRK kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4223	Homo sapiens	Kd	uM	10.0
	2890929	CHEMBL1060247	Binding constant for FRK kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL4223	Homo sapiens	Kd	uM	10.0
	2890930	CHEMBL1060247	Binding constant for FRK kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	0.31	CHEMBL4223	Homo sapiens	Kd	nM	0.31
	2890931	CHEMBL1060247	Binding constant for FRK kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	=	Kd	nM	680.0	CHEMBL4223	Homo sapiens	Kd	nM	680.0
	2890932	CHEMBL1060247	Binding constant for FRK kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	2000.0	CHEMBL4223	Homo sapiens	Kd	nM	2000.0
	2890933	CHEMBL1060247	Binding constant for FRK kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL4223	Homo sapiens	Kd	uM	10.0
	2890934	CHEMBL1060247	Binding constant for FRK kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Kd	nM	2000.0	CHEMBL4223	Homo sapiens	Kd	nM	2000.0
	2890935	CHEMBL1060247	Binding constant for FRK kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4223	Homo sapiens	Kd	uM	10.0
	2890936	CHEMBL1060247	Binding constant for FRK kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	750.0	CHEMBL4223	Homo sapiens	Kd	nM	750.0
	2890937	CHEMBL1060247	Binding constant for FRK kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Kd	nM	1500.0	CHEMBL4223	Homo sapiens	Kd	nM	1500.0
	2903448	CHEMBL1060247	Binding constant for FRK kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	>	Kd	nM	10000.0	CHEMBL4223	Homo sapiens	Kd	uM	10.0
	2903449	CHEMBL1060247	Binding constant for FRK kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4223	Homo sapiens	Kd	uM	10.0
	2903450	CHEMBL1060247	Binding constant for FRK kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL4223	Homo sapiens	Kd	uM	10.0
	2903451	CHEMBL1060247	Binding constant for FRK kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4223	Homo sapiens	Kd	uM	10.0
	2903452	CHEMBL1060247	Binding constant for FRK kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL4223	Homo sapiens	Kd	uM	10.0
	2903453	CHEMBL1060247	Binding constant for FRK kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4223	Homo sapiens	Kd	uM	10.0
	2903454	CHEMBL1060247	Binding constant for FRK kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	2400.0	CHEMBL4223	Homo sapiens	Kd	nM	2400.0
	2903455	CHEMBL1060247	Binding constant for FRK kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	Kd	nM	1800.0	CHEMBL4223	Homo sapiens	Kd	nM	1800.0
	2903456	CHEMBL1060247	Binding constant for FRK kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL4223	Homo sapiens	Kd	uM	10.0
	2903457	CHEMBL1060247	Binding constant for FRK kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Kd	nM	3100.0	CHEMBL4223	Homo sapiens	Kd	nM	3100.0
	2903458	CHEMBL1060247	Binding constant for FRK kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Kd	nM	1800.0	CHEMBL4223	Homo sapiens	Kd	nM	1800.0
	2903459	CHEMBL1060247	Binding constant for FRK kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL4223	Homo sapiens	Kd	uM	10.0
	2903460	CHEMBL1060247	Binding constant for FRK kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	510.0	CHEMBL4223	Homo sapiens	Kd	nM	510.0
	2903461	CHEMBL1060247	Binding constant for FRK kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	45.0	CHEMBL4223	Homo sapiens	Kd	nM	45.0
	2903462	CHEMBL1060247	Binding constant for FRK kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL4223	Homo sapiens	Kd	uM	10.0
	2903463	CHEMBL1060247	Binding constant for FRK kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	530.0	CHEMBL4223	Homo sapiens	Kd	nM	530.0
	2903464	CHEMBL1060247	Binding constant for FRK kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	3800.0	CHEMBL4223	Homo sapiens	Kd	nM	3800.0
	2903465	CHEMBL1060247	Binding constant for FRK kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4223	Homo sapiens	Kd	uM	10.0
	2903466	CHEMBL1060247	Binding constant for FRK kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	170.0	CHEMBL4223	Homo sapiens	Kd	nM	170.0
	2921324	CHEMBL1053741	Inhibition of FRK assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	17.0	CHEMBL4223	Homo sapiens	Activity	%	17.0
	2928478	CHEMBL1049976	Binding affinity to FRK assessed as percentage of kinase remaining bound to the bead at 1 uM by T7 phage display based binding assay	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	Activity	%	0.3	CHEMBL4223	Homo sapiens	Activity	%	0.3
	3052616	CHEMBL1037592	Residual activity of FRK at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	90.0	CHEMBL4223	Homo sapiens	Residual activity	%	90.0
	3053925	CHEMBL1045135	Residual activity of FRK at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	24.0	CHEMBL4223	Homo sapiens	Residual activity	%	24.0
	3054177	CHEMBL1040645	Residual activity of FRK at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	100.0	CHEMBL4223	Homo sapiens	Residual activity	%	100.0
	3055464	CHEMBL1037592	Residual activity of FRK at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	84.0	CHEMBL4223	Homo sapiens	Residual activity	%	84.0
	3056769	CHEMBL1045135	Residual activity of FRK at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	61.0	CHEMBL4223	Homo sapiens	Residual activity	%	61.0
	3057021	CHEMBL1040645	Residual activity of FRK at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	100.0	CHEMBL4223	Homo sapiens	Residual activity	%	100.0
	3058341	CHEMBL1037592	Residual activity of FRK at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	95.0	CHEMBL4223	Homo sapiens	Residual activity	%	95.0
	3058593	CHEMBL1045135	Residual activity of FRK at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	71.0	CHEMBL4223	Homo sapiens	Residual activity	%	71.0
	3072939	CHEMBL1040645	Residual activity of FRK at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	99.0	CHEMBL4223	Homo sapiens	Residual activity	%	99.0
	3213821	CHEMBL1108408	Inhibition of FRK at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	101.0	CHEMBL4223	Homo sapiens	INH	%	101.0
	3224830	CHEMBL1099667	Inhibition of FRK at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL4223	Homo sapiens	INH	%	50.0
	3225080	CHEMBL1099667	Inhibition of FRK at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL4223	Homo sapiens	INH	%	50.0
	3331955	CHEMBL1169245	Inhibition of FRK at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL4223	Homo sapiens	INH	%	50.0
	3333370	CHEMBL1169245	Inhibition of FRK at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL4223	Homo sapiens	INH	%	50.0
	3334775	CHEMBL1169245	Inhibition of FRK at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL4223	Homo sapiens	INH	%	50.0
	3336195	CHEMBL1169245	Inhibition of FRK at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	=	Inhibition	%	66.0	CHEMBL4223	Homo sapiens	INH	%	66.0
	3337541	CHEMBL1169245	Inhibition of FRK at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL4223	Homo sapiens	INH	%	50.0
	3337791	CHEMBL1169245	Inhibition of FRK at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL4223	Homo sapiens	INH	%	50.0
	3339125	CHEMBL1169245	Inhibition of FRK at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL4223	Homo sapiens	INH	%	50.0
	3340427	CHEMBL1169245	Inhibition of FRK at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL4223	Homo sapiens	INH	%	50.0
	3340723	CHEMBL1169245	Inhibition of FRK at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL4223	Homo sapiens	INH	%	50.0
	3342139	CHEMBL1169245	Inhibition of FRK at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL4223	Homo sapiens	INH	%	50.0
	3358591	CHEMBL1174436	Inhibition of FRK at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	0.15	CHEMBL4223	Homo sapiens	INH	%	0.15
	3359033	CHEMBL1174436	Inhibition of FRK at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	0.15	CHEMBL4223	Homo sapiens	INH	%	0.15
	3443406	CHEMBL1244439	Inhibition of FRK at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	99.0	CHEMBL4223	Homo sapiens	INH	%	99.0
	3443623	CHEMBL1244439	Inhibition of FRK at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	98.0	CHEMBL4223	Homo sapiens	INH	%	98.0
	3444778	CHEMBL1244439	Inhibition of FRK at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	84.0	CHEMBL4223	Homo sapiens	INH	%	84.0
	3444988	CHEMBL1244852	Binding affinity to FRK	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	=	Kd	nM	1800.0	CHEMBL4223	Homo sapiens	Kd	nM	1800.0
	3445130	CHEMBL1244852	Binding affinity to FRK	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	740.0	CHEMBL4223	Homo sapiens	Kd	nM	740.0
	3445402	CHEMBL1244439	Inhibition of FRK at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	67.0	CHEMBL4223	Homo sapiens	INH	%	67.0
	3445619	CHEMBL1244439	Inhibition of FRK at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	32.0	CHEMBL4223	Homo sapiens	INH	%	32.0
	3445827	CHEMBL1244439	Inhibition of FRK at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	99.0	CHEMBL4223	Homo sapiens	INH	%	99.0
	3446017	CHEMBL1244439	Inhibition of FRK at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	60.0	CHEMBL4223	Homo sapiens	INH	%	60.0
	3446189	CHEMBL1244329	Inhibition of FRK	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	IC50	nM	2.2	CHEMBL4223	Homo sapiens	IC50	nM	2.2
	3448441	CHEMBL1244852	Binding affinity to FRK	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4223	Homo sapiens	Kd	uM	10.0
	3448938	CHEMBL1244852	Binding affinity to FRK	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	2400.0	CHEMBL4223	Homo sapiens	Kd	nM	2400.0
	3449199	CHEMBL1244852	Binding affinity to FRK	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	510.0	CHEMBL4223	Homo sapiens	Kd	nM	510.0
	3449200	CHEMBL1244852	Binding affinity to FRK	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	530.0	CHEMBL4223	Homo sapiens	Kd	nM	530.0
	3449436	CHEMBL1244852	Binding affinity to FRK	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	=	Kd	nM	4500.0	CHEMBL4223	Homo sapiens	Kd	nM	4500.0
	3463239	CHEMBL1252427	Inhibition of FRK at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	6.0	CHEMBL4223	Homo sapiens	INH	%	6.0
	3463458	CHEMBL1252427	Inhibition of FRK at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	11.0	CHEMBL4223	Homo sapiens	INH	%	11.0
	3464002	CHEMBL1252427	Inhibition of FRK at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	16.0	CHEMBL4223	Homo sapiens	INH	%	16.0
	5120302	CHEMBL1648696	Inhibition of human PTK5 at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	98.0	CHEMBL4223	Homo sapiens	INH	%	98.0
	5223288	CHEMBL1679281	Binding affinity to FRK at 10 uM by immobilized ligand displacement assay	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2		CHEMBL1672987	>	Inhibition	%	90.0	CHEMBL4223	Homo sapiens	INH	%	90.0
	5223289	CHEMBL1679281	Binding affinity to FRK at 10 uM by immobilized ligand displacement assay	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL1673039	>	Inhibition	%	90.0	CHEMBL4223	Homo sapiens	INH	%	90.0
	6341065	CHEMBL1828234	Activity of FRK kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	100.0	CHEMBL4223	Homo sapiens	Activity	%	100.0
	7567250	CHEMBL1908552	Binding constant for FRK kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Kd	nM	720.0	CHEMBL4223	Homo sapiens	Kd	nM	720.0
	7567709	CHEMBL1908552	Binding constant for FRK kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4223	Homo sapiens	Kd	nM	10000.0
	7568180	CHEMBL1908552	Binding constant for FRK kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Kd	nM	1500.0	CHEMBL4223	Homo sapiens	Kd	nM	1500.0
	7568638	CHEMBL1908552	Binding constant for FRK kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	1800.0	CHEMBL4223	Homo sapiens	Kd	nM	1800.0
	7569223	CHEMBL1908552	Binding constant for FRK kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL4223	Homo sapiens	Kd	nM	10000.0
	7569683	CHEMBL1908552	Binding constant for FRK kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	2900.0	CHEMBL4223	Homo sapiens	Kd	nM	2900.0
	7570176	CHEMBL1908552	Binding constant for FRK kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL4223	Homo sapiens	Kd	nM	10000.0
	7570603	CHEMBL1908552	Binding constant for FRK kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	530.0	CHEMBL4223	Homo sapiens	Kd	nM	530.0
	7571199	CHEMBL1908552	Binding constant for FRK kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL4223	Homo sapiens	Kd	nM	10000.0
	7571656	CHEMBL1908552	Binding constant for FRK kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	0.31	CHEMBL4223	Homo sapiens	Kd	nM	0.31
	7571690	CHEMBL1908552	Binding constant for FRK kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL4223	Homo sapiens	Kd	nM	10000.0
	7572153	CHEMBL1908552	Binding constant for FRK kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4223	Homo sapiens	Kd	nM	10000.0
	7572569	CHEMBL1908552	Binding constant for FRK kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	27.0	CHEMBL4223	Homo sapiens	Kd	nM	27.0
	7573180	CHEMBL1908552	Binding constant for FRK kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	2700.0	CHEMBL4223	Homo sapiens	Kd	nM	2700.0
	7573671	CHEMBL1908552	Binding constant for FRK kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	5500.0	CHEMBL4223	Homo sapiens	Kd	nM	5500.0
	7574140	CHEMBL1908552	Binding constant for FRK kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	2400.0	CHEMBL4223	Homo sapiens	Kd	nM	2400.0
	7574548	CHEMBL1908552	Binding constant for FRK kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL4223	Homo sapiens	Kd	nM	10000.0
	7575177	CHEMBL1908552	Binding constant for FRK kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	2000.0	CHEMBL4223	Homo sapiens	Kd	nM	2000.0
	7575648	CHEMBL1908552	Binding constant for FRK kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	=	Kd	nM	310.0	CHEMBL4223	Homo sapiens	Kd	nM	310.0
	7576113	CHEMBL1908552	Binding constant for FRK kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	=	Kd	nM	1900.0	CHEMBL4223	Homo sapiens	Kd	nM	1900.0
	7576521	CHEMBL1908552	Binding constant for FRK kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	200.0	CHEMBL4223	Homo sapiens	Kd	nM	200.0
	7576690	CHEMBL1908552	Binding constant for FRK kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	=	Kd	nM	1400.0	CHEMBL4223	Homo sapiens	Kd	nM	1400.0
	7577149	CHEMBL1908552	Binding constant for FRK kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	3.8	CHEMBL4223	Homo sapiens	Kd	nM	3.8
	7577627	CHEMBL1908552	Binding constant for FRK kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	2100.0	CHEMBL4223	Homo sapiens	Kd	nM	2100.0
	7578097	CHEMBL1908552	Binding constant for FRK kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	570.0	CHEMBL4223	Homo sapiens	Kd	nM	570.0
	7578502	CHEMBL1908552	Binding constant for FRK kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	170.0	CHEMBL4223	Homo sapiens	Kd	nM	170.0
	7578698	CHEMBL1908552	Binding constant for FRK kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL4223	Homo sapiens	Kd	nM	10000.0
	7579072	CHEMBL1908552	Binding constant for FRK kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	1200.0	CHEMBL4223	Homo sapiens	Kd	nM	1200.0
	7579522	CHEMBL1908552	Binding constant for FRK kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	1200.0	CHEMBL4223	Homo sapiens	Kd	nM	1200.0
	7579996	CHEMBL1908552	Binding constant for FRK kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4223	Homo sapiens	Kd	nM	10000.0
	7580465	CHEMBL1908552	Binding constant for FRK kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	Kd	nM	1800.0	CHEMBL4223	Homo sapiens	Kd	nM	1800.0
	7580868	CHEMBL1908552	Binding constant for FRK kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	3800.0	CHEMBL4223	Homo sapiens	Kd	nM	3800.0
	7581056	CHEMBL1908552	Binding constant for FRK kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	=	Kd	nM	87.0	CHEMBL4223	Homo sapiens	Kd	nM	87.0
	7581441	CHEMBL1908552	Binding constant for FRK kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL4223	Homo sapiens	Kd	nM	10000.0
	7581886	CHEMBL1908552	Binding constant for FRK kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL4223	Homo sapiens	Kd	nM	10000.0
	7582357	CHEMBL1908552	Binding constant for FRK kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL4223	Homo sapiens	Kd	nM	10000.0
	7582821	CHEMBL1908552	Binding constant for FRK kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	68.0	CHEMBL4223	Homo sapiens	Kd	nM	68.0
	7583402	CHEMBL1908552	Binding constant for FRK kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	400.0	CHEMBL4223	Homo sapiens	Kd	nM	400.0
	7583799	CHEMBL1908552	Binding constant for FRK kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL4223	Homo sapiens	Kd	nM	10000.0
	7584244	CHEMBL1908552	Binding constant for FRK kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL4223	Homo sapiens	Kd	nM	10000.0
	7584715	CHEMBL1908552	Binding constant for FRK kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL4223	Homo sapiens	Kd	nM	10000.0
	7585139	CHEMBL1908552	Binding constant for FRK kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4223	Homo sapiens	Kd	nM	10000.0
	7585732	CHEMBL1908552	Binding constant for FRK kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	=	Kd	nM	1800.0	CHEMBL4223	Homo sapiens	Kd	nM	1800.0
	7586140	CHEMBL1908552	Binding constant for FRK kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL4223	Homo sapiens	Kd	nM	10000.0
	7586586	CHEMBL1908552	Binding constant for FRK kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Kd	nM	2000.0	CHEMBL4223	Homo sapiens	Kd	nM	2000.0
	7587069	CHEMBL1908552	Binding constant for FRK kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL4223	Homo sapiens	Kd	nM	10000.0
	7587693	CHEMBL1908552	Binding constant for FRK kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL4223	Homo sapiens	Kd	nM	10000.0
	7588112	CHEMBL1908552	Binding constant for FRK kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	740.0	CHEMBL4223	Homo sapiens	Kd	nM	740.0
	7588594	CHEMBL1908552	Binding constant for FRK kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL4223	Homo sapiens	Kd	nM	10000.0
	7589045	CHEMBL1908552	Binding constant for FRK kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Kd	nM	1800.0	CHEMBL4223	Homo sapiens	Kd	nM	1800.0
	7589658	CHEMBL1908552	Binding constant for FRK kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	=	Kd	nM	99.0	CHEMBL4223	Homo sapiens	Kd	nM	99.0
	7590082	CHEMBL1908552	Binding constant for FRK kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	2300.0	CHEMBL4223	Homo sapiens	Kd	nM	2300.0
	7590107	CHEMBL1908552	Binding constant for FRK kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL4223	Homo sapiens	Kd	nM	10000.0
	7590581	CHEMBL1908552	Binding constant for FRK kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4223	Homo sapiens	Kd	nM	10000.0
	7591032	CHEMBL1908552	Binding constant for FRK kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL4223	Homo sapiens	Kd	nM	10000.0
	7592083	CHEMBL1908552	Binding constant for FRK kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL4223	Homo sapiens	Kd	nM	10000.0
	7592556	CHEMBL1908552	Binding constant for FRK kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL4223	Homo sapiens	Kd	nM	10000.0
	7593009	CHEMBL1908552	Binding constant for FRK kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	1.4	CHEMBL4223	Homo sapiens	Kd	nM	1.4
	7593156	CHEMBL1908552	Binding constant for FRK kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	26.0	CHEMBL4223	Homo sapiens	Kd	nM	26.0
	7593591	CHEMBL1908552	Binding constant for FRK kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	=	Kd	nM	590.0	CHEMBL4223	Homo sapiens	Kd	nM	590.0
	7594063	CHEMBL1908552	Binding constant for FRK kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL4223	Homo sapiens	Kd	nM	10000.0
	7594536	CHEMBL1908552	Binding constant for FRK kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	Kd	nM	86.0	CHEMBL4223	Homo sapiens	Kd	nM	86.0
	7594988	CHEMBL1908552	Binding constant for FRK kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	510.0	CHEMBL4223	Homo sapiens	Kd	nM	510.0
	7595124	CHEMBL1908552	Binding constant for FRK kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL4223	Homo sapiens	Kd	nM	10000.0
	7595568	CHEMBL1908552	Binding constant for FRK kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	3400.0	CHEMBL4223	Homo sapiens	Kd	nM	3400.0
	7596042	CHEMBL1908552	Binding constant for FRK kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4223	Homo sapiens	Kd	nM	10000.0
	7596513	CHEMBL1908552	Binding constant for FRK kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	750.0	CHEMBL4223	Homo sapiens	Kd	nM	750.0
	7596960	CHEMBL1908552	Binding constant for FRK kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	45.0	CHEMBL4223	Homo sapiens	Kd	nM	45.0
	7597096	CHEMBL1908552	Binding constant for FRK kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL4223	Homo sapiens	Kd	nM	10000.0
	7597549	CHEMBL1908552	Binding constant for FRK kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL4223	Homo sapiens	Kd	nM	10000.0
	7598022	CHEMBL1908552	Binding constant for FRK kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL4223	Homo sapiens	Kd	nM	10000.0
	7598492	CHEMBL1908552	Binding constant for FRK kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	4.1	CHEMBL4223	Homo sapiens	Kd	nM	4.1
	7931090	CHEMBL1919267	Inhibition of FRK relative to control	B	Cc1ccccc1Nc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916891	=	Inhibition	%	60.0	CHEMBL4223	Homo sapiens	INH	%	60.0
	7931091	CHEMBL1919267	Inhibition of FRK relative to control	B	Cc1ccccc1Nc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916891	=	IC50	nM	611.0	CHEMBL4223	Homo sapiens	IC50	nM	611.0
	8047123	CHEMBL1958949	Inhibition of FRK at 1 uM	B	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4ccc5c(c4)OCCO5)s3)cc2)CC1		CHEMBL1956070	<	Inhibition	%	50.0	CHEMBL4223	Homo sapiens	INH	%	50.0
	8061591	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	1.85	CHEMBL4223	Homo sapiens	Inhibition	%	1.85
	8061698	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	0.85	CHEMBL4223	Homo sapiens	Inhibition	%	0.85
	8061922	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	1.83	CHEMBL4223	Homo sapiens	Inhibition	%	1.83
	8062113	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	0.71	CHEMBL4223	Homo sapiens	Inhibition	%	0.71
	8062229	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	2.5	CHEMBL4223	Homo sapiens	Inhibition	%	2.5
	8062453	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	0.98	CHEMBL4223	Homo sapiens	Inhibition	%	0.98
	8062615	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	2.31	CHEMBL4223	Homo sapiens	Inhibition	%	2.31
	8062937	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	0.17	CHEMBL4223	Homo sapiens	Inhibition	%	0.17
	8063069	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	5.22	CHEMBL4223	Homo sapiens	Inhibition	%	5.22
	8063293	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	35.26	CHEMBL4223	Homo sapiens	Inhibition	%	35.26
	8063460	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	1.65	CHEMBL4223	Homo sapiens	Inhibition	%	1.65
	8063792	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	0.98	CHEMBL4223	Homo sapiens	Inhibition	%	0.98
	8063974	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	3.75	CHEMBL4223	Homo sapiens	Inhibition	%	3.75
	8064313	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	1.06	CHEMBL4223	Homo sapiens	Inhibition	%	1.06
	8064523	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	0.71	CHEMBL4223	Homo sapiens	Inhibition	%	0.71
	8064885	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	-0.09	CHEMBL4223	Homo sapiens	Inhibition	%	-0.09
	8065051	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	0.79	CHEMBL4223	Homo sapiens	Inhibition	%	0.79
	8065391	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	-0.16	CHEMBL4223	Homo sapiens	Inhibition	%	-0.16
	8065566	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	0.89	CHEMBL4223	Homo sapiens	Inhibition	%	0.89
	8065905	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	1.12	CHEMBL4223	Homo sapiens	Inhibition	%	1.12
	8066115	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	2.18	CHEMBL4223	Homo sapiens	Inhibition	%	2.18
	8066475	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	4.33	CHEMBL4223	Homo sapiens	Inhibition	%	4.33
	8066641	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	0.53	CHEMBL4223	Homo sapiens	Inhibition	%	0.53
	8066989	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	2.82	CHEMBL4223	Homo sapiens	Inhibition	%	2.82
	8067164	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	5.26	CHEMBL4223	Homo sapiens	Inhibition	%	5.26
	8067388	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	2.02	CHEMBL4223	Homo sapiens	Inhibition	%	2.02
	8067509	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	0.64	CHEMBL4223	Homo sapiens	Inhibition	%	0.64
	8067719	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	0.24	CHEMBL4223	Homo sapiens	Inhibition	%	0.24
	8067943	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	-0.39	CHEMBL4223	Homo sapiens	Inhibition	%	-0.39
	8068078	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	1.76	CHEMBL4223	Homo sapiens	Inhibition	%	1.76
	8068242	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	-0.31	CHEMBL4223	Homo sapiens	Inhibition	%	-0.31
	8068466	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	0.92	CHEMBL4223	Homo sapiens	Inhibition	%	0.92
	8068591	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	1.12	CHEMBL4223	Homo sapiens	Inhibition	%	1.12
	8068989	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	0.33	CHEMBL4223	Homo sapiens	Inhibition	%	0.33
	8069114	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	0.42	CHEMBL4223	Homo sapiens	Inhibition	%	0.42
	8069338	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	1.58	CHEMBL4223	Homo sapiens	Inhibition	%	1.58
	8069409	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	5.05	CHEMBL4223	Homo sapiens	Inhibition	%	5.05
	8069794	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	3.54	CHEMBL4223	Homo sapiens	Inhibition	%	3.54
	8069920	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	0.6	CHEMBL4223	Homo sapiens	Inhibition	%	0.6
	8070144	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	1.01	CHEMBL4223	Homo sapiens	Inhibition	%	1.01
	8070316	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	2.23	CHEMBL4223	Homo sapiens	Inhibition	%	2.23
	8070665	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	-0.8	CHEMBL4223	Homo sapiens	Inhibition	%	-0.8
	8070739	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	2.39	CHEMBL4223	Homo sapiens	Inhibition	%	2.39
	8070963	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	15.43	CHEMBL4223	Homo sapiens	Inhibition	%	15.43
	8071120	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	1.54	CHEMBL4223	Homo sapiens	Inhibition	%	1.54
	8071470	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	1.55	CHEMBL4223	Homo sapiens	Inhibition	%	1.55
	8071643	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	1.18	CHEMBL4223	Homo sapiens	Inhibition	%	1.18
	8071992	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	-0.88	CHEMBL4223	Homo sapiens	Inhibition	%	-0.88
	8072306	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	-0.02	CHEMBL4223	Homo sapiens	Inhibition	%	-0.02
	8072463	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	3.32	CHEMBL4223	Homo sapiens	Inhibition	%	3.32
	8072812	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	-0.81	CHEMBL4223	Homo sapiens	Inhibition	%	-0.81
	8072979	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	1.22	CHEMBL4223	Homo sapiens	Inhibition	%	1.22
	8073203	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	4.35	CHEMBL4223	Homo sapiens	Inhibition	%	4.35
	8073328	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	0.62	CHEMBL4223	Homo sapiens	Inhibition	%	0.62
	8073671	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	-0.61	CHEMBL4223	Homo sapiens	Inhibition	%	-0.61
	8073904	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	1.37	CHEMBL4223	Homo sapiens	Inhibition	%	1.37
	8074056	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	1.73	CHEMBL4223	Homo sapiens	Inhibition	%	1.73
	8074280	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	1.93	CHEMBL4223	Homo sapiens	Inhibition	%	1.93
	8074410	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	0.68	CHEMBL4223	Homo sapiens	Inhibition	%	0.68
	8074791	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	1.11	CHEMBL4223	Homo sapiens	Inhibition	%	1.11
	8074918	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	4.14	CHEMBL4223	Homo sapiens	Inhibition	%	4.14
	8075253	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	0.7	CHEMBL4223	Homo sapiens	Inhibition	%	0.7
	8075490	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	0.91	CHEMBL4223	Homo sapiens	Inhibition	%	0.91
	8075855	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	-0.46	CHEMBL4223	Homo sapiens	Inhibition	%	-0.46
	8075997	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	-0.25	CHEMBL4223	Homo sapiens	Inhibition	%	-0.25
	8076369	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	3.64	CHEMBL4223	Homo sapiens	Inhibition	%	3.64
	8076503	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	0.82	CHEMBL4223	Homo sapiens	Inhibition	%	0.82
	8076727	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	1.26	CHEMBL4223	Homo sapiens	Inhibition	%	1.26
	8076829	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	0.05	CHEMBL4223	Homo sapiens	Inhibition	%	0.05
	8077076	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-0.12	CHEMBL4223	Homo sapiens	Inhibition	%	-0.12
	8077428	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	2.48	CHEMBL4223	Homo sapiens	Inhibition	%	2.48
	8077579	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-0.74	CHEMBL4223	Homo sapiens	Inhibition	%	-0.74
	8077803	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	1.39	CHEMBL4223	Homo sapiens	Inhibition	%	1.39
	8077946	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	0.72	CHEMBL4223	Homo sapiens	Inhibition	%	0.72
	8078309	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-1.68	CHEMBL4223	Homo sapiens	Inhibition	%	-1.68
	8078411	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-1.57	CHEMBL4223	Homo sapiens	Inhibition	%	-1.57
	8078635	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	2.38	CHEMBL4223	Homo sapiens	Inhibition	%	2.38
	8078661	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	-0.39	CHEMBL4223	Homo sapiens	Inhibition	%	-0.39
	8078885	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	0.63	CHEMBL4223	Homo sapiens	Inhibition	%	0.63
	8079001	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	2.05	CHEMBL4223	Homo sapiens	Inhibition	%	2.05
	8079383	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	0.8	CHEMBL4223	Homo sapiens	Inhibition	%	0.8
	8079525	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	1.86	CHEMBL4223	Homo sapiens	Inhibition	%	1.86
	8079888	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	0.93	CHEMBL4223	Homo sapiens	Inhibition	%	0.93
	8080217	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-1.06	CHEMBL4223	Homo sapiens	Inhibition	%	-1.06
	8080469	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	-0.58	CHEMBL4223	Homo sapiens	Inhibition	%	-0.58
	8080584	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	2.02	CHEMBL4223	Homo sapiens	Inhibition	%	2.02
	8080808	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	0.42	CHEMBL4223	Homo sapiens	Inhibition	%	0.42
	8080972	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	2.17	CHEMBL4223	Homo sapiens	Inhibition	%	2.17
	8081107	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	0.91	CHEMBL4223	Homo sapiens	Inhibition	%	0.91
	8081331	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	1.11	CHEMBL4223	Homo sapiens	Inhibition	%	1.11
	8081475	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	4.23	CHEMBL4223	Homo sapiens	Inhibition	%	4.23
	8081802	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	-0.47	CHEMBL4223	Homo sapiens	Inhibition	%	-0.47
	8082054	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	1.92	CHEMBL4223	Homo sapiens	Inhibition	%	1.92
	8082391	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	0.42	CHEMBL4223	Homo sapiens	Inhibition	%	0.42
	8082564	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.53	CHEMBL4223	Homo sapiens	Inhibition	%	0.53
	8082911	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	1.45	CHEMBL4223	Homo sapiens	Inhibition	%	1.45
	8083067	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	19.33	CHEMBL4223	Homo sapiens	Inhibition	%	19.33
	8083390	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	1.74	CHEMBL4223	Homo sapiens	Inhibition	%	1.74
	8083644	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	0.25	CHEMBL4223	Homo sapiens	Inhibition	%	0.25
	8083978	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	0.15	CHEMBL4223	Homo sapiens	Inhibition	%	0.15
	8084163	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	1.84	CHEMBL4223	Homo sapiens	Inhibition	%	1.84
	8084505	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	0.56	CHEMBL4223	Homo sapiens	Inhibition	%	0.56
	8084666	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	2.01	CHEMBL4223	Homo sapiens	Inhibition	%	2.01
	8084890	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	2.76	CHEMBL4223	Homo sapiens	Inhibition	%	2.76
	8084988	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	0.86	CHEMBL4223	Homo sapiens	Inhibition	%	0.86
	8085244	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	0.75	CHEMBL4223	Homo sapiens	Inhibition	%	0.75
	8085468	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	0.54	CHEMBL4223	Homo sapiens	Inhibition	%	0.54
	8085576	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	1.13	CHEMBL4223	Homo sapiens	Inhibition	%	1.13
	8085765	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	0.32	CHEMBL4223	Homo sapiens	Inhibition	%	0.32
	8085989	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	4.11	CHEMBL4223	Homo sapiens	Inhibition	%	4.11
	8086104	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	1.92	CHEMBL4223	Homo sapiens	Inhibition	%	1.92
	8086490	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	1.77	CHEMBL4223	Homo sapiens	Inhibition	%	1.77
	8086589	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	0.42	CHEMBL4223	Homo sapiens	Inhibition	%	0.42
	8086813	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	0.98	CHEMBL4223	Homo sapiens	Inhibition	%	0.98
	8087024	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	3.04	CHEMBL4223	Homo sapiens	Inhibition	%	3.04
	8087182	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	4.95	CHEMBL4223	Homo sapiens	Inhibition	%	4.95
	8087406	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	2.5	CHEMBL4223	Homo sapiens	Inhibition	%	2.5
	8087520	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	70.19	CHEMBL4223	Homo sapiens	Inhibition	%	70.19
	8087882	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	3.13	CHEMBL4223	Homo sapiens	Inhibition	%	3.13
	8088024	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	3.81	CHEMBL4223	Homo sapiens	Inhibition	%	3.81
	8088396	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	-0.3	CHEMBL4223	Homo sapiens	Inhibition	%	-0.3
	8088524	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	3.52	CHEMBL4223	Homo sapiens	Inhibition	%	3.52
	8088748	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	5.42	CHEMBL4223	Homo sapiens	Inhibition	%	5.42
	8088841	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	0.05	CHEMBL4223	Homo sapiens	Inhibition	%	0.05
	8089193	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	-0.17	CHEMBL4223	Homo sapiens	Inhibition	%	-0.17
	8089341	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	-0.09	CHEMBL4223	Homo sapiens	Inhibition	%	-0.09
	8089565	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	1.44	CHEMBL4223	Homo sapiens	Inhibition	%	1.44
	8089685	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	0.39	CHEMBL4223	Homo sapiens	Inhibition	%	0.39
	8089865	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-1.38	CHEMBL4223	Homo sapiens	Inhibition	%	-1.38
	8090089	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	1.04	CHEMBL4223	Homo sapiens	Inhibition	%	1.04
	8090254	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	0.37	CHEMBL4223	Homo sapiens	Inhibition	%	0.37
	8090421	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	1.77	CHEMBL4223	Homo sapiens	Inhibition	%	1.77
	8090645	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	3.57	CHEMBL4223	Homo sapiens	Inhibition	%	3.57
	8090784	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	0.63	CHEMBL4223	Homo sapiens	Inhibition	%	0.63
	8090989	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	2.91	CHEMBL4223	Homo sapiens	Inhibition	%	2.91
	8091213	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	0.38	CHEMBL4223	Homo sapiens	Inhibition	%	0.38
	8091350	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	11.04	CHEMBL4223	Homo sapiens	Inhibition	%	11.04
	8091729	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	2.55	CHEMBL4223	Homo sapiens	Inhibition	%	2.55
	8091845	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	3.68	CHEMBL4223	Homo sapiens	Inhibition	%	3.68
	8092206	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	1.48	CHEMBL4223	Homo sapiens	Inhibition	%	1.48
	8092357	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	4.59	CHEMBL4223	Homo sapiens	Inhibition	%	4.59
	8092581	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	4.58	CHEMBL4223	Homo sapiens	Inhibition	%	4.58
	8092729	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	1.63	CHEMBL4223	Homo sapiens	Inhibition	%	1.63
	8093082	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	4.28	CHEMBL4223	Homo sapiens	Inhibition	%	4.28
	8093170	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	1.69	CHEMBL4223	Homo sapiens	Inhibition	%	1.69
	8093394	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	0.71	CHEMBL4223	Homo sapiens	Inhibition	%	0.71
	8093534	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	0.23	CHEMBL4223	Homo sapiens	Inhibition	%	0.23
	8093897	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	5.49	CHEMBL4223	Homo sapiens	Inhibition	%	5.49
	8094017	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	0.68	CHEMBL4223	Homo sapiens	Inhibition	%	0.68
	8094241	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	4.99	CHEMBL4223	Homo sapiens	Inhibition	%	4.99
	8094421	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	-0.44	CHEMBL4223	Homo sapiens	Inhibition	%	-0.44
	8094596	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	1.24	CHEMBL4223	Homo sapiens	Inhibition	%	1.24
	8094976	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	2.61	CHEMBL4223	Homo sapiens	Inhibition	%	2.61
	8095116	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	5.62	CHEMBL4223	Homo sapiens	Inhibition	%	5.62
	8095543	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	0.96	CHEMBL4223	Homo sapiens	Inhibition	%	0.96
	8095684	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	1.94	CHEMBL4223	Homo sapiens	Inhibition	%	1.94
	8096056	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	1.94	CHEMBL4223	Homo sapiens	Inhibition	%	1.94
	8096173	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	5.01	CHEMBL4223	Homo sapiens	Inhibition	%	5.01
	8096397	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	4.64	CHEMBL4223	Homo sapiens	Inhibition	%	4.64
	8096536	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	1.29	CHEMBL4223	Homo sapiens	Inhibition	%	1.29
	8096916	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	3.68	CHEMBL4223	Homo sapiens	Inhibition	%	3.68
	8097063	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	1.12	CHEMBL4223	Homo sapiens	Inhibition	%	1.12
	8097374	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	4.73	CHEMBL4223	Homo sapiens	Inhibition	%	4.73
	8097594	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	1.35	CHEMBL4223	Homo sapiens	Inhibition	%	1.35
	8097744	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	1.13	CHEMBL4223	Homo sapiens	Inhibition	%	1.13
	8098101	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	0.4	CHEMBL4223	Homo sapiens	Inhibition	%	0.4
	8098445	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	0.0	CHEMBL4223	Homo sapiens	Inhibition	%	0.0
	8098625	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	-0.05	CHEMBL4223	Homo sapiens	Inhibition	%	-0.05
	8098810	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	2.93	CHEMBL4223	Homo sapiens	Inhibition	%	2.93
	8099034	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	12.66	CHEMBL4223	Homo sapiens	Inhibition	%	12.66
	8099178	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	1.08	CHEMBL4223	Homo sapiens	Inhibition	%	1.08
	8099320	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	40.91	CHEMBL4223	Homo sapiens	Inhibition	%	40.91
	8099544	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	0.97	CHEMBL4223	Homo sapiens	Inhibition	%	0.97
	8099738	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	1.44	CHEMBL4223	Homo sapiens	Inhibition	%	1.44
	8099885	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	4.17	CHEMBL4223	Homo sapiens	Inhibition	%	4.17
	8100109	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	2.86	CHEMBL4223	Homo sapiens	Inhibition	%	2.86
	8100255	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	6.16	CHEMBL4223	Homo sapiens	Inhibition	%	6.16
	8100595	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	4.39	CHEMBL4223	Homo sapiens	Inhibition	%	4.39
	8100735	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	0.22	CHEMBL4223	Homo sapiens	Inhibition	%	0.22
	8100959	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	1.48	CHEMBL4223	Homo sapiens	Inhibition	%	1.48
	8101119	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	4.92	CHEMBL4223	Homo sapiens	Inhibition	%	4.92
	8101261	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	2.35	CHEMBL4223	Homo sapiens	Inhibition	%	2.35
	8101485	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	0.5	CHEMBL4223	Homo sapiens	Inhibition	%	0.5
	8101670	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	3.26	CHEMBL4223	Homo sapiens	Inhibition	%	3.26
	8101923	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	1.61	CHEMBL4223	Homo sapiens	Inhibition	%	1.61
	8102078	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	1.5	CHEMBL4223	Homo sapiens	Inhibition	%	1.5
	8102302	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	61.63	CHEMBL4223	Homo sapiens	Inhibition	%	61.63
	8102433	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	0.91	CHEMBL4223	Homo sapiens	Inhibition	%	0.91
	8102777	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	0.01	CHEMBL4223	Homo sapiens	Inhibition	%	0.01
	8102955	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	-0.18	CHEMBL4223	Homo sapiens	Inhibition	%	-0.18
	8103375	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	-0.38	CHEMBL4223	Homo sapiens	Inhibition	%	-0.38
	8103513	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	0.27	CHEMBL4223	Homo sapiens	Inhibition	%	0.27
	8103887	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	2.94	CHEMBL4223	Homo sapiens	Inhibition	%	2.94
	8104072	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	0.3	CHEMBL4223	Homo sapiens	Inhibition	%	0.3
	8104444	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	5.6	CHEMBL4223	Homo sapiens	Inhibition	%	5.6
	8104590	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	1.59	CHEMBL4223	Homo sapiens	Inhibition	%	1.59
	8104928	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	2.75	CHEMBL4223	Homo sapiens	Inhibition	%	2.75
	8105292	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	0.37	CHEMBL4223	Homo sapiens	Inhibition	%	0.37
	8105458	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	5.68	CHEMBL4223	Homo sapiens	Inhibition	%	5.68
	8105820	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	4.26	CHEMBL4223	Homo sapiens	Inhibition	%	4.26
	8106100	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	0.81	CHEMBL4223	Homo sapiens	Inhibition	%	0.81
	8106265	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	3.28	CHEMBL4223	Homo sapiens	Inhibition	%	3.28
	8106645	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	93.92	CHEMBL4223	Homo sapiens	Inhibition	%	93.92
	8106774	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	1.39	CHEMBL4223	Homo sapiens	Inhibition	%	1.39
	8106998	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	9.88	CHEMBL4223	Homo sapiens	Inhibition	%	9.88
	8107119	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	1.32	CHEMBL4223	Homo sapiens	Inhibition	%	1.32
	8107291	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	0.89	CHEMBL4223	Homo sapiens	Inhibition	%	0.89
	8107515	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	0.62	CHEMBL4223	Homo sapiens	Inhibition	%	0.62
	8107716	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	2.68	CHEMBL4223	Homo sapiens	Inhibition	%	2.68
	8107851	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	1.18	CHEMBL4223	Homo sapiens	Inhibition	%	1.18
	8108075	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	11.82	CHEMBL4223	Homo sapiens	Inhibition	%	11.82
	8108233	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	1.48	CHEMBL4223	Homo sapiens	Inhibition	%	1.48
	8108408	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	0.45	CHEMBL4223	Homo sapiens	Inhibition	%	0.45
	8108632	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	0.48	CHEMBL4223	Homo sapiens	Inhibition	%	0.48
	8108779	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	3.53	CHEMBL4223	Homo sapiens	Inhibition	%	3.53
	8108921	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	1.95	CHEMBL4223	Homo sapiens	Inhibition	%	1.95
	8109145	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	1.09	CHEMBL4223	Homo sapiens	Inhibition	%	1.09
	8109259	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	4.03	CHEMBL4223	Homo sapiens	Inhibition	%	4.03
	8109613	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	1.55	CHEMBL4223	Homo sapiens	Inhibition	%	1.55
	8109784	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	3.35	CHEMBL4223	Homo sapiens	Inhibition	%	3.35
	8110140	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	0.8	CHEMBL4223	Homo sapiens	Inhibition	%	0.8
	8110419	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	2.51	CHEMBL4223	Homo sapiens	Inhibition	%	2.51
	8110585	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	-0.09	CHEMBL4223	Homo sapiens	Inhibition	%	-0.09
	8110809	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	1.37	CHEMBL4223	Homo sapiens	Inhibition	%	1.37
	8110967	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-0.39	CHEMBL4223	Homo sapiens	Inhibition	%	-0.39
	8111314	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	-0.04	CHEMBL4223	Homo sapiens	Inhibition	%	-0.04
	8111441	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	1.39	CHEMBL4223	Homo sapiens	Inhibition	%	1.39
	8111831	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	-0.62	CHEMBL4223	Homo sapiens	Inhibition	%	-0.62
	8112036	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	-0.04	CHEMBL4223	Homo sapiens	Inhibition	%	-0.04
	8112397	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.1	CHEMBL4223	Homo sapiens	Inhibition	%	0.1
	8112565	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	3.75	CHEMBL4223	Homo sapiens	Inhibition	%	3.75
	8112961	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	-0.85	CHEMBL4223	Homo sapiens	Inhibition	%	-0.85
	8113113	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	3.93	CHEMBL4223	Homo sapiens	Inhibition	%	3.93
	8113473	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	0.79	CHEMBL4223	Homo sapiens	Inhibition	%	0.79
	8113597	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	2.34	CHEMBL4223	Homo sapiens	Inhibition	%	2.34
	8113821	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	3.3	CHEMBL4223	Homo sapiens	Inhibition	%	3.3
	8113937	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-0.1	CHEMBL4223	Homo sapiens	Inhibition	%	-0.1
	8114113	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	3.66	CHEMBL4223	Homo sapiens	Inhibition	%	3.66
	8114337	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	2.67	CHEMBL4223	Homo sapiens	Inhibition	%	2.67
	8114469	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	4.62	CHEMBL4223	Homo sapiens	Inhibition	%	4.62
	8114745	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	0.19	CHEMBL4223	Homo sapiens	Inhibition	%	0.19
	8115135	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	2.63	CHEMBL4223	Homo sapiens	Inhibition	%	2.63
	8115300	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-0.01	CHEMBL4223	Homo sapiens	Inhibition	%	-0.01
	8115644	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	2.98	CHEMBL4223	Homo sapiens	Inhibition	%	2.98
	8115777	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	-0.88	CHEMBL4223	Homo sapiens	Inhibition	%	-0.88
	8116001	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	0.68	CHEMBL4223	Homo sapiens	Inhibition	%	0.68
	8116160	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	-0.08	CHEMBL4223	Homo sapiens	Inhibition	%	-0.08
	8116363	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	3.76	CHEMBL4223	Homo sapiens	Inhibition	%	3.76
	8116721	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	-0.17	CHEMBL4223	Homo sapiens	Inhibition	%	-0.17
	8116893	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	2.22	CHEMBL4223	Homo sapiens	Inhibition	%	2.22
	8117117	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	14.18	CHEMBL4223	Homo sapiens	Inhibition	%	14.18
	8117288	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	0.98	CHEMBL4223	Homo sapiens	Inhibition	%	0.98
	8117446	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	3.46	CHEMBL4223	Homo sapiens	Inhibition	%	3.46
	8117800	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	0.96	CHEMBL4223	Homo sapiens	Inhibition	%	0.96
	8118162	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	2.06	CHEMBL4223	Homo sapiens	Inhibition	%	2.06
	8118278	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	1.4	CHEMBL4223	Homo sapiens	Inhibition	%	1.4
	8118674	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	3.25	CHEMBL4223	Homo sapiens	Inhibition	%	3.25
	8118810	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	4.23	CHEMBL4223	Homo sapiens	Inhibition	%	4.23
	8119034	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	3.25	CHEMBL4223	Homo sapiens	Inhibition	%	3.25
	8119081	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	0.68	CHEMBL4223	Homo sapiens	Inhibition	%	0.68
	8119305	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	0.21	CHEMBL4223	Homo sapiens	Inhibition	%	0.21
	8119464	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	19.15	CHEMBL4223	Homo sapiens	Inhibition	%	19.15
	8119631	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	0.61	CHEMBL4223	Homo sapiens	Inhibition	%	0.61
	8119855	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	1.2	CHEMBL4223	Homo sapiens	Inhibition	%	1.2
	8119974	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	-0.58	CHEMBL4223	Homo sapiens	Inhibition	%	-0.58
	8120337	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	-1.35	CHEMBL4223	Homo sapiens	Inhibition	%	-1.35
	8120497	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	-0.01	CHEMBL4223	Homo sapiens	Inhibition	%	-0.01
	8120698	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	0.94	CHEMBL4223	Homo sapiens	Inhibition	%	0.94
	8120922	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	2.25	CHEMBL4223	Homo sapiens	Inhibition	%	2.25
	8121050	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	-0.9	CHEMBL4223	Homo sapiens	Inhibition	%	-0.9
	8121446	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	1.3	CHEMBL4223	Homo sapiens	Inhibition	%	1.3
	8121613	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	-0.74	CHEMBL4223	Homo sapiens	Inhibition	%	-0.74
	8121776	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	3.09	CHEMBL4223	Homo sapiens	Inhibition	%	3.09
	8122000	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	2.57	CHEMBL4223	Homo sapiens	Inhibition	%	2.57
	8122121	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	2.22	CHEMBL4223	Homo sapiens	Inhibition	%	2.22
	8122483	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	2.77	CHEMBL4223	Homo sapiens	Inhibition	%	2.77
	8122603	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	2.55	CHEMBL4223	Homo sapiens	Inhibition	%	2.55
	8122827	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	3.5	CHEMBL4223	Homo sapiens	Inhibition	%	3.5
	8122994	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	4.78	CHEMBL4223	Homo sapiens	Inhibition	%	4.78
	8123360	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	3.08	CHEMBL4223	Homo sapiens	Inhibition	%	3.08
	8123638	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	1.0	CHEMBL4223	Homo sapiens	Inhibition	%	1.0
	8123788	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	0.86	CHEMBL4223	Homo sapiens	Inhibition	%	0.86
	8124179	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-0.1	CHEMBL4223	Homo sapiens	Inhibition	%	-0.1
	8124298	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	2.43	CHEMBL4223	Homo sapiens	Inhibition	%	2.43
	8124661	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	-0.65	CHEMBL4223	Homo sapiens	Inhibition	%	-0.65
	8124826	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	0.07	CHEMBL4223	Homo sapiens	Inhibition	%	0.07
	8125050	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-1.26	CHEMBL4223	Homo sapiens	Inhibition	%	-1.26
	8125251	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	0.83	CHEMBL4223	Homo sapiens	Inhibition	%	0.83
	8125381	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	2.77	CHEMBL4223	Homo sapiens	Inhibition	%	2.77
	8125773	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	1.99	CHEMBL4223	Homo sapiens	Inhibition	%	1.99
	8125937	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	-0.31	CHEMBL4223	Homo sapiens	Inhibition	%	-0.31
	8126325	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	3.29	CHEMBL4223	Homo sapiens	Inhibition	%	3.29
	8126440	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	2.3	CHEMBL4223	Homo sapiens	Inhibition	%	2.3
	8126664	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	11.81	CHEMBL4223	Homo sapiens	Inhibition	%	11.81
	8126800	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	2.34	CHEMBL4223	Homo sapiens	Inhibition	%	2.34
	8127146	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	2.37	CHEMBL4223	Homo sapiens	Inhibition	%	2.37
	8127313	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	3.94	CHEMBL4223	Homo sapiens	Inhibition	%	3.94
	8127679	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	3.46	CHEMBL4223	Homo sapiens	Inhibition	%	3.46
	8127967	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	0.9	CHEMBL4223	Homo sapiens	Inhibition	%	0.9
	8128119	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	3.44	CHEMBL4223	Homo sapiens	Inhibition	%	3.44
	8128510	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	0.9	CHEMBL4223	Homo sapiens	Inhibition	%	0.9
	8128629	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	0.08	CHEMBL4223	Homo sapiens	Inhibition	%	0.08
	8128853	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	4.45	CHEMBL4223	Homo sapiens	Inhibition	%	4.45
	8128990	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	0.72	CHEMBL4223	Homo sapiens	Inhibition	%	0.72
	8129385	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-1.02	CHEMBL4223	Homo sapiens	Inhibition	%	-1.02
	8129574	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	-0.45	CHEMBL4223	Homo sapiens	Inhibition	%	-0.45
	8129713	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-0.62	CHEMBL4223	Homo sapiens	Inhibition	%	-0.62
	8129937	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-0.08	CHEMBL4223	Homo sapiens	Inhibition	%	-0.08
	8130098	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	1.82	CHEMBL4223	Homo sapiens	Inhibition	%	1.82
	8130270	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	0.31	CHEMBL4223	Homo sapiens	Inhibition	%	0.31
	8130494	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	1.25	CHEMBL4223	Homo sapiens	Inhibition	%	1.25
	8130654	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	2.63	CHEMBL4223	Homo sapiens	Inhibition	%	2.63
	8130994	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	2.69	CHEMBL4223	Homo sapiens	Inhibition	%	2.69
	8131133	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	3.93	CHEMBL4223	Homo sapiens	Inhibition	%	3.93
	8131477	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	2.86	CHEMBL4223	Homo sapiens	Inhibition	%	2.86
	8131644	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	10.51	CHEMBL4223	Homo sapiens	Inhibition	%	10.51
	8131868	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	46.39	CHEMBL4223	Homo sapiens	Inhibition	%	46.39
	8132009	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	4.28	CHEMBL4223	Homo sapiens	Inhibition	%	4.28
	8132295	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	0.75	CHEMBL4223	Homo sapiens	Inhibition	%	0.75
	8132442	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	-0.14	CHEMBL4223	Homo sapiens	Inhibition	%	-0.14
	8132666	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	1.73	CHEMBL4223	Homo sapiens	Inhibition	%	1.73
	8132834	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	0.04	CHEMBL4223	Homo sapiens	Inhibition	%	0.04
	8133179	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	0.01	CHEMBL4223	Homo sapiens	Inhibition	%	0.01
	8133317	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	0.95	CHEMBL4223	Homo sapiens	Inhibition	%	0.95
	8133713	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	0.49	CHEMBL4223	Homo sapiens	Inhibition	%	0.49
	8133893	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	1.47	CHEMBL4223	Homo sapiens	Inhibition	%	1.47
	8134265	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	0.49	CHEMBL4223	Homo sapiens	Inhibition	%	0.49
	8134425	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	1.72	CHEMBL4223	Homo sapiens	Inhibition	%	1.72
	8134833	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-0.66	CHEMBL4223	Homo sapiens	Inhibition	%	-0.66
	8134993	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	3.76	CHEMBL4223	Homo sapiens	Inhibition	%	3.76
	8135332	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	2.33	CHEMBL4223	Homo sapiens	Inhibition	%	2.33
	8135473	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	3.08	CHEMBL4223	Homo sapiens	Inhibition	%	3.08
	8135697	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	3.1	CHEMBL4223	Homo sapiens	Inhibition	%	3.1
	8135818	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	2.03	CHEMBL4223	Homo sapiens	Inhibition	%	2.03
	8136210	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	2.06	CHEMBL4223	Homo sapiens	Inhibition	%	2.06
	8136354	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	21.22	CHEMBL4223	Homo sapiens	Inhibition	%	21.22
	8136644	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-0.14	CHEMBL4223	Homo sapiens	Inhibition	%	-0.14
	8137003	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	1.03	CHEMBL4223	Homo sapiens	Inhibition	%	1.03
	8137166	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	0.05	CHEMBL4223	Homo sapiens	Inhibition	%	0.05
	8137510	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	1.32	CHEMBL4223	Homo sapiens	Inhibition	%	1.32
	8137658	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	0.59	CHEMBL4223	Homo sapiens	Inhibition	%	0.59
	8137882	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	-2.06	CHEMBL4223	Homo sapiens	Inhibition	%	-2.06
	8138048	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-0.85	CHEMBL4223	Homo sapiens	Inhibition	%	-0.85
	8138227	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	4.04	CHEMBL4223	Homo sapiens	Inhibition	%	4.04
	8138451	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	1.71	CHEMBL4223	Homo sapiens	Inhibition	%	1.71
	8138599	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	0.16	CHEMBL4223	Homo sapiens	Inhibition	%	0.16
	8138757	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	0.1	CHEMBL4223	Homo sapiens	Inhibition	%	0.1
	8138981	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	2.51	CHEMBL4223	Homo sapiens	Inhibition	%	2.51
	8139166	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	0.76	CHEMBL4223	Homo sapiens	Inhibition	%	0.76
	8139325	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	1.59	CHEMBL4223	Homo sapiens	Inhibition	%	1.59
	8139549	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	4.57	CHEMBL4223	Homo sapiens	Inhibition	%	4.57
	8139663	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	3.35	CHEMBL4223	Homo sapiens	Inhibition	%	3.35
	8140028	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	4.01	CHEMBL4223	Homo sapiens	Inhibition	%	4.01
	8140151	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	2.78	CHEMBL4223	Homo sapiens	Inhibition	%	2.78
	8140375	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	2.11	CHEMBL4223	Homo sapiens	Inhibition	%	2.11
	8140534	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	3.36	CHEMBL4223	Homo sapiens	Inhibition	%	3.36
	8140677	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	3.01	CHEMBL4223	Homo sapiens	Inhibition	%	3.01
	8140901	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	4.4	CHEMBL4223	Homo sapiens	Inhibition	%	4.4
	8140979	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	1.16	CHEMBL4223	Homo sapiens	Inhibition	%	1.16
	8141203	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	0.34	CHEMBL4223	Homo sapiens	Inhibition	%	0.34
	8141333	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	7.47	CHEMBL4223	Homo sapiens	Inhibition	%	7.47
	8141493	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	0.57	CHEMBL4223	Homo sapiens	Inhibition	%	0.57
	8141717	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	3.14	CHEMBL4223	Homo sapiens	Inhibition	%	3.14
	8141836	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	1.71	CHEMBL4223	Homo sapiens	Inhibition	%	1.71
	8142221	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	0.87	CHEMBL4223	Homo sapiens	Inhibition	%	0.87
	8142389	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-1.09	CHEMBL4223	Homo sapiens	Inhibition	%	-1.09
	8142789	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	0.38	CHEMBL4223	Homo sapiens	Inhibition	%	0.38
	8142938	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	0.01	CHEMBL4223	Homo sapiens	Inhibition	%	0.01
	8143317	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	0.8	CHEMBL4223	Homo sapiens	Inhibition	%	0.8
	8143504	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	2.55	CHEMBL4223	Homo sapiens	Inhibition	%	2.55
	8143887	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	5.0	CHEMBL4223	Homo sapiens	Inhibition	%	5.0
	8144001	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	2.29	CHEMBL4223	Homo sapiens	Inhibition	%	2.29
	8144225	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	2.64	CHEMBL4223	Homo sapiens	Inhibition	%	2.64
	8144364	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	4.89	CHEMBL4223	Homo sapiens	Inhibition	%	4.89
	8144718	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	1.88	CHEMBL4223	Homo sapiens	Inhibition	%	1.88
	8144871	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	2.42	CHEMBL4223	Homo sapiens	Inhibition	%	2.42
	8145232	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	4.29	CHEMBL4223	Homo sapiens	Inhibition	%	4.29
	8145545	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	0.69	CHEMBL4223	Homo sapiens	Inhibition	%	0.69
	8145669	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	0.93	CHEMBL4223	Homo sapiens	Inhibition	%	0.93
	8146054	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	3.86	CHEMBL4223	Homo sapiens	Inhibition	%	3.86
	8146174	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	17.32	CHEMBL4223	Homo sapiens	Inhibition	%	17.32
	8146398	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	0.1	CHEMBL4223	Homo sapiens	Inhibition	%	0.1
	8146558	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	3.44	CHEMBL4223	Homo sapiens	Inhibition	%	3.44
	8146725	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-0.4	CHEMBL4223	Homo sapiens	Inhibition	%	-0.4
	8146949	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	0.5	CHEMBL4223	Homo sapiens	Inhibition	%	0.5
	8147118	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	-0.83	CHEMBL4223	Homo sapiens	Inhibition	%	-0.83
	8147260	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-0.89	CHEMBL4223	Homo sapiens	Inhibition	%	-0.89
	8147484	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	1.24	CHEMBL4223	Homo sapiens	Inhibition	%	1.24
	8147637	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	1.06	CHEMBL4223	Homo sapiens	Inhibition	%	1.06
	8147824	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	4.15	CHEMBL4223	Homo sapiens	Inhibition	%	4.15
	8148048	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	1.55	CHEMBL4223	Homo sapiens	Inhibition	%	1.55
	8148206	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	30.13	CHEMBL4223	Homo sapiens	Inhibition	%	30.13
	8148544	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	3.25	CHEMBL4223	Homo sapiens	Inhibition	%	3.25
	8148683	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	2.96	CHEMBL4223	Homo sapiens	Inhibition	%	2.96
	8149045	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	2.8	CHEMBL4223	Homo sapiens	Inhibition	%	2.8
	8149204	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	2.21	CHEMBL4223	Homo sapiens	Inhibition	%	2.21
	8149428	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	1.47	CHEMBL4223	Homo sapiens	Inhibition	%	1.47
	8149562	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	3.5	CHEMBL4223	Homo sapiens	Inhibition	%	3.5
	8149884	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	2.61	CHEMBL4223	Homo sapiens	Inhibition	%	2.61
	8150009	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	1.05	CHEMBL4223	Homo sapiens	Inhibition	%	1.05
	8150233	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	0.19	CHEMBL4223	Homo sapiens	Inhibition	%	0.19
	8150393	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	14.5	CHEMBL4223	Homo sapiens	Inhibition	%	14.5
	8150737	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	0.7	CHEMBL4223	Homo sapiens	Inhibition	%	0.7
	8150902	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	1.91	CHEMBL4223	Homo sapiens	Inhibition	%	1.91
	8151289	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-2.56	CHEMBL4223	Homo sapiens	Inhibition	%	-2.56
	8151466	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	3.98	CHEMBL4223	Homo sapiens	Inhibition	%	3.98
	8151828	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	0.8	CHEMBL4223	Homo sapiens	Inhibition	%	0.8
	8151982	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	1.12	CHEMBL4223	Homo sapiens	Inhibition	%	1.12
	8152394	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	7.02	CHEMBL4223	Homo sapiens	Inhibition	%	7.02
	8152552	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	3.95	CHEMBL4223	Homo sapiens	Inhibition	%	3.95
	8152890	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	20.61	CHEMBL4223	Homo sapiens	Inhibition	%	20.61
	8153029	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	2.13	CHEMBL4223	Homo sapiens	Inhibition	%	2.13
	8153253	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	2.16	CHEMBL4223	Homo sapiens	Inhibition	%	2.16
	8153390	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	4.67	CHEMBL4223	Homo sapiens	Inhibition	%	4.67
	8153771	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	2.48	CHEMBL4223	Homo sapiens	Inhibition	%	2.48
	8153904	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	3.22	CHEMBL4223	Homo sapiens	Inhibition	%	3.22
	8154225	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	13.1	CHEMBL4223	Homo sapiens	Inhibition	%	13.1
	8154575	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	2.9	CHEMBL4223	Homo sapiens	Inhibition	%	2.9
	8154734	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	-0.32	CHEMBL4223	Homo sapiens	Inhibition	%	-0.32
	8155078	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	0.07	CHEMBL4223	Homo sapiens	Inhibition	%	0.07
	8155254	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	8.84	CHEMBL4223	Homo sapiens	Inhibition	%	8.84
	8155639	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-4.36	CHEMBL4223	Homo sapiens	Inhibition	%	-4.36
	8155817	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	1.9	CHEMBL4223	Homo sapiens	Inhibition	%	1.9
	8156179	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	2.02	CHEMBL4223	Homo sapiens	Inhibition	%	2.02
	8156391	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	0.85	CHEMBL4223	Homo sapiens	Inhibition	%	0.85
	8156765	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	14.24	CHEMBL4223	Homo sapiens	Inhibition	%	14.24
	8156908	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	1.2	CHEMBL4223	Homo sapiens	Inhibition	%	1.2
	8157252	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	1.26	CHEMBL4223	Homo sapiens	Inhibition	%	1.26
	8157617	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	1.36	CHEMBL4223	Homo sapiens	Inhibition	%	1.36
	8157747	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	2.1	CHEMBL4223	Homo sapiens	Inhibition	%	2.1
	8158132	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	2.07	CHEMBL4223	Homo sapiens	Inhibition	%	2.07
	8158382	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	2.3	CHEMBL4223	Homo sapiens	Inhibition	%	2.3
	8158540	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	2.28	CHEMBL4223	Homo sapiens	Inhibition	%	2.28
	8158764	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	2.38	CHEMBL4223	Homo sapiens	Inhibition	%	2.38
	8158933	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	2.44	CHEMBL4223	Homo sapiens	Inhibition	%	2.44
	8159068	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	0.68	CHEMBL4223	Homo sapiens	Inhibition	%	0.68
	8159292	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	3.74	CHEMBL4223	Homo sapiens	Inhibition	%	3.74
	8159412	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	7.85	CHEMBL4223	Homo sapiens	Inhibition	%	7.85
	8159767	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	2.04	CHEMBL4223	Homo sapiens	Inhibition	%	2.04
	8159908	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	0.91	CHEMBL4223	Homo sapiens	Inhibition	%	0.91
	8160132	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	0.2	CHEMBL4223	Homo sapiens	Inhibition	%	0.2
	8160269	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	2.9	CHEMBL4223	Homo sapiens	Inhibition	%	2.9
	8160419	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	3.88	CHEMBL4223	Homo sapiens	Inhibition	%	3.88
	8160643	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-0.89	CHEMBL4223	Homo sapiens	Inhibition	%	-0.89
	8160713	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	2.14	CHEMBL4223	Homo sapiens	Inhibition	%	2.14
	8160937	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	0.91	CHEMBL4223	Homo sapiens	Inhibition	%	0.91
	8161087	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	1.69	CHEMBL4223	Homo sapiens	Inhibition	%	1.69
	8161230	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	1.36	CHEMBL4223	Homo sapiens	Inhibition	%	1.36
	8161454	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	1.69	CHEMBL4223	Homo sapiens	Inhibition	%	1.69
	8161579	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	6.47	CHEMBL4223	Homo sapiens	Inhibition	%	6.47
	8161941	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	0.31	CHEMBL4223	Homo sapiens	Inhibition	%	0.31
	8162071	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	1.2	CHEMBL4223	Homo sapiens	Inhibition	%	1.2
	8162295	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	1.76	CHEMBL4223	Homo sapiens	Inhibition	%	1.76
	8162455	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-0.13	CHEMBL4223	Homo sapiens	Inhibition	%	-0.13
	8162708	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	3.16	CHEMBL4223	Homo sapiens	Inhibition	%	3.16
	8163080	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	4.28	CHEMBL4223	Homo sapiens	Inhibition	%	4.28
	8163249	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	0.71	CHEMBL4223	Homo sapiens	Inhibition	%	0.71
	8163607	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	2.3	CHEMBL4223	Homo sapiens	Inhibition	%	2.3
	8163730	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	1.6	CHEMBL4223	Homo sapiens	Inhibition	%	1.6
	8163954	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	2.05	CHEMBL4223	Homo sapiens	Inhibition	%	2.05
	8164088	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	7.2	CHEMBL4223	Homo sapiens	Inhibition	%	7.2
	8164452	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	0.92	CHEMBL4223	Homo sapiens	Inhibition	%	0.92
	8164607	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	1.5	CHEMBL4223	Homo sapiens	Inhibition	%	1.5
	8164975	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	5.08	CHEMBL4223	Homo sapiens	Inhibition	%	5.08
	8165269	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	2.49	CHEMBL4223	Homo sapiens	Inhibition	%	2.49
	8165410	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	0.89	CHEMBL4223	Homo sapiens	Inhibition	%	0.89
	8165777	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	3.19	CHEMBL4223	Homo sapiens	Inhibition	%	3.19
	8165903	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	0.88	CHEMBL4223	Homo sapiens	Inhibition	%	0.88
	8166127	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	0.39	CHEMBL4223	Homo sapiens	Inhibition	%	0.39
	8166265	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	1.05	CHEMBL4223	Homo sapiens	Inhibition	%	1.05
	8166619	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	2.98	CHEMBL4223	Homo sapiens	Inhibition	%	2.98
	8166720	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	1.94	CHEMBL4223	Homo sapiens	Inhibition	%	1.94
	8166944	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	11.51	CHEMBL4223	Homo sapiens	Inhibition	%	11.51
	8167032	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	2.04	CHEMBL4223	Homo sapiens	Inhibition	%	2.04
	8167397	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	4.47	CHEMBL4223	Homo sapiens	Inhibition	%	4.47
	8167561	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	2.64	CHEMBL4223	Homo sapiens	Inhibition	%	2.64
	8167918	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	2.61	CHEMBL4223	Homo sapiens	Inhibition	%	2.61
	8168266	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	1.9	CHEMBL4223	Homo sapiens	Inhibition	%	1.9
	8168407	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	20.54	CHEMBL4223	Homo sapiens	Inhibition	%	20.54
	8168767	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	1.66	CHEMBL4223	Homo sapiens	Inhibition	%	1.66
	8168931	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	5.2	CHEMBL4223	Homo sapiens	Inhibition	%	5.2
	8169297	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	1.21	CHEMBL4223	Homo sapiens	Inhibition	%	1.21
	8169601	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	2.98	CHEMBL4223	Homo sapiens	Inhibition	%	2.98
	8169735	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	1.41	CHEMBL4223	Homo sapiens	Inhibition	%	1.41
	8169959	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	0.33	CHEMBL4223	Homo sapiens	Inhibition	%	0.33
	8170104	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	1.36	CHEMBL4223	Homo sapiens	Inhibition	%	1.36
	8170453	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	1.71	CHEMBL4223	Homo sapiens	Inhibition	%	1.71
	8170593	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	2.07	CHEMBL4223	Homo sapiens	Inhibition	%	2.07
	8170952	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	16.51	CHEMBL4223	Homo sapiens	Inhibition	%	16.51
	8171149	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	5.78	CHEMBL4223	Homo sapiens	Inhibition	%	5.78
	8171366	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	2.25	CHEMBL4223	Homo sapiens	Inhibition	%	2.25
	8171590	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	0.86	CHEMBL4223	Homo sapiens	Inhibition	%	0.86
	8171731	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	2.92	CHEMBL4223	Homo sapiens	Inhibition	%	2.92
	8171884	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	1.48	CHEMBL4223	Homo sapiens	Inhibition	%	1.48
	8172108	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	1.84	CHEMBL4223	Homo sapiens	Inhibition	%	1.84
	8172240	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	1.89	CHEMBL4223	Homo sapiens	Inhibition	%	1.89
	8172592	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	1.47	CHEMBL4223	Homo sapiens	Inhibition	%	1.47
	8172734	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	4.1	CHEMBL4223	Homo sapiens	Inhibition	%	4.1
	8172958	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	3.97	CHEMBL4223	Homo sapiens	Inhibition	%	3.97
	8173094	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	0.47	CHEMBL4223	Homo sapiens	Inhibition	%	0.47
	8173259	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	15.98	CHEMBL4223	Homo sapiens	Inhibition	%	15.98
	8173483	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	2.72	CHEMBL4223	Homo sapiens	Inhibition	%	2.72
	8173624	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	1.03	CHEMBL4223	Homo sapiens	Inhibition	%	1.03
	8173935	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	0.73	CHEMBL4223	Homo sapiens	Inhibition	%	0.73
	8174291	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	2.26	CHEMBL4223	Homo sapiens	Inhibition	%	2.26
	8174439	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	4.51	CHEMBL4223	Homo sapiens	Inhibition	%	4.51
	8174785	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	0.62	CHEMBL4223	Homo sapiens	Inhibition	%	0.62
	8174928	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	1.13	CHEMBL4223	Homo sapiens	Inhibition	%	1.13
	8175152	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	1.21	CHEMBL4223	Homo sapiens	Inhibition	%	1.21
	8175288	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	0.49	CHEMBL4223	Homo sapiens	Inhibition	%	0.49
	8175544	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	2.78	CHEMBL4223	Homo sapiens	Inhibition	%	2.78
	8175931	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	3.71	CHEMBL4223	Homo sapiens	Inhibition	%	3.71
	8176084	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	8.45	CHEMBL4223	Homo sapiens	Inhibition	%	8.45
	8176457	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	2.7	CHEMBL4223	Homo sapiens	Inhibition	%	2.7
	8176589	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	6.33	CHEMBL4223	Homo sapiens	Inhibition	%	6.33
	8176813	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	8.07	CHEMBL4223	Homo sapiens	Inhibition	%	8.07
	8176943	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	1.69	CHEMBL4223	Homo sapiens	Inhibition	%	1.69
	8177309	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	6.95	CHEMBL4223	Homo sapiens	Inhibition	%	6.95
	8177447	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	1.64	CHEMBL4223	Homo sapiens	Inhibition	%	1.64
	8177835	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	5.75	CHEMBL4223	Homo sapiens	Inhibition	%	5.75
	8177975	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	1.84	CHEMBL4223	Homo sapiens	Inhibition	%	1.84
	8178199	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	5.49	CHEMBL4223	Homo sapiens	Inhibition	%	5.49
	8178287	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	3.44	CHEMBL4223	Homo sapiens	Inhibition	%	3.44
	8178638	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	6.54	CHEMBL4223	Homo sapiens	Inhibition	%	6.54
	8178787	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	1.88	CHEMBL4223	Homo sapiens	Inhibition	%	1.88
	8179011	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	0.07	CHEMBL4223	Homo sapiens	Inhibition	%	0.07
	8179134	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	1.7	CHEMBL4223	Homo sapiens	Inhibition	%	1.7
	8179502	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	1.15	CHEMBL4223	Homo sapiens	Inhibition	%	1.15
	8179639	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	1.12	CHEMBL4223	Homo sapiens	Inhibition	%	1.12
	8179896	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	3.04	CHEMBL4223	Homo sapiens	Inhibition	%	3.04
	8180120	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	2.63	CHEMBL4223	Homo sapiens	Inhibition	%	2.63
	8180274	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	11.59	CHEMBL4223	Homo sapiens	Inhibition	%	11.59
	8180430	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	1.83	CHEMBL4223	Homo sapiens	Inhibition	%	1.83
	8180654	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	1.83	CHEMBL4223	Homo sapiens	Inhibition	%	1.83
	8180802	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	1.57	CHEMBL4223	Homo sapiens	Inhibition	%	1.57
	8181159	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	88.95	CHEMBL4223	Homo sapiens	Inhibition	%	88.95
	8181290	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	2.79	CHEMBL4223	Homo sapiens	Inhibition	%	2.79
	8181654	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	33.82	CHEMBL4223	Homo sapiens	Inhibition	%	33.82
	8181793	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	-0.26	CHEMBL4223	Homo sapiens	Inhibition	%	-0.26
	8182017	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	0.68	CHEMBL4223	Homo sapiens	Inhibition	%	0.68
	8182180	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	2.59	CHEMBL4223	Homo sapiens	Inhibition	%	2.59
	8182544	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	0.45	CHEMBL4223	Homo sapiens	Inhibition	%	0.45
	8182636	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	1.37	CHEMBL4223	Homo sapiens	Inhibition	%	1.37
	8182860	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	1.4	CHEMBL4223	Homo sapiens	Inhibition	%	1.4
	8182982	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	4.95	CHEMBL4223	Homo sapiens	Inhibition	%	4.95
	8183355	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	4.05	CHEMBL4223	Homo sapiens	Inhibition	%	4.05
	8183484	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	1.79	CHEMBL4223	Homo sapiens	Inhibition	%	1.79
	8183708	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	1.38	CHEMBL4223	Homo sapiens	Inhibition	%	1.38
	8183850	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	0.41	CHEMBL4223	Homo sapiens	Inhibition	%	0.41
	8183986	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	0.49	CHEMBL4223	Homo sapiens	Inhibition	%	0.49
	8184210	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	2.46	CHEMBL4223	Homo sapiens	Inhibition	%	2.46
	8184476	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	2.86	CHEMBL4223	Homo sapiens	Inhibition	%	2.86
	8184623	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	2.14	CHEMBL4223	Homo sapiens	Inhibition	%	2.14
	8185004	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	5.64	CHEMBL4223	Homo sapiens	Inhibition	%	5.64
	8185153	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	2.09	CHEMBL4223	Homo sapiens	Inhibition	%	2.09
	8185508	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	95.66	CHEMBL4223	Homo sapiens	Inhibition	%	95.66
	8185639	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	1.09	CHEMBL4223	Homo sapiens	Inhibition	%	1.09
	8185863	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	0.76	CHEMBL4223	Homo sapiens	Inhibition	%	0.76
	8186002	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	2.92	CHEMBL4223	Homo sapiens	Inhibition	%	2.92
	8186367	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	0.7	CHEMBL4223	Homo sapiens	Inhibition	%	0.7
	8186531	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	2.66	CHEMBL4223	Homo sapiens	Inhibition	%	2.66
	8186894	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	0.39	CHEMBL4223	Homo sapiens	Inhibition	%	0.39
	8187216	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	2.65	CHEMBL4223	Homo sapiens	Inhibition	%	2.65
	8187340	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	1.58	CHEMBL4223	Homo sapiens	Inhibition	%	1.58
	8187564	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	1.94	CHEMBL4223	Homo sapiens	Inhibition	%	1.94
	8187712	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	26.93	CHEMBL4223	Homo sapiens	Inhibition	%	26.93
	8188065	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	2.35	CHEMBL4223	Homo sapiens	Inhibition	%	2.35
	8188208	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	1.76	CHEMBL4223	Homo sapiens	Inhibition	%	1.76
	8188567	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	0.47	CHEMBL4223	Homo sapiens	Inhibition	%	0.47
	8188841	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	3.11	CHEMBL4223	Homo sapiens	Inhibition	%	3.11
	8188989	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	2.25	CHEMBL4223	Homo sapiens	Inhibition	%	2.25
	8189213	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	2.61	CHEMBL4223	Homo sapiens	Inhibition	%	2.61
	8189369	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	25.43	CHEMBL4223	Homo sapiens	Inhibition	%	25.43
	8189518	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	1.61	CHEMBL4223	Homo sapiens	Inhibition	%	1.61
	8189742	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	1.03	CHEMBL4223	Homo sapiens	Inhibition	%	1.03
	8189874	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	5.22	CHEMBL4223	Homo sapiens	Inhibition	%	5.22
	8190230	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	0.6	CHEMBL4223	Homo sapiens	Inhibition	%	0.6
	8190370	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	2.17	CHEMBL4223	Homo sapiens	Inhibition	%	2.17
	8190594	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	3.05	CHEMBL4223	Homo sapiens	Inhibition	%	3.05
	8190731	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	2.26	CHEMBL4223	Homo sapiens	Inhibition	%	2.26
	8190895	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	2.66	CHEMBL4223	Homo sapiens	Inhibition	%	2.66
	8191119	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	0.27	CHEMBL4223	Homo sapiens	Inhibition	%	0.27
	8191257	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	0.22	CHEMBL4223	Homo sapiens	Inhibition	%	0.22
	8191577	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	14.2	CHEMBL4223	Homo sapiens	Inhibition	%	14.2
	8191923	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	1.99	CHEMBL4223	Homo sapiens	Inhibition	%	1.99
	8192072	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	0.72	CHEMBL4223	Homo sapiens	Inhibition	%	0.72
	8192425	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	0.66	CHEMBL4223	Homo sapiens	Inhibition	%	0.66
	8192569	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	1.45	CHEMBL4223	Homo sapiens	Inhibition	%	1.45
	8192793	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	1.01	CHEMBL4223	Homo sapiens	Inhibition	%	1.01
	8192929	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	3.05	CHEMBL4223	Homo sapiens	Inhibition	%	3.05
	8193201	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	4.91	CHEMBL4223	Homo sapiens	Inhibition	%	4.91
	8193570	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	1.87	CHEMBL4223	Homo sapiens	Inhibition	%	1.87
	8193727	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	3.47	CHEMBL4223	Homo sapiens	Inhibition	%	3.47
	8194100	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-0.17	CHEMBL4223	Homo sapiens	Inhibition	%	-0.17
	8194231	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	4.16	CHEMBL4223	Homo sapiens	Inhibition	%	4.16
	8194455	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	7.74	CHEMBL4223	Homo sapiens	Inhibition	%	7.74
	8194586	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	2.12	CHEMBL4223	Homo sapiens	Inhibition	%	2.12
	8194953	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	7.89	CHEMBL4223	Homo sapiens	Inhibition	%	7.89
	8195086	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	0.17	CHEMBL4223	Homo sapiens	Inhibition	%	0.17
	8195474	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	1.7	CHEMBL4223	Homo sapiens	Inhibition	%	1.7
	8195613	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	0.97	CHEMBL4223	Homo sapiens	Inhibition	%	0.97
	8195837	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	2.25	CHEMBL4223	Homo sapiens	Inhibition	%	2.25
	8195935	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	-0.24	CHEMBL4223	Homo sapiens	Inhibition	%	-0.24
	8196276	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	2.62	CHEMBL4223	Homo sapiens	Inhibition	%	2.62
	8196426	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	2.05	CHEMBL4223	Homo sapiens	Inhibition	%	2.05
	8196650	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	3.09	CHEMBL4223	Homo sapiens	Inhibition	%	3.09
	8196778	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	1.5	CHEMBL4223	Homo sapiens	Inhibition	%	1.5
	8197143	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	1.8	CHEMBL4223	Homo sapiens	Inhibition	%	1.8
	8197280	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	-0.17	CHEMBL4223	Homo sapiens	Inhibition	%	-0.17
	8197555	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	1.66	CHEMBL4223	Homo sapiens	Inhibition	%	1.66
	8197919	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	2.63	CHEMBL4223	Homo sapiens	Inhibition	%	2.63
	8198076	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	5.58	CHEMBL4223	Homo sapiens	Inhibition	%	5.58
	8198438	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	0.0	CHEMBL4223	Homo sapiens	Inhibition	%	0.0
	8198792	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	19.92	CHEMBL4223	Homo sapiens	Inhibition	%	19.92
	8198923	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	2.55	CHEMBL4223	Homo sapiens	Inhibition	%	2.55
	8199295	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	-0.33	CHEMBL4223	Homo sapiens	Inhibition	%	-0.33
	8199429	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	1.02	CHEMBL4223	Homo sapiens	Inhibition	%	1.02
	8199653	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	1.23	CHEMBL4223	Homo sapiens	Inhibition	%	1.23
	8199816	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	7.16	CHEMBL4223	Homo sapiens	Inhibition	%	7.16
	8200178	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	2.05	CHEMBL4223	Homo sapiens	Inhibition	%	2.05
	8200282	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	1.73	CHEMBL4223	Homo sapiens	Inhibition	%	1.73
	8200506	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	0.95	CHEMBL4223	Homo sapiens	Inhibition	%	0.95
	8200621	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	0.81	CHEMBL4223	Homo sapiens	Inhibition	%	0.81
	8200995	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	14.24	CHEMBL4223	Homo sapiens	Inhibition	%	14.24
	8201125	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	1.41	CHEMBL4223	Homo sapiens	Inhibition	%	1.41
	8201484	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	2.0	CHEMBL4223	Homo sapiens	Inhibition	%	2.0
	8201617	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	-0.61	CHEMBL4223	Homo sapiens	Inhibition	%	-0.61
	8201841	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-0.28	CHEMBL4223	Homo sapiens	Inhibition	%	-0.28
	8201896	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	1.82	CHEMBL4223	Homo sapiens	Inhibition	%	1.82
	8202120	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	2.17	CHEMBL4223	Homo sapiens	Inhibition	%	2.17
	8202260	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	2.45	CHEMBL4223	Homo sapiens	Inhibition	%	2.45
	8202427	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	1.92	CHEMBL4223	Homo sapiens	Inhibition	%	1.92
	8202651	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	3.19	CHEMBL4223	Homo sapiens	Inhibition	%	3.19
	8202776	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	2.82	CHEMBL4223	Homo sapiens	Inhibition	%	2.82
	8203130	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	4.38	CHEMBL4223	Homo sapiens	Inhibition	%	4.38
	8203261	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	3.4	CHEMBL4223	Homo sapiens	Inhibition	%	3.4
	8203485	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	10.38	CHEMBL4223	Homo sapiens	Inhibition	%	10.38
	8203631	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	3.88	CHEMBL4223	Homo sapiens	Inhibition	%	3.88
	8203989	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	1.62	CHEMBL4223	Homo sapiens	Inhibition	%	1.62
	8204155	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	3.51	CHEMBL4223	Homo sapiens	Inhibition	%	3.51
	8204516	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	18.87	CHEMBL4223	Homo sapiens	Inhibition	%	18.87
	8204845	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	3.48	CHEMBL4223	Homo sapiens	Inhibition	%	3.48
	8204960	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	2.72	CHEMBL4223	Homo sapiens	Inhibition	%	2.72
	8205333	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	1.71	CHEMBL4223	Homo sapiens	Inhibition	%	1.71
	8205469	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	1.32	CHEMBL4223	Homo sapiens	Inhibition	%	1.32
	8205693	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	1.66	CHEMBL4223	Homo sapiens	Inhibition	%	1.66
	8205832	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	1.07	CHEMBL4223	Homo sapiens	Inhibition	%	1.07
	8206188	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-0.05	CHEMBL4223	Homo sapiens	Inhibition	%	-0.05
	8206464	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	3.48	CHEMBL4223	Homo sapiens	Inhibition	%	3.48
	8206607	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	0.6	CHEMBL4223	Homo sapiens	Inhibition	%	0.6
	8207011	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	2.2	CHEMBL4223	Homo sapiens	Inhibition	%	2.2
	8207137	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	1.26	CHEMBL4223	Homo sapiens	Inhibition	%	1.26
	8207361	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	3.21	CHEMBL4223	Homo sapiens	Inhibition	%	3.21
	8207491	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	2.96	CHEMBL4223	Homo sapiens	Inhibition	%	2.96
	8207847	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	46.12	CHEMBL4223	Homo sapiens	Inhibition	%	46.12
	8207992	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	0.16	CHEMBL4223	Homo sapiens	Inhibition	%	0.16
	8208348	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	3.08	CHEMBL4223	Homo sapiens	Inhibition	%	3.08
	8208514	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	20.1	CHEMBL4223	Homo sapiens	Inhibition	%	20.1
	8208738	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	2.73	CHEMBL4223	Homo sapiens	Inhibition	%	2.73
	8208871	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	68.23	CHEMBL4223	Homo sapiens	Inhibition	%	68.23
	8209200	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	0.61	CHEMBL4223	Homo sapiens	Inhibition	%	0.61
	8209316	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	3.55	CHEMBL4223	Homo sapiens	Inhibition	%	3.55
	8209540	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	2.13	CHEMBL4223	Homo sapiens	Inhibition	%	2.13
	8209690	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	1.99	CHEMBL4223	Homo sapiens	Inhibition	%	1.99
	8210050	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	-0.64	CHEMBL4223	Homo sapiens	Inhibition	%	-0.64
	8210191	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	2.5	CHEMBL4223	Homo sapiens	Inhibition	%	2.5
	8210551	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-1.17	CHEMBL4223	Homo sapiens	Inhibition	%	-1.17
	8210810	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	1.52	CHEMBL4223	Homo sapiens	Inhibition	%	1.52
	8210954	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	3.29	CHEMBL4223	Homo sapiens	Inhibition	%	3.29
	8211178	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	2.68	CHEMBL4223	Homo sapiens	Inhibition	%	2.68
	8211348	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	1.55	CHEMBL4223	Homo sapiens	Inhibition	%	1.55
	8211695	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	3.32	CHEMBL4223	Homo sapiens	Inhibition	%	3.32
	8211824	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	14.69	CHEMBL4223	Homo sapiens	Inhibition	%	14.69
	8212180	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	3.66	CHEMBL4223	Homo sapiens	Inhibition	%	3.66
	8212321	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	0.39	CHEMBL4223	Homo sapiens	Inhibition	%	0.39
	8212545	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	1.74	CHEMBL4223	Homo sapiens	Inhibition	%	1.74
	8212678	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	2.92	CHEMBL4223	Homo sapiens	Inhibition	%	2.92
	8213072	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	17.31	CHEMBL4223	Homo sapiens	Inhibition	%	17.31
	8213201	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	3.06	CHEMBL4223	Homo sapiens	Inhibition	%	3.06
	8213529	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	11.7	CHEMBL4223	Homo sapiens	Inhibition	%	11.7
	8213866	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	1.57	CHEMBL4223	Homo sapiens	Inhibition	%	1.57
	8214013	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	1.62	CHEMBL4223	Homo sapiens	Inhibition	%	1.62
	8214374	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	2.17	CHEMBL4223	Homo sapiens	Inhibition	%	2.17
	8214508	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	2.58	CHEMBL4223	Homo sapiens	Inhibition	%	2.58
	8214732	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	48.58	CHEMBL4223	Homo sapiens	Inhibition	%	48.58
	8214884	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-0.21	CHEMBL4223	Homo sapiens	Inhibition	%	-0.21
	8215135	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	2.43	CHEMBL4223	Homo sapiens	Inhibition	%	2.43
	8215512	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	2.31	CHEMBL4223	Homo sapiens	Inhibition	%	2.31
	8215676	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	3.08	CHEMBL4223	Homo sapiens	Inhibition	%	3.08
	8216019	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	2.85	CHEMBL4223	Homo sapiens	Inhibition	%	2.85
	8216138	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	2.41	CHEMBL4223	Homo sapiens	Inhibition	%	2.41
	8216362	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	2.51	CHEMBL4223	Homo sapiens	Inhibition	%	2.51
	8216498	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	1.68	CHEMBL4223	Homo sapiens	Inhibition	%	1.68
	8216860	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	2.21	CHEMBL4223	Homo sapiens	Inhibition	%	2.21
	8216994	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	1.96	CHEMBL4223	Homo sapiens	Inhibition	%	1.96
	8217218	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	3.45	CHEMBL4223	Homo sapiens	Inhibition	%	3.45
	8217392	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	-0.25	CHEMBL4223	Homo sapiens	Inhibition	%	-0.25
	8217523	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	1.87	CHEMBL4223	Homo sapiens	Inhibition	%	1.87
	8217747	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	3.38	CHEMBL4223	Homo sapiens	Inhibition	%	3.38
	8217848	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-0.84	CHEMBL4223	Homo sapiens	Inhibition	%	-0.84
	8218187	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	2.18	CHEMBL4223	Homo sapiens	Inhibition	%	2.18
	8218314	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	1.3	CHEMBL4223	Homo sapiens	Inhibition	%	1.3
	8218538	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	3.91	CHEMBL4223	Homo sapiens	Inhibition	%	3.91
	8218681	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	2.07	CHEMBL4223	Homo sapiens	Inhibition	%	2.07
	8219036	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	87.61	CHEMBL4223	Homo sapiens	Inhibition	%	87.61
	8219196	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	2.08	CHEMBL4223	Homo sapiens	Inhibition	%	2.08
	8219446	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	1.5	CHEMBL4223	Homo sapiens	Inhibition	%	1.5
	8219670	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	1.08	CHEMBL4223	Homo sapiens	Inhibition	%	1.08
	8219831	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	1.9	CHEMBL4223	Homo sapiens	Inhibition	%	1.9
	8220000	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	2.35	CHEMBL4223	Homo sapiens	Inhibition	%	2.35
	8220224	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	1.97	CHEMBL4223	Homo sapiens	Inhibition	%	1.97
	8220353	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	4.03	CHEMBL4223	Homo sapiens	Inhibition	%	4.03
	8220691	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	2.35	CHEMBL4223	Homo sapiens	Inhibition	%	2.35
	8220829	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	2.6	CHEMBL4223	Homo sapiens	Inhibition	%	2.6
	8221053	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	3.64	CHEMBL4223	Homo sapiens	Inhibition	%	3.64
	8221189	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	1.01	CHEMBL4223	Homo sapiens	Inhibition	%	1.01
	8221546	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	4.04	CHEMBL4223	Homo sapiens	Inhibition	%	4.04
	8221711	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	1.21	CHEMBL4223	Homo sapiens	Inhibition	%	1.21
	8222066	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	4.36	CHEMBL4223	Homo sapiens	Inhibition	%	4.36
	8222164	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	0.85	CHEMBL4223	Homo sapiens	Inhibition	%	0.85
	8222388	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	3.25	CHEMBL4223	Homo sapiens	Inhibition	%	3.25
	8222522	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	1.99	CHEMBL4223	Homo sapiens	Inhibition	%	1.99
	8222864	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	12.18	CHEMBL4223	Homo sapiens	Inhibition	%	12.18
	8223008	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	11.52	CHEMBL4223	Homo sapiens	Inhibition	%	11.52
	8223232	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	64.96	CHEMBL4223	Homo sapiens	Inhibition	%	64.96
	8223361	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	1.86	CHEMBL4223	Homo sapiens	Inhibition	%	1.86
	8223522	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	0.63	CHEMBL4223	Homo sapiens	Inhibition	%	0.63
	8223746	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	-0.22	CHEMBL4223	Homo sapiens	Inhibition	%	-0.22
	8223996	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	3.55	CHEMBL4223	Homo sapiens	Inhibition	%	3.55
	8224158	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	2.14	CHEMBL4223	Homo sapiens	Inhibition	%	2.14
	8224552	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	1.89	CHEMBL4223	Homo sapiens	Inhibition	%	1.89
	8224687	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	3.22	CHEMBL4223	Homo sapiens	Inhibition	%	3.22
	8225025	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	3.64	CHEMBL4223	Homo sapiens	Inhibition	%	3.64
	8225383	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	0.88	CHEMBL4223	Homo sapiens	Inhibition	%	0.88
	8225521	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	3.49	CHEMBL4223	Homo sapiens	Inhibition	%	3.49
	8225880	CHEMBL1962157	GSK_PKIS: PTK5 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	4.07	CHEMBL4223	Homo sapiens	Inhibition	%	4.07
	8226038	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.26	CHEMBL4223	Homo sapiens	Inhibition	%	0.26
	8226387	CHEMBL1962156	GSK_PKIS: PTK5 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	2.59	CHEMBL4223	Homo sapiens	Inhibition	%	2.59
active	9552654	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1cccc(-c2[nH]c(-c3ccnc(N)n3)cc2C(N)=O)c1C		CHEMBL1964290	=	Ki	nM	1258.93	CHEMBL4223	Homo sapiens	pKi		5.9
inactive	9552655	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1n[nH]c2ccc(-c3cncc(OCCN)c3)cc12		CHEMBL1967887	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9552656	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Nc1ncnc2onc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL213505	=	Ki	nM	7.943	CHEMBL4223	Homo sapiens	pKi		8.1
inactive	9552657	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CC(=O)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL2000568	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9552658	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)cc1C		CHEMBL2000335	=	Ki	nM	50.12	CHEMBL4223	Homo sapiens	pKi		7.3
active	9552659	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	=	Ki	nM	39.81	CHEMBL4223	Homo sapiens	pKi		7.4
active	9552660	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1cccc(Nc2nc(NC3CCCCC3N)cnc2C(N)=O)c1		CHEMBL1974328	=	Ki	nM	10.0	CHEMBL4223	Homo sapiens	pKi		8.0
active	9552661	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cn1cc(-c2cnn3c(N)c(-c4ccc(NC(=O)Nc5cccc(C(F)(F)F)c5)cc4)cnc23)cn1		CHEMBL1988717	=	Ki	nM	6.31	CHEMBL4223	Homo sapiens	pKi		8.2
active	9552662	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Ki	nM	2.512	CHEMBL4223	Homo sapiens	pKi		8.6
active	9552663	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	N#CCOc1ccc(Nc2nc(Nc3cccc(S(N)(=O)=O)c3)ncc2Br)cc1		CHEMBL1987034	=	Ki	nM	15.85	CHEMBL4223	Homo sapiens	pKi		7.8
active	9552664	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CCCn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1993941	=	Ki	nM	25.12	CHEMBL4223	Homo sapiens	pKi		7.6
inactive	9552665	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9552666	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NCC(O)c4cccc(Cl)c4)cc[nH]c3=O)nc12		CHEMBL2005886	=	Ki	nM	12.59	CHEMBL4223	Homo sapiens	pKi		7.9
inactive	9552667	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C(Nc1ccc2[nH]ncc2c1)c1ccc(Cl)cc1		CHEMBL1973808	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9552668	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2000429	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9552669	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL481491	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9552670	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CC(=O)Nc1c(C(N)=O)sc2ccc(Cl)c(Cl)c12		CHEMBL1973142	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9552671	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1ccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)cc1		CHEMBL1972576	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9552672	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9552673	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4nc(N)nc(N)c34)cc2)c1		CHEMBL1973145	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9552674	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1cccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982924	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9552675	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1992342	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9552676	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CCCC(=O)Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL2005936	=	Ki	nM	1258.93	CHEMBL4223	Homo sapiens	pKi		5.9
active	9552677	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	NC1CCC(Nc2nccc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1966628	=	Ki	nM	501.19	CHEMBL4223	Homo sapiens	pKi		6.3
inactive	9552678	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1cc(Cl)ccc1NC(=S)NNC(=O)C(O)(c1ccccc1)c1ccccc1		CHEMBL1988173	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9552679	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	=	Ki	nM	125.89	CHEMBL4223	Homo sapiens	pKi		6.9
inactive	9552680	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc(C(N)=O)c3)cc2)c1		CHEMBL1971141	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9552681	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	NC1CCCCC1Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL1995813	=	Ki	nM	1584.89	CHEMBL4223	Homo sapiens	pKi		5.8
inactive	9552682	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	N#CC1=C(N)n2c(sc(=Cc3ccco3)c2=O)=C(C(N)=O)C1c1ccco1		CHEMBL1989805	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9552683	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	NC(COCc1ccccc1)COc1cncc(C=Cc2ccncc2)c1		CHEMBL1993781	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9552684	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3cn[nH]c3c2)n1		CHEMBL244378	=	Ki	nM	31.62	CHEMBL4223	Homo sapiens	pKi		7.5
active	9552685	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CC(C)Cn1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL1965423	=	Ki	nM	31.62	CHEMBL4223	Homo sapiens	pKi		7.5
inactive	9552686	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(OCC(F)(F)F)nccn23)n1		CHEMBL2001957	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9552687	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COCCNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1969372	=	Ki	nM	1584.89	CHEMBL4223	Homo sapiens	pKi		5.8
inactive	9552688	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	NC(Cc1c[nH]c2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1983945	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9552689	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C(NCc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1977135	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9552690	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	398.11	CHEMBL4223	Homo sapiens	pKi		6.4
inactive	9552691	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C1NC(=S)SC1=C1C(=O)Nc2ccc(Br)cc21		CHEMBL2001920	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9552692	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1nc2ccc(NS(=O)(=O)c3ccc(N)cc3)cc2nc1C		CHEMBL2006263	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9552693	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CS(=O)(=O)N(Cc1ccc2[nH]c(=O)c3cccn3c2c1)C1CC1		CHEMBL1978448	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9552694	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	OC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1993584	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9552695	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CCn1c(C)c(-c2ccnc(Nc3cccc(OC)c3)n2)sc1=O		CHEMBL1986263	=	Ki	nM	316.23	CHEMBL4223	Homo sapiens	pKi		6.5
inactive	9552696	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CSc1c[nH]c2ncnc(NCCCO)c12		CHEMBL2000114	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9552697	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CCN(CC)CC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2001257	=	Ki	nM	31.62	CHEMBL4223	Homo sapiens	pKi		7.5
inactive	9552698	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cccc12		CHEMBL1975647	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9552699	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1ccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)cc1		CHEMBL1992536	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9552700	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1968380	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9552701	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C(NCc1ccccc1)Nc1ncc([N+](=O)[O-])s1		CHEMBL1964644	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9552702	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C(NCc1ccc(Cl)c(Cl)c1)Nc1ccc2[nH]ncc2c1		CHEMBL1981782	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9552703	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CNC(=O)c1cc2c(-c3ccccc3F)n[nH]c2s1		CHEMBL1977681	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9552704	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CNC(=O)C(C)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(C)cc5)cc4)csc23)cn1		CHEMBL1970142	=	Ki	nM	3.162	CHEMBL4223	Homo sapiens	pKi		8.5
inactive	9552705	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	OCCNc1cc2cc(-c3cccnc3)ccc2cn1		CHEMBL1990912	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9552706	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	OCCCn1cnc(-c2ccccc2)c1-c1ccncc1		CHEMBL2002373	=	Ki	nM	1995.26	CHEMBL4223	Homo sapiens	pKi		5.7
inactive	9552707	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1cccc(Cl)c1		CHEMBL1973348	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9552708	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Ki	nM	19.95	CHEMBL4223	Homo sapiens	pKi		7.7
inactive	9552709	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2NCCCN)c1		CHEMBL2006188	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9552710	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1967531	=	Ki	nM	158.49	CHEMBL4223	Homo sapiens	pKi		6.8
inactive	9552711	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CCCC(=O)Nc1nn(C(=O)CC)c2nc3ccccc3cc12		CHEMBL1970913	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9552712	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(C)=O)c3c2)cc1		CHEMBL1973893	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9552713	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1cccc(C(C)NC(=O)c2cc(C)c(-c3ccc4[nH]nc(C)c4c3)s2)c1		CHEMBL1997534	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9552714	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(-c4ccccc4)c3n2)c1		CHEMBL1988163	=	Ki	nM	39.81	CHEMBL4223	Homo sapiens	pKi		7.4
inactive	9552715	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	NC(=O)Cn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL1985095	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9552716	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1996500	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9552717	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C1CCCc2oc3cc(C(F)(F)F)ccc3c(=O)c21		CHEMBL2006493	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9552718	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	=	Ki	nM	6.31	CHEMBL4223	Homo sapiens	pKi		8.2
inactive	9552719	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)cn2c1		CHEMBL1682540	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9552720	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1C		CHEMBL1983449	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9552721	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=c1[nH]cnc2c1oc1ccc(Cl)cc12		CHEMBL1992323	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9552722	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(Cl)nccn23)n1		CHEMBL1969735	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9552723	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CCc1c(-c2ccc(C(C)(C)O)cc2)[nH]c2nccnc12		CHEMBL1976420	=	Ki	nM	251.19	CHEMBL4223	Homo sapiens	pKi		6.6
active	9552724	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1ccc2c(c1)C(=Cc1c[nH]cn1)C(=O)N2		CHEMBL2002649	=	Ki	nM	25.12	CHEMBL4223	Homo sapiens	pKi		7.6
inactive	9552725	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1		CHEMBL1994864	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9552726	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=c1nc(-c2cc3c(Oc4ccc(I)cc4)cncc3s2)[nH]o1		CHEMBL497151	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9552727	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1cc(N2CCN(C)CC2)ccc1C(=O)Nc1n[nH]c2ccc(Cc3cc(F)cc(F)c3)cc12		CHEMBL1973961	=	Ki	nM	1258.93	CHEMBL4223	Homo sapiens	pKi		5.9
active	9552728	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	NCC1CCC(CNc2nc(NCc3ccccc3Cl)ncc2[N+](=O)[O-])CC1		CHEMBL246970	=	Ki	nM	398.11	CHEMBL4223	Homo sapiens	pKi		6.4
inactive	9552729	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1cc(O)ccc1-n1cc(C(N)=O)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL340921	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9552730	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	N#Cc1ccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)nc1		CHEMBL1999718	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9552731	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C1Nc2ccc3ncsc3c2C1=CNc1ccc(S(=O)(=O)Nc2ccccn2)cc1		CHEMBL1973540	=	Ki	nM	31.62	CHEMBL4223	Homo sapiens	pKi		7.5
inactive	9552732	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C1Nc2ccccc2Nc2nnc(I)cc21		CHEMBL1977346	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9552733	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL1971649	=	Ki	nM	1584.89	CHEMBL4223	Homo sapiens	pKi		5.8
active	9552734	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Fc1ccc(-c2nc3sccn3c2-c2ccncc2)cc1		CHEMBL2000508	=	Ki	nM	398.11	CHEMBL4223	Homo sapiens	pKi		6.4
inactive	9552735	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CCCCNc1n[s+]([O-])nc1Nc1ccc(F)cc1		CHEMBL1971694	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9552736	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CCc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2001547	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9552737	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	=	Ki	nM	1584.89	CHEMBL4223	Homo sapiens	pKi		5.8
inactive	9552738	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1cc(NC(=O)CCNC(=O)Nc2nc(C)c(-c3ccc(-n4cccn4)cc3)s2)no1		CHEMBL1986603	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9552739	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Ki	nM	316.23	CHEMBL4223	Homo sapiens	pKi		6.5
inactive	9552740	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Clc1cc(-c2c[nH]c3ncccc23)nc(NC2CCCCC2)n1		CHEMBL2006439	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9552741	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1ccc(-c2ccc(NC(=O)Nc3cc(F)cc(F)c3)cc2)c2c(N)noc12		CHEMBL1969190	=	Ki	nM	398.11	CHEMBL4223	Homo sapiens	pKi		6.4
active	9552742	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CCO)c5)cnc(N)c34)cc2)cc1		CHEMBL1977148	=	Ki	nM	15.85	CHEMBL4223	Homo sapiens	pKi		7.8
active	9552743	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Ki	nM	12.59	CHEMBL4223	Homo sapiens	pKi		7.9
active	9552744	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)n[nH]c12		CHEMBL1973937	=	Ki	nM	50.12	CHEMBL4223	Homo sapiens	pKi		7.3
active	9552745	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	OC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1991674	=	Ki	nM	1000.0	CHEMBL4223	Homo sapiens	pKi		6.0
inactive	9552746	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1cc(C=C2SC(=O)NC2=O)ccc1O		CHEMBL2003286	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9552747	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccn1		CHEMBL1992306	=	Ki	nM	1.995	CHEMBL4223	Homo sapiens	pKi		8.7
active	9552748	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CC(O)Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL2002165	=	Ki	nM	25.12	CHEMBL4223	Homo sapiens	pKi		7.6
active	9552749	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	NC(=O)c1ccc(-c2c[nH]c3nccc(Cl)c23)cc1		CHEMBL1982711	=	Ki	nM	1584.89	CHEMBL4223	Homo sapiens	pKi		5.8
inactive	9552750	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1n[nH]c2c1C(c1ccccc1I)C(C#N)=C(N)O2		CHEMBL1979318	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9552751	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	NCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1989518	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9552752	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1998585	=	Ki	nM	5.012	CHEMBL4223	Homo sapiens	pKi		8.3
inactive	9552753	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cn1cncc1C(OCc1c(-c2ccc(OC(F)(F)F)cc2)cc(C#N)c(=O)n1C)c1ccc(C#N)cc1		CHEMBL127898	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9552754	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2C		CHEMBL519697	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9552755	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(F)c2)c1		CHEMBL2004934	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9552756	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3I)cc12		CHEMBL1975128	=	Ki	nM	1584.89	CHEMBL4223	Homo sapiens	pKi		5.8
inactive	9552757	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1ccc(-c2cc3c(NCCN)ccc(C(N)=O)c3[nH]2)cc1		CHEMBL1996048	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9552758	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1ccc(Cl)cc1		CHEMBL1998829	=	Ki	nM	1000.0	CHEMBL4223	Homo sapiens	pKi		6.0
inactive	9552759	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL461876	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9552760	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1cnc(Nc2cccc(S(N)(=O)=O)c2)nc1Nc1ccc(OCC(N)=O)cc1		CHEMBL1988838	=	Ki	nM	79.43	CHEMBL4223	Homo sapiens	pKi		7.1
active	9552761	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C(C)C(=O)N(C)C)c5)cnc(N)c34)cc2)cc1		CHEMBL2001485	=	Ki	nM	15.85	CHEMBL4223	Homo sapiens	pKi		7.8
active	9552762	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Ki	nM	79.43	CHEMBL4223	Homo sapiens	pKi		7.1
inactive	9552763	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CN(C)CCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1966425	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9552764	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1cc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)ccc1F		CHEMBL1984363	=	Ki	nM	251.19	CHEMBL4223	Homo sapiens	pKi		6.6
active	9552765	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CNC(=O)COc1ccc(Nc2nc(Nc3ccc(C)c(S(N)(=O)=O)c3)ncc2F)cc1		CHEMBL1978099	=	Ki	nM	398.11	CHEMBL4223	Homo sapiens	pKi		6.4
inactive	9552766	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CC(=O)Nc1cccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)c1		CHEMBL1988608	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9552767	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1ccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)cc1C		CHEMBL184847	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9552768	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COCCn1cc(-c2ccncn2)c(-c2ccc(Cl)cc2)n1		CHEMBL1982866	=	Ki	nM	1584.89	CHEMBL4223	Homo sapiens	pKi		5.8
inactive	9552769	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CN(C)c1ccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)cc1		CHEMBL1984367	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9552770	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Nc1c(-c2ccccc2)c2cc(Cl)ccc2[nH]c1=O		CHEMBL462120	=	Ki	nM	1258.93	CHEMBL4223	Homo sapiens	pKi		5.9
inactive	9552771	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccccc4)nn12)CCCC3		CHEMBL2007592	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9552772	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4ccccc4F)cc3)c12		CHEMBL1965570	=	Ki	nM	100.0	CHEMBL4223	Homo sapiens	pKi		7.0
inactive	9552773	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1n[nH]c2cnc(-c3cncc(OCC(N)Cc4cccc(C(F)(F)F)c4)c3)cc12		CHEMBL1998159	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9552774	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COCC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(C)nccn23)n1		CHEMBL1982563	=	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9552775	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C1CCCN1Cc1ccc2c(c1)[nH]c(=O)c1cccn12		CHEMBL539474	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9552776	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	NC(COc1cncc(-c2ccc3[nH]c(=O)oc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1987679	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9552777	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9552778	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(OC(F)F)cc5)cc4)csc23)cn1		CHEMBL1988387	=	Ki	nM	2.512	CHEMBL4223	Homo sapiens	pKi		8.6
active	9552779	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C(CO)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3F)c2-c2ccncn2)CC1		CHEMBL1614705	=	Ki	nM	501.19	CHEMBL4223	Homo sapiens	pKi		6.3
active	9552780	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	=	Ki	nM	3.981	CHEMBL4223	Homo sapiens	pKi		8.4
inactive	9552781	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9552782	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)s2)c1		CHEMBL1984633	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9552783	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Ki	nM	251.19	CHEMBL4223	Homo sapiens	pKi		6.6
inactive	9552784	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1cccc(C(C)NC(=O)N2CC=C(c3c[nH]c4ncccc34)CC2)c1		CHEMBL1965845	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9552785	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CNc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2007372	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9552786	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	=	Ki	nM	199.53	CHEMBL4223	Homo sapiens	pKi		6.7
inactive	9552787	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COCCN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1986970	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9552788	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	NC(=O)c1cccc2[nH]c(-c3ccc(NC(=O)c4cccc(S(=O)(=O)N5CCOCC5)c4)cc3)nc12		CHEMBL1986597	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9552789	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1)c1c(F)cccc1F		CHEMBL2006715	=	Ki	nM	25.12	CHEMBL4223	Homo sapiens	pKi		7.6
inactive	9552790	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=c1cc(-c2ccncc2)nc(NC2CCCCC2)[nH]1		CHEMBL1958401	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9552791	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	NC(=O)c1cccc2[nH]c(-c3ccncc3)nc12		CHEMBL1990482	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9552792	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Fc1ccc(-c2nc3cnccn3c2-c2ccnc(NCC3CC3)n2)cc1		CHEMBL1990904	=	Ki	nM	501.19	CHEMBL4223	Homo sapiens	pKi		6.3
inactive	9552793	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C(NCC1CCCCC1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL2005475	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9552794	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9552795	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=c1[nH]c2cc(-c3ccccc3)cnc2[nH]1		CHEMBL2003456	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9552796	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)cccc12		CHEMBL1966816	=	Ki	nM	125.89	CHEMBL4223	Homo sapiens	pKi		6.9
active	9552797	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	=	Ki	nM	31.62	CHEMBL4223	Homo sapiens	pKi		7.5
active	9552798	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	=	Ki	nM	63.1	CHEMBL4223	Homo sapiens	pKi		7.2
inactive	9552799	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CC(N)C1CCC(C(=O)Nc2ccnc3[nH]ccc23)CC1		CHEMBL2002992	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9552800	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2C)c1		CHEMBL183844	=	Ki	nM	158.49	CHEMBL4223	Homo sapiens	pKi		6.8
inactive	9552801	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	N#Cc1cnc(NC(=O)Nc2ccc3cc(C(=O)O)ccc3c2)cn1		CHEMBL560813	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9552802	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	c1ccc(Nc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682545	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9552803	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL220057	=	Ki	nM	31.62	CHEMBL4223	Homo sapiens	pKi		7.5
inactive	9552804	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1974935	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9552805	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1cc(OC2CCCC2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL2001224	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9552806	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CC(CN2CCCC2)C1		CHEMBL1968791	=	Ki	nM	25.12	CHEMBL4223	Homo sapiens	pKi		7.6
active	9552807	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Ki	nM	251.19	CHEMBL4223	Homo sapiens	pKi		6.6
inactive	9552808	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CC(C)(O)Cc1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1976732	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9552809	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(S(N)(=O)=O)cc4)c(=O)c3=O)ccc21		CHEMBL1969506	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9552810	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C(NC(CO)c1ccccc1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1964937	=	Ki	nM	1995.26	CHEMBL4223	Homo sapiens	pKi		5.7
inactive	9552811	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	c1ccc(COc2ccc(Nc3ncnc4ccccc34)cc2)cc1		CHEMBL1980163	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9552812	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Fc1ccc(-c2nc3occn3c2-c2ccnc(NC3CCNCC3)n2)cc1		CHEMBL1971186	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9552813	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C(Cc1ccc(Cl)cc1)Nc1[nH]nc2c1CCC2		CHEMBL2003482	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9552814	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCCC5)cnc(N)c34)cc2)c1		CHEMBL1973211	=	Ki	nM	50.12	CHEMBL4223	Homo sapiens	pKi		7.3
active	9552815	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1984700	=	Ki	nM	1584.89	CHEMBL4223	Homo sapiens	pKi		5.8
inactive	9552816	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CC(=O)N(c1ccncc1)c1c(NC(C)C(C)(C)C)c(=O)c1=O		CHEMBL2005899	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9552817	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)c(NC3CCCCC3)n2c1		CHEMBL1682552	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9552818	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	Ki	nM	316.23	CHEMBL4223	Homo sapiens	pKi		6.5
inactive	9552819	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1		CHEMBL1972125	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9552820	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(Cl)c4)c3)cc12		CHEMBL1974870	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9552821	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1cc(C)c(C=C2C(=O)Nc3ccccc32)[nH]1		CHEMBL2002702	=	Ki	nM	1584.89	CHEMBL4223	Homo sapiens	pKi		5.8
inactive	9552822	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C(Nc1ccc2[nH]ncc2c1)c1cccc(F)c1		CHEMBL1461728	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9552823	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Ki	nM	316.23	CHEMBL4223	Homo sapiens	pKi		6.5
inactive	9552824	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	c1cc2cc(-c3ccc4cn[nH]c4c3)cnc2[nH]1		CHEMBL1976134	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9552825	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1ccc(C(=O)Nc2c(C(N)=O)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL1965131	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9552826	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL1970903	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9552827	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL1972158	=	Ki	nM	1258.93	CHEMBL4223	Homo sapiens	pKi		5.9
active	9552828	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	=	Ki	nM	158.49	CHEMBL4223	Homo sapiens	pKi		6.8
inactive	9552829	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CC(=O)N1CCC(Nc2nccc(-c3c(-c4ccc(F)cc4)nc4occn34)n2)CC1		CHEMBL1986781	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9552830	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCC#N)c2)n1		CHEMBL1979855	=	Ki	nM	398.11	CHEMBL4223	Homo sapiens	pKi		6.4
inactive	9552831	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=c1nc(-c2ccc3[nH]ncc3c2)cc(-c2ccccc2)[nH]1		CHEMBL526133	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9552832	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Nc1noc2cccc(-c3cccc(O)c3)c12		CHEMBL1970340	=	Ki	nM	39.81	CHEMBL4223	Homo sapiens	pKi		7.4
inactive	9552833	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CC(C)NC(=O)COc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)c1		CHEMBL2005186	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9552834	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1230122	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9552835	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	NCC(O)C(O)Cn1cc(I)c2c(N)ncnc21		CHEMBL1975534	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9552836	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(Cc4ccccc4)c3n2)c1		CHEMBL1993424	=	Ki	nM	10.0	CHEMBL4223	Homo sapiens	pKi		8.0
inactive	9552837	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3[nH]2)cc1		CHEMBL1979057	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556750	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1n[nH]c2c1C(c1ccccc1F)C1=C(CC(C)(C)CC1=O)N2		CHEMBL1966703	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556751	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COCCOCC#Cc1cc(-c2n[nH]c3c2C(=O)c2cc(CN4CCN(C)CC4)ccc2-3)cs1		CHEMBL387971	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556752	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CC(C)N(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1969561	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556753	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556754	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1999428	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556755	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CCN1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1967560	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9556756	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Ki	nM	794.33	CHEMBL4223	Homo sapiens	pKi		6.1
active	9556757	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1cccc(NC(=O)Nc2ccc(-c3noc4ncnc(N)c34)cc2)c1		CHEMBL211378	=	Ki	nM	1584.89	CHEMBL4223	Homo sapiens	pKi		5.8
inactive	9556758	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CN(C)c1cc2sncc2cc1NC(=O)C(=O)O		CHEMBL1997023	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9556759	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccco2)C(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL2001751	=	Ki	nM	316.23	CHEMBL4223	Homo sapiens	pKi		6.5
inactive	9556760	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C(NCCCCCCNC(=O)NCc1cccnc1)NCc1cccnc1		CHEMBL2003420	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9556761	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1cc(C)cc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1964687	=	Ki	nM	1584.89	CHEMBL4223	Homo sapiens	pKi		5.8
active	9556762	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943	=	Ki	nM	1000.0	CHEMBL4223	Homo sapiens	pKi		6.0
active	9556763	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1ccccc1NC(=O)Nc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL1984586	=	Ki	nM	398.11	CHEMBL4223	Homo sapiens	pKi		6.4
active	9556764	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CCOc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1974254	=	Ki	nM	50.12	CHEMBL4223	Homo sapiens	pKi		7.3
inactive	9556765	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1c(O)ccc2c1CCCC2=NNC(=O)Cc1cccc2ccccc12		CHEMBL1972659	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9556766	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1ccc(NC(=O)Nc2ccc(-c3cccc4onc(N)c34)cc2)cc1Cl		CHEMBL272453	=	Ki	nM	316.23	CHEMBL4223	Homo sapiens	pKi		6.5
inactive	9556767	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3C)cc2)c1		CHEMBL1970217	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9556768	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1ccc(C(=O)N2c3ccccc3Sc3c(Cl)cncc32)cc1		CHEMBL1988537	=	Ki	nM	1258.93	CHEMBL4223	Homo sapiens	pKi		5.9
inactive	9556769	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(C)c2)c1		CHEMBL1969049	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9556770	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1ccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)cc1		CHEMBL2005828	=	Ki	nM	316.23	CHEMBL4223	Homo sapiens	pKi		6.5
inactive	9556771	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CCOC(=O)c1ccc2[nH]c3c(c2c1)CCNC3=O		CHEMBL2005528	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9556772	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CCCC(=O)c1ccc(NCc2c[nH]nc2-c2ccc(C(F)(F)F)cc2)cc1		CHEMBL2003405	=	Ki	nM	1995.26	CHEMBL4223	Homo sapiens	pKi		5.7
inactive	9556773	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	c1cc2[nH]ncc2cc1-c1cn(CC2CCOCC2)nn1		CHEMBL1969843	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556774	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)c1		CHEMBL185569	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9556775	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL363648	=	Ki	nM	398.11	CHEMBL4223	Homo sapiens	pKi		6.4
inactive	9556776	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1cc(-c2ccc3[nH]nc(C(=O)Nc4ccccc4)c3c2)ccc1O		CHEMBL2007002	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556777	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CN1CCC(NC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)CC1		CHEMBL1987007	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9556778	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	=	Ki	nM	398.11	CHEMBL4223	Homo sapiens	pKi		6.4
inactive	9556779	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	NC(=O)c1sc2c(Br)ccc(Cl)c2c1N		CHEMBL1998611	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9556780	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Clc1cc(-c2c[nH]c3ncccc23)cc(NCc2ccccc2)n1		CHEMBL1969588	=	Ki	nM	79.43	CHEMBL4223	Homo sapiens	pKi		7.1
active	9556781	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1cc(Nc2ncc(F)c(NC3C4C=CC(C4)C3C(N)=O)n2)ccc1N1CCN(C)CC1		CHEMBL1967878	=	Ki	nM	199.53	CHEMBL4223	Homo sapiens	pKi		6.7
inactive	9556782	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=c1c(NCc2ccc(Cl)c(Cl)c2)c(Nc2ccncc2)c1=O		CHEMBL1975900	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556783	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1cc(C=C2SC(=S)NC2=O)ccc1O		CHEMBL1973098	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556784	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(=O)CC)c3c2)cc1		CHEMBL1972221	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556785	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CCCCn1c(NC(=O)c2ccc(C#N)cc2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL484390	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556786	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556787	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=c1c(NCc2cccc(C(F)(F)F)c2)c(Nc2ccncc2)c1=O		CHEMBL1979252	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556788	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9556789	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1c(F)cccc1F		CHEMBL1996979	=	Ki	nM	3.162	CHEMBL4223	Homo sapiens	pKi		8.5
active	9556790	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CCc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1968406	=	Ki	nM	25.12	CHEMBL4223	Homo sapiens	pKi		7.6
inactive	9556791	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1cccc(C=C2SC(=Nc3ccccc3)NC2=O)c1		CHEMBL1972937	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9556792	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)(C)O)c5)cnc(N)c34)cc2)cc1		CHEMBL2004290	=	Ki	nM	63.1	CHEMBL4223	Homo sapiens	pKi		7.2
active	9556793	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccc(F)cc3)cc12		CHEMBL1986499	=	Ki	nM	1584.89	CHEMBL4223	Homo sapiens	pKi		5.8
active	9556794	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1C1CCOc2c(F)cccc21		CHEMBL2000393	=	Ki	nM	125.89	CHEMBL4223	Homo sapiens	pKi		6.9
active	9556795	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C)c2)c1		CHEMBL2004311	=	Ki	nM	19.95	CHEMBL4223	Homo sapiens	pKi		7.7
active	9556796	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Brc1cnc2[nH]cc(-c3ccccc3)c2c1		CHEMBL1992634	=	Ki	nM	1995.26	CHEMBL4223	Homo sapiens	pKi		5.7
active	9556797	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1242373	=	Ki	nM	199.53	CHEMBL4223	Homo sapiens	pKi		6.7
inactive	9556798	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1998545	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556799	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1csc(NC(=O)c2sc3nc(-c4ccncc4)ccc3c2N)n1		CHEMBL1986869	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9556800	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Fc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL316264	=	Ki	nM	630.96	CHEMBL4223	Homo sapiens	pKi		6.2
active	9556801	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1ccc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1988075	=	Ki	nM	398.11	CHEMBL4223	Homo sapiens	pKi		6.4
inactive	9556802	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1991678	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556803	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Fc1ccc(-c2ncn(CCN3CCOCC3)c2-c2ccc3[nH]ncc3c2)cc1		CHEMBL1682558	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556804	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Nc1ncnc(Nc2cc(CNC(=O)C(F)(F)F)c(O)c(-c3ccc(Cl)cc3)c2)n1		CHEMBL2001239	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556805	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cn1c(NCC(N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL1990496	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556806	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Nc1ncnc2scc(C(=O)Nc3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1988594	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556807	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Nc1ncnc2c1c(I)nn2C1OC(CO)C(O)C1O		CHEMBL2001288	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9556808	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	=	Ki	nM	25.12	CHEMBL4223	Homo sapiens	pKi		7.6
inactive	9556809	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C(NN=Cc1ccc(O)cc1O)Nc1cccc2nsnc12		CHEMBL1999811	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556810	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CSc1ccc2nc3c(c(Cl)c2c1)CCNC3=O		CHEMBL1985074	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9556811	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	NCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL2000481	=	Ki	nM	1000.0	CHEMBL4223	Homo sapiens	pKi		6.0
inactive	9556812	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Nc1nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc2n1CC1CC1		CHEMBL1982874	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556813	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccc(Cl)cc5o4)cc3)c1)CNC2=O		CHEMBL2002479	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556814	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CN(C)CC(=O)NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1991725	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556815	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2007296	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556816	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL208637	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9556817	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3[nH]ncc3c2)n1		CHEMBL396523	=	Ki	nM	63.1	CHEMBL4223	Homo sapiens	pKi		7.2
inactive	9556818	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C(NCc1ccc(Cl)cc1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL1967094	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556819	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C(NC(CO)c1cc(Cl)cc(Cl)c1)c1ccc(-c2ccncc2)cc1		CHEMBL2003341	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556820	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1cc(C)cc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1970203	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556821	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C(c1cc(Cc2n[nH]c(=O)c3c2CCCC3)ccc1F)N1CCN(c2ncccn2)CC1		CHEMBL1986530	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9556822	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1cccc(C=NNc2cc(N3CCOCC3)nc(OCCc3ccccn3)n2)c1		CHEMBL1965351	=	Ki	nM	1584.89	CHEMBL4223	Homo sapiens	pKi		5.8
inactive	9556823	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=c1c(NCCc2ccc(Oc3ccccc3)cc2)c(Nc2ccncc2)c1=O		CHEMBL1999321	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9556824	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4sc(C)nc4c3)csc12		CHEMBL1968590	=	Ki	nM	39.81	CHEMBL4223	Homo sapiens	pKi		7.4
inactive	9556825	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCCCC4)cc3OC)nc2N1C1CCCC1		CHEMBL2005375	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9556826	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Clc1ccc(-c2n[nH]cc2-c2ccncn2)cc1Cl		CHEMBL1984191	=	Ki	nM	316.23	CHEMBL4223	Homo sapiens	pKi		6.5
active	9556827	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Oc1cccc(Nc2ncnc3scc(Cl)c23)c1		CHEMBL1982992	=	Ki	nM	1584.89	CHEMBL4223	Homo sapiens	pKi		5.8
active	9556828	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1cc(-c2ccccc2)n(-c2cc(NN=Cc3ccco3)ncn2)n1		CHEMBL1999590	=	Ki	nM	501.19	CHEMBL4223	Homo sapiens	pKi		6.3
active	9556829	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1F		CHEMBL1981079	=	Ki	nM	1000.0	CHEMBL4223	Homo sapiens	pKi		6.0
inactive	9556830	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CCN(CC)CCCNc1cccc(-c2nc3c(C(N)=O)cccc3[nH]2)n1		CHEMBL1972276	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556831	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=c1c(NCc2ccc(Cl)cc2)c(Nc2ccncc2)c1=O		CHEMBL1980489	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556832	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCc4cccc(F)c4)cc2NC3=O)ccc1O		CHEMBL2000832	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9556833	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL394790	=	Ki	nM	39.81	CHEMBL4223	Homo sapiens	pKi		7.4
inactive	9556834	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C(NCc1ccc(Br)cc1)Nc1ccc2[nH]ncc2c1		CHEMBL1970709	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9556835	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	=	Ki	nM	1995.26	CHEMBL4223	Homo sapiens	pKi		5.7
inactive	9556836	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1nc2c(sc3c(Br)ccc(Cl)c32)c(=O)o1		CHEMBL1974702	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556837	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1ccc(-c2cc3nccn3c(Nc3ccccc3C(N)=O)n2)cc1OC		CHEMBL1998112	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556838	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1996111	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556839	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CC(C)n1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)cc21		CHEMBL1969126	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556840	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1nccn2c(-c3ccnc(NCC4(O)CC4)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1965589	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9556841	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Nc1ncnc2sc(Br)c(-c3ccc(NC(=O)Cc4cccc(Cl)c4)cc3)c12		CHEMBL1980896	=	Ki	nM	1258.93	CHEMBL4223	Homo sapiens	pKi		5.9
active	9556842	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	630.96	CHEMBL4223	Homo sapiens	pKi		6.2
inactive	9556843	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C(NCCCCCCNC(=O)Nc1cccnc1)Nc1cccnc1		CHEMBL1998193	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9556844	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1		CHEMBL1991429	=	Ki	nM	31.62	CHEMBL4223	Homo sapiens	pKi		7.5
active	9556845	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	NC(=O)c1cc2c(Oc3cccc(F)c3)cncc2s1		CHEMBL1964777	=	Ki	nM	1995.26	CHEMBL4223	Homo sapiens	pKi		5.7
inactive	9556846	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1ccc2c(c1)NC(=O)c1ccccc1N2		CHEMBL1999714	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556847	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)C(=O)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1971149	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556848	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C(Cc1ccccc1Cl)Nc1ccc2cn[nH]c2c1		CHEMBL1987533	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556849	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CC(C)(O)CNc1nccc(-c2c(-c3ccc(F)cc3F)nc3c(CC4CC4)nccn23)n1		CHEMBL1994040	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556850	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1nnc(-c2cc3c(Oc4ccc(C(F)(F)F)cc4)cncc3s2)o1		CHEMBL1988153	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556851	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	NC(COc1cncc(-c2ccc3c(c2)CC(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL1967302	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9556852	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	=	Ki	nM	31.62	CHEMBL4223	Homo sapiens	pKi		7.5
inactive	9556853	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	N#Cc1ccc2[nH]c(O)c(-c3ccc(CN4CCOCC4)cn3)c2c1		CHEMBL1969664	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556854	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1cc2cnc3c(c2cc1OC)C(=O)NC3=O		CHEMBL1982506	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9556855	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CCN(CC)CCNC(=O)C=Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2004716	=	Ki	nM	5.012	CHEMBL4223	Homo sapiens	pKi		8.3
inactive	9556856	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1		CHEMBL1968127	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556857	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1cc(C)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1975233	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556858	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cccc(F)c3F)cc12		CHEMBL1985406	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556859	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cn1nc(C(F)(F)F)c2c(=O)c3cc(Cl)ccc3n(O)c21		CHEMBL207400	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556860	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1cc(O)ccc1-n1cc(C(=O)NN)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL2000894	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9556861	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	NCCC(C(=O)Nc1ccc2[nH]ncc2c1)c1ccc(Cl)c(Cl)c1		CHEMBL1998121	=	Ki	nM	398.11	CHEMBL4223	Homo sapiens	pKi		6.4
inactive	9556862	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1ccccc1NC(=O)Nc1ccc2c(c1)CCc1sc3ncnc(N)c3c1-2		CHEMBL1982135	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556863	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Nc1ncnc2c1sc1ncnc(N)c12		CHEMBL1976090	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556864	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CCC(CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL52387	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9556865	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4c(c3)OCO4)csc12		CHEMBL1993243	=	Ki	nM	15.85	CHEMBL4223	Homo sapiens	pKi		7.8
inactive	9556866	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3o2)cc1		CHEMBL2004771	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556867	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1nn(-c2ccccc2)c2c1c(=O)c1cc(Cl)ccc1n2O		CHEMBL379835	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556868	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1997597	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556869	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	S=c1[nH]nc2c3c4c(sc3n3c(=S)[nH]nc3n12)CCC4		CHEMBL1969537	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556870	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1976093	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556871	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cn1cc(C(CN)c2cncc(C=Cc3ccncc3)c2)c2ccccc21		CHEMBL1979357	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9556872	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CCCCOc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1996817	=	Ki	nM	158.49	CHEMBL4223	Homo sapiens	pKi		6.8
inactive	9556873	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1cccs1		CHEMBL1975256	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9556874	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(-c5cnn(C)c5)cnn4c3N)cc2)c1		CHEMBL508928	=	Ki	nM	15.85	CHEMBL4223	Homo sapiens	pKi		7.8
active	9556875	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2ccncc2)c1-c1ccccc1		CHEMBL1419458	=	Ki	nM	1584.89	CHEMBL4223	Homo sapiens	pKi		5.8
inactive	9556876	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1cccc(-c2cc3c(=O)[nH]c4ccccc4n3c2)c1		CHEMBL1991356	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9556877	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	=	Ki	nM	100.0	CHEMBL4223	Homo sapiens	pKi		7.0
inactive	9556878	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL2004892	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556879	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CCn1c2cc(Cl)c(F)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL468280	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556880	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	NC(=O)c1cc2c(Oc3ccc(Br)cc3)cncc2s1		CHEMBL116070	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9556881	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1cc(C)c2oc(Nc3ccc(-c4cccc(C(N)=O)c4N)cc3F)nc2c1		CHEMBL1990884	=	Ki	nM	79.43	CHEMBL4223	Homo sapiens	pKi		7.1
active	9556882	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1cc(C)c(C)c(OCCCc2c(C(=O)O)[nH]c3c(-c4ccccc4C)cccc23)c1		CHEMBL1990821	=	Ki	nM	1584.89	CHEMBL4223	Homo sapiens	pKi		5.8
active	9556883	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C		CHEMBL1990885	=	Ki	nM	125.89	CHEMBL4223	Homo sapiens	pKi		6.9
active	9556884	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL256835	=	Ki	nM	794.33	CHEMBL4223	Homo sapiens	pKi		6.1
active	9556885	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	NC(=O)c1cc(-c2cccc(N)c2)cc2cccnc12		CHEMBL1970314	=	Ki	nM	1995.26	CHEMBL4223	Homo sapiens	pKi		5.7
inactive	9556886	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	OCCCn1cnc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL2004871	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556887	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncn3)cc2)c1		CHEMBL2004872	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556888	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CC1CCN(C(=O)CO)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL1969879	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556889	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1980142	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556890	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL41783	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556891	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C(Nc1cnccn1)Nc1ccnc2ccccc12		CHEMBL1981720	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556892	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1cccc2c1Nc1cc(Nc3ccncc3)ccc1C(=O)N2		CHEMBL2006276	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556893	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CC(N)COc1cnc(Cl)c(C=Cc2ccncc2)c1		CHEMBL1993548	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9556894	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)noc12		CHEMBL271381	=	Ki	nM	19.95	CHEMBL4223	Homo sapiens	pKi		7.7
active	9556895	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3nsc4ncnc(N)c34)cc2)c1		CHEMBL262433	=	Ki	nM	19.95	CHEMBL4223	Homo sapiens	pKi		7.7
inactive	9556896	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1ccc(C(=O)Nc2c(C#N)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL2006785	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9556897	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1982466	=	Ki	nM	5.012	CHEMBL4223	Homo sapiens	pKi		8.3
active	9556898	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	Ki	nM	3.162	CHEMBL4223	Homo sapiens	pKi		8.5
inactive	9556899	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C(NNC(=S)Nc1ccc(Cl)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1966722	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556900	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1cc(-c2ccc3c(c2)Nc2ccc([N+](=O)[O-])cc2NC3=O)ccc1O		CHEMBL1995740	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9556901	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCNC(C)=O)cc2NC3=O)ccc1O		CHEMBL1975500	=	Ki	nM	1584.89	CHEMBL4223	Homo sapiens	pKi		5.8
active	9556902	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ccnc(N)c34)cc2)c1		CHEMBL394619	=	Ki	nM	251.19	CHEMBL4223	Homo sapiens	pKi		6.6
active	9556903	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	398.11	CHEMBL4223	Homo sapiens	pKi		6.4
inactive	9556904	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C(O)c1c2c(nc3ccccc13)C(=C1CCCC1)CC2		CHEMBL1996831	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9556905	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc1)CCN2		CHEMBL411903	=	Ki	nM	1000.0	CHEMBL4223	Homo sapiens	pKi		6.0
inactive	9556906	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL234085	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556907	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1995832	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556908	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1		CHEMBL422897	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556909	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Oc1ccc(Nc2[nH]nc(-c3ccc(O)cc3)c2-c2ccc(O)cc2)cc1		CHEMBL1969042	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556910	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL1989646	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556911	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	<	Ki	nM	1995.26	CHEMBL4223	Homo sapiens	pKi		5.7
active	9556912	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1ccccc1		CHEMBL1999931	=	Ki	nM	125.89	CHEMBL4223	Homo sapiens	pKi		6.9
inactive	9556913	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1nccn2c(-c3ccnc(NCCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1978200	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556914	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1cc(C=C2SC(=Nc3ccccc3)NC2=O)ccc1O		CHEMBL1970522	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9556915	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	=	Ki	nM	63.1	CHEMBL4223	Homo sapiens	pKi		7.2
inactive	9556916	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	C(=Cc1cncc(OC2CCNC2)c1)c1ccncc1		CHEMBL1966087	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556917	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1375418	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9556918	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1[nH]c(C=C2C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL2007064	=	Ki	nM	1995.26	CHEMBL4223	Homo sapiens	pKi		5.7
active	9556919	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cn1nc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)cncc21		CHEMBL1964692	=	Ki	nM	2.512	CHEMBL4223	Homo sapiens	pKi		8.6
inactive	9556920	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C(NC(CO)Cc1ccc(Cl)cc1)c1ccc(-c2ccncc2)cc1		CHEMBL1996931	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9556921	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COC(C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL1981047	=	Ki	nM	1.259	CHEMBL4223	Homo sapiens	pKi		8.9
inactive	9556922	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccc(Cl)c(Cl)c4)c3)cc12		CHEMBL1991063	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556923	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL1973483	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556924	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1cccc(C(CN)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1976240	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556925	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCC(O)C1		CHEMBL1997340	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556926	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1cccc(Nc2ncnc3ccccc23)c1		CHEMBL117697	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556927	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=c1[nH]c2sccc2c2nc(-c3ccncc3)nn12		CHEMBL1968151	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9556928	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Ki	nM	158.49	CHEMBL4223	Homo sapiens	pKi		6.8
active	9556929	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1ccc(-c2ccc(NC(=O)Nc3ccc(F)c(C)c3)cc2)c2c(N)noc12		CHEMBL1979093	=	Ki	nM	251.19	CHEMBL4223	Homo sapiens	pKi		6.6
active	9556930	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cn1cc(-c2ccncn2)c(-c2ccc(F)cc2)n1		CHEMBL1989474	=	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9556931	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1		CHEMBL1090360	=	Ki	nM	31.62	CHEMBL4223	Homo sapiens	pKi		7.5
inactive	9556932	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1cccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)c1		CHEMBL1987009	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556933	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C(Nc1cnccn1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL2003817	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556934	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccccc4)c3)cc12		CHEMBL2002726	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556935	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Nc1nnc(-c2cc3c(Oc4ccc(Cl)cc4)cncc3s2)o1		CHEMBL1994830	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556936	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C(Nc1nc2ccccc2n1CCCO)c1cccc([N+](=O)[O-])c1		CHEMBL210887	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9556937	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl		CHEMBL458997	=	Ki	nM	19.95	CHEMBL4223	Homo sapiens	pKi		7.7
inactive	9556938	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21		CHEMBL226403	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556939	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(OC(F)(F)F)c4)c3)cc12		CHEMBL1965836	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9556940	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C(F)(F)F)c2)c1		CHEMBL1971021	=	Ki	nM	31.62	CHEMBL4223	Homo sapiens	pKi		7.5
active	9556941	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=c1[nH]cnc2c1sc1c(Cl)ccc(Cl)c12		CHEMBL583144	=	Ki	nM	1995.26	CHEMBL4223	Homo sapiens	pKi		5.7
active	9556942	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	NC(=O)c1cc2c(-c3ccc(F)cc3)cncc2s1		CHEMBL1974310	=	Ki	nM	398.11	CHEMBL4223	Homo sapiens	pKi		6.4
inactive	9556943	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556944	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Nc1ncnc2sc3c(c12)-c1ccc(NC(=O)Nc2ccccc2)cc1CC3		CHEMBL1994693	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9556945	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Nc1ncc(C=CC(=O)NCCCn2ccnc2)c2scc(-c3ccc(Br)cc3)c12		CHEMBL1994938	=	Ki	nM	3.162	CHEMBL4223	Homo sapiens	pKi		8.5
active	9556946	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	=	Ki	nM	316.23	CHEMBL4223	Homo sapiens	pKi		6.5
active	9556947	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	NC(=O)c1cccc(-c2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982957	=	Ki	nM	158.49	CHEMBL4223	Homo sapiens	pKi		6.8
active	9556948	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Ki	nM	63.1	CHEMBL4223	Homo sapiens	pKi		7.2
inactive	9556949	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	NCCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL1966279	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556950	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C(NNC(=S)Nc1ccc(F)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1975138	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556951	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Clc1cc(NC2CCCCC2)nc(-c2c[nH]c3ncccc23)n1		CHEMBL1997846	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556952	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CC(C)Cn1c(N)nc2c(F)cc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2004419	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556953	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1cc2nnc(SCc3cn4ccccc4n3)n2c2ccccc12		CHEMBL1980704	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556954	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	NC(=O)c1sc2ccc(Cl)c(Cl)c2c1NC(=O)c1ccc(Cl)cc1		CHEMBL2003271	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556955	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccncc4)nn12)CCCC3		CHEMBL1966808	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556956	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CC(C)(C)c1n[nH]c2c1C(c1ccccc1F)C(C#N)=C(N)O2		CHEMBL2004447	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9556957	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Ki	nM	79.43	CHEMBL4223	Homo sapiens	pKi		7.1
inactive	9556958	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	OCCNc1cc2cc(-c3ccsc3)ccc2cn1		CHEMBL1973860	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556959	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C(Nc1ccc2cn[nH]c2c1)c1ccc(Cl)cc1		CHEMBL1972489	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556960	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Nc1n[nH]c2nnc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL260135	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556961	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Brc1ccc2[nH]nc(-c3ccccc3)c2c1		CHEMBL1994074	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556962	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21		CHEMBL220241	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556963	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=c1[nH]cc(I)c2nc(-c3cccc(Cl)c3)cn12		CHEMBL1982610	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9556964	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1cccc(C2(c3cccc(C)c3)CC2C(=O)Nc2ccncc2)c1		CHEMBL1999496	=	Ki	nM	1584.89	CHEMBL4223	Homo sapiens	pKi		5.8
active	9556965	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Nc1ccc(-c2csc3c(C=Cc4nc5ccccc5[nH]4)cnc(N)c23)cc1		CHEMBL1988300	=	Ki	nM	158.49	CHEMBL4223	Homo sapiens	pKi		6.8
inactive	9556966	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C(Nc1cccc(N2CCOCC2)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1972119	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9556967	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1ccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)cc1OC		CHEMBL1991078	=	Ki	nM	79.43	CHEMBL4223	Homo sapiens	pKi		7.1
inactive	9556968	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CCCCNc1ccc2c3c(cccc13)C(=O)N(CCNCCO)C2=O		CHEMBL1987359	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556969	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CN(C)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1986328	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556970	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL95692	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9556971	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1		CHEMBL1090356	=	Ki	nM	6.31	CHEMBL4223	Homo sapiens	pKi		8.2
inactive	9556972	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(C(F)(F)F)cc12		CHEMBL1976455	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9556973	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1		CHEMBL1983923	=	Ki	nM	39.81	CHEMBL4223	Homo sapiens	pKi		7.4
active	9556974	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Ki	nM	251.19	CHEMBL4223	Homo sapiens	pKi		6.6
inactive	9556975	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556976	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	c1ccc(CNc2nc3ccc(-c4ccncc4)cc3s2)cc1		CHEMBL1983534	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556977	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=c1c(NCc2ccccc2F)c(Nc2ccncc2)c1=O		CHEMBL1982361	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556978	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CCOC(=O)C1=c2sc(=Cc3ccco3)c(=O)n2C(N)=C(C#N)C1c1ccco1		CHEMBL1999112	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9556979	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C(Nc1ccc(-c2cccc3sncc23)cc1)Nc1ccc(F)c(C(F)(F)F)c1		CHEMBL2000801	=	Ki	nM	794.33	CHEMBL4223	Homo sapiens	pKi		6.1
inactive	9556980	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	OCCC(Nc1nc2ccc(-c3ccncc3)cc2s1)c1ccccc1		CHEMBL1982122	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556981	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	c1ccc(CNc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682546	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556982	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1991395	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9556983	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CN1CCN(c2cccc(Nc3nccc(-c4c(C(N)=O)nc5ccccn45)n3)c2)CC1		CHEMBL1971245	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9556984	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	=	Ki	nM	1995.26	CHEMBL4223	Homo sapiens	pKi		5.7
inactive	9560897	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C(NCc1ccccc1)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL1972142	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9560898	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C1NN=Cc2c[nH]c3cc(NC(=O)C4CC4c4ccccc4)cc1c23		CHEMBL1969502	=	Ki	nM	398.11	CHEMBL4223	Homo sapiens	pKi		6.4
active	9560899	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CC(C)Nc1c(-c2ccc3[nH]ncc3c2)nc2ncccn12		CHEMBL1682553	=	Ki	nM	31.62	CHEMBL4223	Homo sapiens	pKi		7.5
active	9560900	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1cccc(-c2c(-c3ccncc3)nc(NCC(N)Cc3ccccc3)n(C)c2=O)c1		CHEMBL1971430	=	Ki	nM	794.33	CHEMBL4223	Homo sapiens	pKi		6.1
inactive	9560901	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1ccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)cc1		CHEMBL1997764	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9560902	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1cccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)c1		CHEMBL1983963	=	Ki	nM	125.89	CHEMBL4223	Homo sapiens	pKi		6.9
active	9560903	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cccc(F)c1		CHEMBL2003638	=	Ki	nM	501.19	CHEMBL4223	Homo sapiens	pKi		6.3
active	9560904	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	N#Cc1ccc2nc(N)n(-c3nc(-c4ccccc4)cs3)c2c1		CHEMBL1996066	=	Ki	nM	1258.93	CHEMBL4223	Homo sapiens	pKi		5.9
active	9560905	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Oc1ccc(-c2n[nH]c(Nc3cccc(Cl)c3)c2-c2ccc(O)cc2)cc1		CHEMBL1985092	=	Ki	nM	1258.93	CHEMBL4223	Homo sapiens	pKi		5.9
inactive	9560906	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1ccccc1		CHEMBL2004692	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9560907	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CNc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL1981410	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9560908	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=c1[nH]c2sc3c(c2c2nc(-c4cccnc4)nn12)CCCC3		CHEMBL1970806	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9560909	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CC1(O)CC(c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn23)C1		CHEMBL1996234	=	Ki	nM	1000.0	CHEMBL4223	Homo sapiens	pKi		6.0
inactive	9560910	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1ccc(C=C2C(=O)ON=C2c2ccc(Br)cc2)cc1OC		CHEMBL1991434	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9560911	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CN(C)c1cccc2c(S(=O)(=O)N(CCN)c3cncc(-c4ccc5cnccc5c4)c3)cccc12		CHEMBL1967544	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9560912	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1nc(COc2ccccc2Cl)sc1-c1ccnc(N)n1		CHEMBL1375640	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9560913	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	=	Ki	nM	15.85	CHEMBL4223	Homo sapiens	pKi		7.8
active	9560914	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	NC(=O)c1cn(-c2ccc(O)cc2Cl)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL340384	=	Ki	nM	794.33	CHEMBL4223	Homo sapiens	pKi		6.1
inactive	9560915	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1996587	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9560916	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CS(=O)(=O)NCCOc1cncc(-c2ccc3cnccc3c2)c1		CHEMBL1964804	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9560917	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1ccc(C=C2SC(=Nc3ccccc3)NC2=O)cc1O		CHEMBL2000354	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9560918	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1cccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1965507	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9560919	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CN1CCN(CCCNc2cccc(-c3nc4c(C(N)=O)cccc4[nH]3)n2)CC1		CHEMBL2006237	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9560920	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CCCC(=O)Nc1n[nH]c2nc3ccccc3cc12		CHEMBL1967564	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9560921	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	NCCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL592030	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9560922	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	OCCCNc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL2000071	=	Ki	nM	794.33	CHEMBL4223	Homo sapiens	pKi		6.1
inactive	9560923	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1ccc2c(NC(=O)Nc3cc(C(F)(F)F)ccn3)ccnc2c1		CHEMBL1979176	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9560924	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CC(C)(C(N)=O)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1967720	=	Ki	nM	63.1	CHEMBL4223	Homo sapiens	pKi		7.2
inactive	9560925	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	NC1C2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)CC12		CHEMBL1624529	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9560926	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1cn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc2c(C)n1		CHEMBL2000408	=	Ki	nM	1995.26	CHEMBL4223	Homo sapiens	pKi		5.7
active	9560927	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Nc1nccn2c(C3CC(CN4CCCC4)C3)nc(-c3cccc(OCc4ccccc4)c3)c12		CHEMBL1991138	=	Ki	nM	251.19	CHEMBL4223	Homo sapiens	pKi		6.6
active	9560928	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1979516	=	Ki	nM	39.81	CHEMBL4223	Homo sapiens	pKi		7.4
inactive	9560929	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1F		CHEMBL1969755	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9560930	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C(O)c1ccc(N2C(=O)c3ccccc3C2=O)cc1O		CHEMBL1972820	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9560931	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CN1CCC(C(=O)n2nc(N)c3cc(-c4cn(Cc5ccccc5)nn4)ccc32)CC1		CHEMBL1978014	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9560932	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CC(C)OC1=NNC(=O)C1=Cc1c[nH]c2ccccc12		CHEMBL1989029	=	Ki	nM	398.11	CHEMBL4223	Homo sapiens	pKi		6.4
inactive	9560933	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CSc1ccccc1CNc1ncc([N+](=O)[O-])c(NCC2CCC(CN)CC2)n1		CHEMBL392642	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9560934	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C(Nc1cnccn1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1994538	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9560935	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1975490	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9560936	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1964444	=	Ki	nM	100.0	CHEMBL4223	Homo sapiens	pKi		7.0
inactive	9560937	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1ccccc1NC(=O)Nc1ccc(NC(=O)c2csc3ncnc(N)c23)cc1		CHEMBL1980144	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9560938	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2OC)c1		CHEMBL1991188	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9560939	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Clc1csc2ncnc(Nc3ccccc3)c12		CHEMBL1986139	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9560940	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1972849	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9560941	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)cccc12		CHEMBL1980540	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9560942	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN(C)C)cnc(N)c34)cc2)c1		CHEMBL1979883	=	Ki	nM	39.81	CHEMBL4223	Homo sapiens	pKi		7.4
active	9560943	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL231209	=	Ki	nM	1000.0	CHEMBL4223	Homo sapiens	pKi		6.0
active	9560944	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(C)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1984162	=	Ki	nM	1.0	CHEMBL4223	Homo sapiens	pKi		9.0
active	9560945	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Br)c4)cc3)c12		CHEMBL1976220	=	Ki	nM	50.12	CHEMBL4223	Homo sapiens	pKi		7.3
active	9560946	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Fc1cnc(Nc2ccccc2)nc1Nc1ccccc1		CHEMBL491758	=	Ki	nM	794.33	CHEMBL4223	Homo sapiens	pKi		6.1
active	9560947	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL259922	=	Ki	nM	3.981	CHEMBL4223	Homo sapiens	pKi		8.4
inactive	9560948	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CCCCn1c(NC(=O)c2cccc(C#N)c2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL1969301	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9560949	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C(C)(C)C		CHEMBL1986186	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9560950	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CCN)nccn23)n1		CHEMBL1982383	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9560951	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CSc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17370	=	Ki	nM	398.11	CHEMBL4223	Homo sapiens	pKi		6.4
inactive	9560952	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1n[nH]c2c1C(c1ccccc1Cl)C(C#N)=C(N)O2		CHEMBL1970189	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9560953	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1		CHEMBL371206	=	Ki	nM	25.12	CHEMBL4223	Homo sapiens	pKi		7.6
inactive	9560954	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Nc1ncnc2c1c(I)nn2C1CCC(O)CC1		CHEMBL1996791	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9560955	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1ccc(C=NNc2ncnc3c2[nH]c2ccccc23)cc1OC		CHEMBL1974664	=	Ki	nM	1000.0	CHEMBL4223	Homo sapiens	pKi		6.0
inactive	9560956	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1ccc2c(NC(=O)Nc3cccc(Br)n3)ccnc2c1		CHEMBL1983932	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9560957	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4ccccc4C(F)(F)F)cc3)c12		CHEMBL1987910	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9560958	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	630.96	CHEMBL4223	Homo sapiens	pKi		6.2
active	9560959	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	=	Ki	nM	1.995	CHEMBL4223	Homo sapiens	pKi		8.7
inactive	9560960	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C(NC(CO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1974288	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9560961	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9560962	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1cc(OCC2CCC(C(=O)O)C2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL1991285	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9560963	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)c1		CHEMBL196363	=	Ki	nM	39.81	CHEMBL4223	Homo sapiens	pKi		7.4
active	9560964	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C(O)c1ccccc1Nc1ccnc(Nc2cccc(O)c2)n1		CHEMBL243088	=	Ki	nM	63.1	CHEMBL4223	Homo sapiens	pKi		7.2
inactive	9560965	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1cc(-c2ccc3c(c2)NC(=O)c2ccc(-c4ccccc4NS(C)(=O)=O)cc2N3)cc(OC)c1OC		CHEMBL1984038	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9560966	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)cc1OC		CHEMBL1190711	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9560967	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1cccc(F)c1F		CHEMBL1974416	=	Ki	nM	398.11	CHEMBL4223	Homo sapiens	pKi		6.4
active	9560968	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(OC)c(OC)c(OC)c2)ncc1Cl		CHEMBL1993661	=	Ki	nM	1.0	CHEMBL4223	Homo sapiens	pKi		9.0
inactive	9560969	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CCCC(=O)Nc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3cc(OCCN4CCCC4)ccc3n2)c1		CHEMBL1968705	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9560970	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2		CHEMBL1980391	=	Ki	nM	79.43	CHEMBL4223	Homo sapiens	pKi		7.1
inactive	9560971	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	O=C(c1cccc(-c2cnc3[nH]ccc3c2)c1)N1CCOCC1		CHEMBL1997872	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
inactive	9560972	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	CC(C)Cc1cc(-c2ccc3[nH]nc(N)c3c2)on1		CHEMBL1966343	<	Ki	nM	2511.89	CHEMBL4223	Homo sapiens	pKi		5.6
active	9560973	CHEMBL1964118	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FRK	F	Cc1cccc(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL404367	=	Ki	nM	79.43	CHEMBL4223	Homo sapiens	pKi		7.1
	10838593	CHEMBL2014433	Inhibition of FRK at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	10.0	CHEMBL4223	Homo sapiens	INH	%	10.0
	12046312	CHEMBL2156642	Inhibition of Frk at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	6.4	CHEMBL4223	Homo sapiens	INH	%	6.4
Active	12155954	CHEMBL2185151	Inhibition of FRK assessed as residual activity at 1000 nM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041		Inhibition	%		CHEMBL4223	Homo sapiens	INH		
	12173598	CHEMBL2213537	Inhibition of FRK assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL4223	Homo sapiens	Activity	%	100.0
	12183884	CHEMBL2211503	Inhibition of FRK	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL4223	Homo sapiens	pIC50		5.0
	12272114	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	100.0	CHEMBL4223	Homo sapiens	Residual Activity	%	100.0
	12272115	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	80.0	CHEMBL4223	Homo sapiens	Residual Activity	%	80.0
	12272116	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	101.0	CHEMBL4223	Homo sapiens	Residual Activity	%	101.0
	12272117	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	94.0	CHEMBL4223	Homo sapiens	Residual Activity	%	94.0
	12272118	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	92.0	CHEMBL4223	Homo sapiens	Residual Activity	%	92.0
	12272119	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	107.0	CHEMBL4223	Homo sapiens	Residual Activity	%	107.0
	12272120	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	74.0	CHEMBL4223	Homo sapiens	Residual Activity	%	74.0
	12272121	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	53.0	CHEMBL4223	Homo sapiens	Residual Activity	%	53.0
	12272122	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	99.0	CHEMBL4223	Homo sapiens	Residual Activity	%	99.0
	12272123	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	72.0	CHEMBL4223	Homo sapiens	Residual Activity	%	72.0
	12272124	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	97.0	CHEMBL4223	Homo sapiens	Residual Activity	%	97.0
	12272125	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	97.0	CHEMBL4223	Homo sapiens	Residual Activity	%	97.0
	12272126	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	94.0	CHEMBL4223	Homo sapiens	Residual Activity	%	94.0
	12272127	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	26.0	CHEMBL4223	Homo sapiens	Residual Activity	%	26.0
	12272128	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	93.0	CHEMBL4223	Homo sapiens	Residual Activity	%	93.0
	12272129	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	103.0	CHEMBL4223	Homo sapiens	Residual Activity	%	103.0
	12272130	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	108.0	CHEMBL4223	Homo sapiens	Residual Activity	%	108.0
	12272131	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	94.0	CHEMBL4223	Homo sapiens	Residual Activity	%	94.0
	12272132	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	91.0	CHEMBL4223	Homo sapiens	Residual Activity	%	91.0
	12272133	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	74.0	CHEMBL4223	Homo sapiens	Residual Activity	%	74.0
	12272134	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	92.0	CHEMBL4223	Homo sapiens	Residual Activity	%	92.0
	12272135	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	83.0	CHEMBL4223	Homo sapiens	Residual Activity	%	83.0
	12272136	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	105.0	CHEMBL4223	Homo sapiens	Residual Activity	%	105.0
	12272137	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	19.0	CHEMBL4223	Homo sapiens	Residual Activity	%	19.0
	12272138	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	93.0	CHEMBL4223	Homo sapiens	Residual Activity	%	93.0
	12272139	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	40.0	CHEMBL4223	Homo sapiens	Residual Activity	%	40.0
	12272140	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	37.0	CHEMBL4223	Homo sapiens	Residual Activity	%	37.0
	12272141	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	35.0	CHEMBL4223	Homo sapiens	Residual Activity	%	35.0
	12272142	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	96.0	CHEMBL4223	Homo sapiens	Residual Activity	%	96.0
	12272143	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	102.0	CHEMBL4223	Homo sapiens	Residual Activity	%	102.0
	12272144	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	84.0	CHEMBL4223	Homo sapiens	Residual Activity	%	84.0
	12272145	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	2.0	CHEMBL4223	Homo sapiens	Residual Activity	%	2.0
	12272146	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	99.0	CHEMBL4223	Homo sapiens	Residual Activity	%	99.0
	12272147	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	115.0	CHEMBL4223	Homo sapiens	Residual Activity	%	115.0
	12272148	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	102.0	CHEMBL4223	Homo sapiens	Residual Activity	%	102.0
	12272149	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	89.0	CHEMBL4223	Homo sapiens	Residual Activity	%	89.0
	12272150	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	25.0	CHEMBL4223	Homo sapiens	Residual Activity	%	25.0
	12272151	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	95.0	CHEMBL4223	Homo sapiens	Residual Activity	%	95.0
	12272152	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	110.0	CHEMBL4223	Homo sapiens	Residual Activity	%	110.0
	12272153	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	102.0	CHEMBL4223	Homo sapiens	Residual Activity	%	102.0
	12272154	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	105.0	CHEMBL4223	Homo sapiens	Residual Activity	%	105.0
	12272155	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	109.0	CHEMBL4223	Homo sapiens	Residual Activity	%	109.0
	12272156	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	42.0	CHEMBL4223	Homo sapiens	Residual Activity	%	42.0
	12272157	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	69.0	CHEMBL4223	Homo sapiens	Residual Activity	%	69.0
	12272158	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	6.0	CHEMBL4223	Homo sapiens	Residual Activity	%	6.0
	12272159	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	88.0	CHEMBL4223	Homo sapiens	Residual Activity	%	88.0
	12272160	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	106.0	CHEMBL4223	Homo sapiens	Residual Activity	%	106.0
	12272161	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	89.0	CHEMBL4223	Homo sapiens	Residual Activity	%	89.0
	12272162	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	95.0	CHEMBL4223	Homo sapiens	Residual Activity	%	95.0
	12272163	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	101.0	CHEMBL4223	Homo sapiens	Residual Activity	%	101.0
	12272164	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	97.0	CHEMBL4223	Homo sapiens	Residual Activity	%	97.0
	12272165	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	2.0	CHEMBL4223	Homo sapiens	Residual Activity	%	2.0
	12272166	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	83.0	CHEMBL4223	Homo sapiens	Residual Activity	%	83.0
	12272167	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	87.0	CHEMBL4223	Homo sapiens	Residual Activity	%	87.0
	12272168	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	97.0	CHEMBL4223	Homo sapiens	Residual Activity	%	97.0
	12272169	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	107.0	CHEMBL4223	Homo sapiens	Residual Activity	%	107.0
	12272170	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	109.0	CHEMBL4223	Homo sapiens	Residual Activity	%	109.0
	12272171	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	101.0	CHEMBL4223	Homo sapiens	Residual Activity	%	101.0
	12272172	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	110.0	CHEMBL4223	Homo sapiens	Residual Activity	%	110.0
	12272173	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	97.0	CHEMBL4223	Homo sapiens	Residual Activity	%	97.0
	12272174	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	56.0	CHEMBL4223	Homo sapiens	Residual Activity	%	56.0
	12272175	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	33.0	CHEMBL4223	Homo sapiens	Residual Activity	%	33.0
	12272176	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	102.0	CHEMBL4223	Homo sapiens	Residual Activity	%	102.0
	12272177	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	89.0	CHEMBL4223	Homo sapiens	Residual Activity	%	89.0
	12272178	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	108.0	CHEMBL4223	Homo sapiens	Residual Activity	%	108.0
	12272179	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	97.0	CHEMBL4223	Homo sapiens	Residual Activity	%	97.0
	12272180	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	114.0	CHEMBL4223	Homo sapiens	Residual Activity	%	114.0
	12272181	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	117.0	CHEMBL4223	Homo sapiens	Residual Activity	%	117.0
	12272182	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	110.0	CHEMBL4223	Homo sapiens	Residual Activity	%	110.0
	12272183	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	39.0	CHEMBL4223	Homo sapiens	Residual Activity	%	39.0
	12272184	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	105.0	CHEMBL4223	Homo sapiens	Residual Activity	%	105.0
	12272185	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	53.0	CHEMBL4223	Homo sapiens	Residual Activity	%	53.0
	12272186	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	102.0	CHEMBL4223	Homo sapiens	Residual Activity	%	102.0
	12272187	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	98.0	CHEMBL4223	Homo sapiens	Residual Activity	%	98.0
	12272188	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	72.0	CHEMBL4223	Homo sapiens	Residual Activity	%	72.0
	12272189	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	107.0	CHEMBL4223	Homo sapiens	Residual Activity	%	107.0
	12272190	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	101.0	CHEMBL4223	Homo sapiens	Residual Activity	%	101.0
	12272191	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	31.0	CHEMBL4223	Homo sapiens	Residual Activity	%	31.0
	12272192	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	90.0	CHEMBL4223	Homo sapiens	Residual Activity	%	90.0
	12272193	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	1.0	CHEMBL4223	Homo sapiens	Residual Activity	%	1.0
	12272194	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	108.0	CHEMBL4223	Homo sapiens	Residual Activity	%	108.0
	12272195	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	90.0	CHEMBL4223	Homo sapiens	Residual Activity	%	90.0
	12272196	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	94.0	CHEMBL4223	Homo sapiens	Residual Activity	%	94.0
	12272197	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	98.0	CHEMBL4223	Homo sapiens	Residual Activity	%	98.0
	12272198	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	54.0	CHEMBL4223	Homo sapiens	Residual Activity	%	54.0
	12272199	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	97.0	CHEMBL4223	Homo sapiens	Residual Activity	%	97.0
	12272200	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	90.0	CHEMBL4223	Homo sapiens	Residual Activity	%	90.0
	12272201	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	71.0	CHEMBL4223	Homo sapiens	Residual Activity	%	71.0
	12272202	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	94.0	CHEMBL4223	Homo sapiens	Residual Activity	%	94.0
	12272203	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	13.0	CHEMBL4223	Homo sapiens	Residual Activity	%	13.0
	12272204	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	95.0	CHEMBL4223	Homo sapiens	Residual Activity	%	95.0
	12272205	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	99.0	CHEMBL4223	Homo sapiens	Residual Activity	%	99.0
	12272206	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	46.0	CHEMBL4223	Homo sapiens	Residual Activity	%	46.0
	12272207	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	90.0	CHEMBL4223	Homo sapiens	Residual Activity	%	90.0
	12272208	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	90.0	CHEMBL4223	Homo sapiens	Residual Activity	%	90.0
	12272209	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	115.0	CHEMBL4223	Homo sapiens	Residual Activity	%	115.0
	12272210	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	71.0	CHEMBL4223	Homo sapiens	Residual Activity	%	71.0
	12272211	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	70.0	CHEMBL4223	Homo sapiens	Residual Activity	%	70.0
	12272212	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	87.0	CHEMBL4223	Homo sapiens	Residual Activity	%	87.0
	12272213	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	88.0	CHEMBL4223	Homo sapiens	Residual Activity	%	88.0
	12272214	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	87.0	CHEMBL4223	Homo sapiens	Residual Activity	%	87.0
	12272215	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	25.0	CHEMBL4223	Homo sapiens	Residual Activity	%	25.0
	12272216	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	93.0	CHEMBL4223	Homo sapiens	Residual Activity	%	93.0
	12272217	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	71.0	CHEMBL4223	Homo sapiens	Residual Activity	%	71.0
	12272218	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	67.0	CHEMBL4223	Homo sapiens	Residual Activity	%	67.0
	12272219	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	88.0	CHEMBL4223	Homo sapiens	Residual Activity	%	88.0
	12272220	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	91.0	CHEMBL4223	Homo sapiens	Residual Activity	%	91.0
	12272221	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	95.0	CHEMBL4223	Homo sapiens	Residual Activity	%	95.0
	12272222	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	90.0	CHEMBL4223	Homo sapiens	Residual Activity	%	90.0
	12272223	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	68.0	CHEMBL4223	Homo sapiens	Residual Activity	%	68.0
	12272224	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	57.0	CHEMBL4223	Homo sapiens	Residual Activity	%	57.0
	12272225	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	1.0	CHEMBL4223	Homo sapiens	Residual Activity	%	1.0
	12272226	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	54.0	CHEMBL4223	Homo sapiens	Residual Activity	%	54.0
	12272227	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	83.0	CHEMBL4223	Homo sapiens	Residual Activity	%	83.0
	12272228	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	94.0	CHEMBL4223	Homo sapiens	Residual Activity	%	94.0
	12272229	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	88.0	CHEMBL4223	Homo sapiens	Residual Activity	%	88.0
	12272230	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	63.0	CHEMBL4223	Homo sapiens	Residual Activity	%	63.0
	12272231	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	100.0	CHEMBL4223	Homo sapiens	Residual Activity	%	100.0
	12272232	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	92.0	CHEMBL4223	Homo sapiens	Residual Activity	%	92.0
	12272233	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	99.0	CHEMBL4223	Homo sapiens	Residual Activity	%	99.0
	12272234	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	59.0	CHEMBL4223	Homo sapiens	Residual Activity	%	59.0
	12272235	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	43.0	CHEMBL4223	Homo sapiens	Residual Activity	%	43.0
	12272236	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	75.0	CHEMBL4223	Homo sapiens	Residual Activity	%	75.0
	12272237	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	77.0	CHEMBL4223	Homo sapiens	Residual Activity	%	77.0
	12272238	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	11.0	CHEMBL4223	Homo sapiens	Residual Activity	%	11.0
	12272239	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	90.0	CHEMBL4223	Homo sapiens	Residual Activity	%	90.0
	12272240	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	59.0	CHEMBL4223	Homo sapiens	Residual Activity	%	59.0
	12272241	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	104.0	CHEMBL4223	Homo sapiens	Residual Activity	%	104.0
	12272242	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	60.0	CHEMBL4223	Homo sapiens	Residual Activity	%	60.0
	12272243	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	20.0	CHEMBL4223	Homo sapiens	Residual Activity	%	20.0
	12272244	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	95.0	CHEMBL4223	Homo sapiens	Residual Activity	%	95.0
	12272245	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	73.0	CHEMBL4223	Homo sapiens	Residual Activity	%	73.0
	12272246	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	91.0	CHEMBL4223	Homo sapiens	Residual Activity	%	91.0
	12272247	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	88.0	CHEMBL4223	Homo sapiens	Residual Activity	%	88.0
	12272248	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	1.0	CHEMBL4223	Homo sapiens	Residual Activity	%	1.0
	12272249	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	72.0	CHEMBL4223	Homo sapiens	Residual Activity	%	72.0
	12272250	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	98.0	CHEMBL4223	Homo sapiens	Residual Activity	%	98.0
	12272251	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	78.0	CHEMBL4223	Homo sapiens	Residual Activity	%	78.0
	12272252	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	2.0	CHEMBL4223	Homo sapiens	Residual Activity	%	2.0
	12272253	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	87.0	CHEMBL4223	Homo sapiens	Residual Activity	%	87.0
	12272254	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	94.0	CHEMBL4223	Homo sapiens	Residual Activity	%	94.0
	12272255	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	101.0	CHEMBL4223	Homo sapiens	Residual Activity	%	101.0
	12272256	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	95.0	CHEMBL4223	Homo sapiens	Residual Activity	%	95.0
	12272257	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	65.0	CHEMBL4223	Homo sapiens	Residual Activity	%	65.0
	12272258	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	98.0	CHEMBL4223	Homo sapiens	Residual Activity	%	98.0
	12272259	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	72.0	CHEMBL4223	Homo sapiens	Residual Activity	%	72.0
	12272260	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	17.0	CHEMBL4223	Homo sapiens	Residual Activity	%	17.0
	12272261	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	75.0	CHEMBL4223	Homo sapiens	Residual Activity	%	75.0
	12272262	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	87.0	CHEMBL4223	Homo sapiens	Residual Activity	%	87.0
	12272263	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	102.0	CHEMBL4223	Homo sapiens	Residual Activity	%	102.0
	12272264	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	105.0	CHEMBL4223	Homo sapiens	Residual Activity	%	105.0
	12272265	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	102.0	CHEMBL4223	Homo sapiens	Residual Activity	%	102.0
	12272266	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	109.0	CHEMBL4223	Homo sapiens	Residual Activity	%	109.0
	12272267	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	97.0	CHEMBL4223	Homo sapiens	Residual Activity	%	97.0
	12272268	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	88.0	CHEMBL4223	Homo sapiens	Residual Activity	%	88.0
	12272269	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	93.0	CHEMBL4223	Homo sapiens	Residual Activity	%	93.0
	12272270	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	65.0	CHEMBL4223	Homo sapiens	Residual Activity	%	65.0
	12272271	CHEMBL2219131	Millipore: Percentage of residual kinase activity of FRK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	28.0	CHEMBL4223	Homo sapiens	Residual Activity	%	28.0
	12272272	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	76.0	CHEMBL4223	Homo sapiens	Residual Activity	%	76.0
	12272273	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	41.0	CHEMBL4223	Homo sapiens	Residual Activity	%	41.0
	12272274	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	73.0	CHEMBL4223	Homo sapiens	Residual Activity	%	73.0
	12272275	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	129.0	CHEMBL4223	Homo sapiens	Residual Activity	%	129.0
	12272276	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	37.0	CHEMBL4223	Homo sapiens	Residual Activity	%	37.0
	12273921	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	90.0	CHEMBL4223	Homo sapiens	Residual Activity	%	90.0
	12273922	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	35.0	CHEMBL4223	Homo sapiens	Residual Activity	%	35.0
	12273923	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	6.0	CHEMBL4223	Homo sapiens	Residual Activity	%	6.0
	12273924	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	76.0	CHEMBL4223	Homo sapiens	Residual Activity	%	76.0
	12273925	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	28.0	CHEMBL4223	Homo sapiens	Residual Activity	%	28.0
	12273926	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	92.0	CHEMBL4223	Homo sapiens	Residual Activity	%	92.0
	12273927	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	90.0	CHEMBL4223	Homo sapiens	Residual Activity	%	90.0
	12273928	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	59.0	CHEMBL4223	Homo sapiens	Residual Activity	%	59.0
	12273929	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	0.0	CHEMBL4223	Homo sapiens	Residual Activity	%	0.0
	12273930	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	56.0	CHEMBL4223	Homo sapiens	Residual Activity	%	56.0
	12273931	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	97.0	CHEMBL4223	Homo sapiens	Residual Activity	%	97.0
	12273932	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	123.0	CHEMBL4223	Homo sapiens	Residual Activity	%	123.0
	12273933	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	69.0	CHEMBL4223	Homo sapiens	Residual Activity	%	69.0
	12273934	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	80.0	CHEMBL4223	Homo sapiens	Residual Activity	%	80.0
	12273935	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	60.0	CHEMBL4223	Homo sapiens	Residual Activity	%	60.0
	12273936	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	85.0	CHEMBL4223	Homo sapiens	Residual Activity	%	85.0
	12273937	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	41.0	CHEMBL4223	Homo sapiens	Residual Activity	%	41.0
	12273938	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	105.0	CHEMBL4223	Homo sapiens	Residual Activity	%	105.0
	12273939	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	1.0	CHEMBL4223	Homo sapiens	Residual Activity	%	1.0
	12273940	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	87.0	CHEMBL4223	Homo sapiens	Residual Activity	%	87.0
	12273941	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	5.0	CHEMBL4223	Homo sapiens	Residual Activity	%	5.0
	12273942	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	7.0	CHEMBL4223	Homo sapiens	Residual Activity	%	7.0
	12273943	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	5.0	CHEMBL4223	Homo sapiens	Residual Activity	%	5.0
	12273944	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	127.0	CHEMBL4223	Homo sapiens	Residual Activity	%	127.0
	12273945	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	91.0	CHEMBL4223	Homo sapiens	Residual Activity	%	91.0
	12273946	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	25.0	CHEMBL4223	Homo sapiens	Residual Activity	%	25.0
	12273947	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	-3.0	CHEMBL4223	Homo sapiens	Residual Activity	%	-3.0
	12273948	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	107.0	CHEMBL4223	Homo sapiens	Residual Activity	%	107.0
	12273949	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	90.0	CHEMBL4223	Homo sapiens	Residual Activity	%	90.0
	12273950	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	104.0	CHEMBL4223	Homo sapiens	Residual Activity	%	104.0
	12273951	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	93.0	CHEMBL4223	Homo sapiens	Residual Activity	%	93.0
	12273952	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	3.0	CHEMBL4223	Homo sapiens	Residual Activity	%	3.0
	12273953	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	112.0	CHEMBL4223	Homo sapiens	Residual Activity	%	112.0
	12273954	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	92.0	CHEMBL4223	Homo sapiens	Residual Activity	%	92.0
	12273955	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	103.0	CHEMBL4223	Homo sapiens	Residual Activity	%	103.0
	12273956	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	119.0	CHEMBL4223	Homo sapiens	Residual Activity	%	119.0
	12273957	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	99.0	CHEMBL4223	Homo sapiens	Residual Activity	%	99.0
	12273958	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	33.0	CHEMBL4223	Homo sapiens	Residual Activity	%	33.0
	12273959	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	35.0	CHEMBL4223	Homo sapiens	Residual Activity	%	35.0
	12273960	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	1.0	CHEMBL4223	Homo sapiens	Residual Activity	%	1.0
	12273961	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	97.0	CHEMBL4223	Homo sapiens	Residual Activity	%	97.0
	12273962	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	108.0	CHEMBL4223	Homo sapiens	Residual Activity	%	108.0
	12273963	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	66.0	CHEMBL4223	Homo sapiens	Residual Activity	%	66.0
	12273964	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	84.0	CHEMBL4223	Homo sapiens	Residual Activity	%	84.0
	12273965	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	94.0	CHEMBL4223	Homo sapiens	Residual Activity	%	94.0
	12273966	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	86.0	CHEMBL4223	Homo sapiens	Residual Activity	%	86.0
	12273967	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	2.0	CHEMBL4223	Homo sapiens	Residual Activity	%	2.0
	12273968	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	33.0	CHEMBL4223	Homo sapiens	Residual Activity	%	33.0
	12273969	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	70.0	CHEMBL4223	Homo sapiens	Residual Activity	%	70.0
	12273970	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	97.0	CHEMBL4223	Homo sapiens	Residual Activity	%	97.0
	12273971	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	101.0	CHEMBL4223	Homo sapiens	Residual Activity	%	101.0
	12273972	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	76.0	CHEMBL4223	Homo sapiens	Residual Activity	%	76.0
	12273973	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	89.0	CHEMBL4223	Homo sapiens	Residual Activity	%	89.0
	12273974	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	79.0	CHEMBL4223	Homo sapiens	Residual Activity	%	79.0
	12273975	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	93.0	CHEMBL4223	Homo sapiens	Residual Activity	%	93.0
	12273976	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	5.0	CHEMBL4223	Homo sapiens	Residual Activity	%	5.0
	12273977	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	23.0	CHEMBL4223	Homo sapiens	Residual Activity	%	23.0
	12273978	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	91.0	CHEMBL4223	Homo sapiens	Residual Activity	%	91.0
	12273979	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	96.0	CHEMBL4223	Homo sapiens	Residual Activity	%	96.0
	12273980	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	105.0	CHEMBL4223	Homo sapiens	Residual Activity	%	105.0
	12273981	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	76.0	CHEMBL4223	Homo sapiens	Residual Activity	%	76.0
	12273982	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	93.0	CHEMBL4223	Homo sapiens	Residual Activity	%	93.0
	12273983	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	104.0	CHEMBL4223	Homo sapiens	Residual Activity	%	104.0
	12273984	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	93.0	CHEMBL4223	Homo sapiens	Residual Activity	%	93.0
	12273985	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	7.0	CHEMBL4223	Homo sapiens	Residual Activity	%	7.0
	12273986	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	88.0	CHEMBL4223	Homo sapiens	Residual Activity	%	88.0
	12273987	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	11.0	CHEMBL4223	Homo sapiens	Residual Activity	%	11.0
	12273988	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	84.0	CHEMBL4223	Homo sapiens	Residual Activity	%	84.0
	12273989	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	123.0	CHEMBL4223	Homo sapiens	Residual Activity	%	123.0
	12273990	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	16.0	CHEMBL4223	Homo sapiens	Residual Activity	%	16.0
	12273991	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	79.0	CHEMBL4223	Homo sapiens	Residual Activity	%	79.0
	12273992	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	107.0	CHEMBL4223	Homo sapiens	Residual Activity	%	107.0
	12273993	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	1.0	CHEMBL4223	Homo sapiens	Residual Activity	%	1.0
	12273994	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	90.0	CHEMBL4223	Homo sapiens	Residual Activity	%	90.0
	12273995	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	-2.0	CHEMBL4223	Homo sapiens	Residual Activity	%	-2.0
	12273996	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	79.0	CHEMBL4223	Homo sapiens	Residual Activity	%	79.0
	12273997	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	38.0	CHEMBL4223	Homo sapiens	Residual Activity	%	38.0
	12273998	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	90.0	CHEMBL4223	Homo sapiens	Residual Activity	%	90.0
	12273999	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	97.0	CHEMBL4223	Homo sapiens	Residual Activity	%	97.0
	12274000	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	48.0	CHEMBL4223	Homo sapiens	Residual Activity	%	48.0
	12274001	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	112.0	CHEMBL4223	Homo sapiens	Residual Activity	%	112.0
	12274002	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	94.0	CHEMBL4223	Homo sapiens	Residual Activity	%	94.0
	12274003	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	17.0	CHEMBL4223	Homo sapiens	Residual Activity	%	17.0
	12274004	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	92.0	CHEMBL4223	Homo sapiens	Residual Activity	%	92.0
	12274005	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	6.0	CHEMBL4223	Homo sapiens	Residual Activity	%	6.0
	12274006	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	99.0	CHEMBL4223	Homo sapiens	Residual Activity	%	99.0
	12274007	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	46.0	CHEMBL4223	Homo sapiens	Residual Activity	%	46.0
	12274008	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	8.0	CHEMBL4223	Homo sapiens	Residual Activity	%	8.0
	12274009	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	74.0	CHEMBL4223	Homo sapiens	Residual Activity	%	74.0
	12274010	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	32.0	CHEMBL4223	Homo sapiens	Residual Activity	%	32.0
	12274011	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	97.0	CHEMBL4223	Homo sapiens	Residual Activity	%	97.0
	12274012	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	47.0	CHEMBL4223	Homo sapiens	Residual Activity	%	47.0
	12274013	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	82.0	CHEMBL4223	Homo sapiens	Residual Activity	%	82.0
	12274014	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	90.0	CHEMBL4223	Homo sapiens	Residual Activity	%	90.0
	12274015	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	92.0	CHEMBL4223	Homo sapiens	Residual Activity	%	92.0
	12274016	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	63.0	CHEMBL4223	Homo sapiens	Residual Activity	%	63.0
	12274017	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	6.0	CHEMBL4223	Homo sapiens	Residual Activity	%	6.0
	12274018	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	86.0	CHEMBL4223	Homo sapiens	Residual Activity	%	86.0
	12274019	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	66.0	CHEMBL4223	Homo sapiens	Residual Activity	%	66.0
	12274020	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	46.0	CHEMBL4223	Homo sapiens	Residual Activity	%	46.0
	12274021	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	80.0	CHEMBL4223	Homo sapiens	Residual Activity	%	80.0
	12274022	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	83.0	CHEMBL4223	Homo sapiens	Residual Activity	%	83.0
	12274023	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	92.0	CHEMBL4223	Homo sapiens	Residual Activity	%	92.0
	12274024	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	99.0	CHEMBL4223	Homo sapiens	Residual Activity	%	99.0
	12274025	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	40.0	CHEMBL4223	Homo sapiens	Residual Activity	%	40.0
	12274026	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	60.0	CHEMBL4223	Homo sapiens	Residual Activity	%	60.0
	12274027	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	2.0	CHEMBL4223	Homo sapiens	Residual Activity	%	2.0
	12274028	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	22.0	CHEMBL4223	Homo sapiens	Residual Activity	%	22.0
	12274029	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	73.0	CHEMBL4223	Homo sapiens	Residual Activity	%	73.0
	12274030	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	106.0	CHEMBL4223	Homo sapiens	Residual Activity	%	106.0
	12274031	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	92.0	CHEMBL4223	Homo sapiens	Residual Activity	%	92.0
	12274032	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	19.0	CHEMBL4223	Homo sapiens	Residual Activity	%	19.0
	12274033	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	125.0	CHEMBL4223	Homo sapiens	Residual Activity	%	125.0
	12274034	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	42.0	CHEMBL4223	Homo sapiens	Residual Activity	%	42.0
	12274035	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	51.0	CHEMBL4223	Homo sapiens	Residual Activity	%	51.0
	12274036	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	25.0	CHEMBL4223	Homo sapiens	Residual Activity	%	25.0
	12274037	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	8.0	CHEMBL4223	Homo sapiens	Residual Activity	%	8.0
	12274038	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	29.0	CHEMBL4223	Homo sapiens	Residual Activity	%	29.0
	12274039	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	78.0	CHEMBL4223	Homo sapiens	Residual Activity	%	78.0
	12274040	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	1.0	CHEMBL4223	Homo sapiens	Residual Activity	%	1.0
	12274041	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	83.0	CHEMBL4223	Homo sapiens	Residual Activity	%	83.0
	12274042	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	9.0	CHEMBL4223	Homo sapiens	Residual Activity	%	9.0
	12274043	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	118.0	CHEMBL4223	Homo sapiens	Residual Activity	%	118.0
	12274044	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	51.0	CHEMBL4223	Homo sapiens	Residual Activity	%	51.0
	12274045	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	0.0	CHEMBL4223	Homo sapiens	Residual Activity	%	0.0
	12274046	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	87.0	CHEMBL4223	Homo sapiens	Residual Activity	%	87.0
	12274047	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	58.0	CHEMBL4223	Homo sapiens	Residual Activity	%	58.0
	12274048	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	58.0	CHEMBL4223	Homo sapiens	Residual Activity	%	58.0
	12274049	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	96.0	CHEMBL4223	Homo sapiens	Residual Activity	%	96.0
	12274050	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	0.0	CHEMBL4223	Homo sapiens	Residual Activity	%	0.0
	12274051	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	11.0	CHEMBL4223	Homo sapiens	Residual Activity	%	11.0
	12274052	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	92.0	CHEMBL4223	Homo sapiens	Residual Activity	%	92.0
	12274053	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	38.0	CHEMBL4223	Homo sapiens	Residual Activity	%	38.0
	12274054	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	0.0	CHEMBL4223	Homo sapiens	Residual Activity	%	0.0
	12274055	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	64.0	CHEMBL4223	Homo sapiens	Residual Activity	%	64.0
	12274056	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	95.0	CHEMBL4223	Homo sapiens	Residual Activity	%	95.0
	12274057	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	106.0	CHEMBL4223	Homo sapiens	Residual Activity	%	106.0
	12274058	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	90.0	CHEMBL4223	Homo sapiens	Residual Activity	%	90.0
	12274059	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	7.0	CHEMBL4223	Homo sapiens	Residual Activity	%	7.0
	12274060	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	89.0	CHEMBL4223	Homo sapiens	Residual Activity	%	89.0
	12274061	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	35.0	CHEMBL4223	Homo sapiens	Residual Activity	%	35.0
	12274062	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	1.0	CHEMBL4223	Homo sapiens	Residual Activity	%	1.0
	12274063	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	72.0	CHEMBL4223	Homo sapiens	Residual Activity	%	72.0
	12274064	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	38.0	CHEMBL4223	Homo sapiens	Residual Activity	%	38.0
	12274065	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	100.0	CHEMBL4223	Homo sapiens	Residual Activity	%	100.0
	12274066	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	63.0	CHEMBL4223	Homo sapiens	Residual Activity	%	63.0
	12274067	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	86.0	CHEMBL4223	Homo sapiens	Residual Activity	%	86.0
	12274068	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	98.0	CHEMBL4223	Homo sapiens	Residual Activity	%	98.0
	12274069	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	105.0	CHEMBL4223	Homo sapiens	Residual Activity	%	105.0
	12274070	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	100.0	CHEMBL4223	Homo sapiens	Residual Activity	%	100.0
	12274071	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	109.0	CHEMBL4223	Homo sapiens	Residual Activity	%	109.0
	12274072	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	12.0	CHEMBL4223	Homo sapiens	Residual Activity	%	12.0
	12274073	CHEMBL2219132	Millipore: Percentage of residual kinase activity of FRK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	22.0	CHEMBL4223	Homo sapiens	Residual Activity	%	22.0
	12660161	CHEMBL2329214	Inhibition of FRK (unknown origin) at 1 uM	B	COc1cc(Oc2ccccc2)ccc1-c1nc([C@H]2C[C@@](C)(O)C2)n2ccnc(N)c12		CHEMBL2325940	>	Inhibition	%	80.0	CHEMBL4223	Homo sapiens	INH	%	80.0
	12727673	CHEMBL2351137	Inhibition of PTK5 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	98.0	CHEMBL4223	Homo sapiens	Activity	%	98.0
	12728959	CHEMBL2349893	Inhibition of PTK5 (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	99.0	CHEMBL4223	Homo sapiens	Activity	%	99.0
	12729952	CHEMBL2352187	Inhibition of FRK (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	80.0	CHEMBL4223	Homo sapiens	Activity	%	80.0
	12730102	CHEMBL2351137	Inhibition of PTK5 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	94.0	CHEMBL4223	Homo sapiens	Activity	%	94.0
	13375855	CHEMBL2405116	Inhibition of FRK (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	-3.0	CHEMBL4223	Homo sapiens	INH	%	-3.0
	13442353	CHEMBL2427785	Competitive binding affinity to FRK (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL4223	Homo sapiens	INH	%	50.0
	13445488	CHEMBL2427785	Competitive binding affinity to FRK (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	<	Inhibition	%	50.0	CHEMBL4223	Homo sapiens	INH	%	50.0
	13448543	CHEMBL2427785	Competitive binding affinity to FRK (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL4223	Homo sapiens	INH	%	50.0
	13448679	CHEMBL2427785	Competitive binding affinity to FRK (unknown origin) at 10 uM in presence of ATP relative to control	B	O=C([C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1)N1CCOCC1		CHEMBL2425649	<	Inhibition	%	50.0	CHEMBL4223	Homo sapiens	INH	%	50.0
	13451474	CHEMBL2427785	Competitive binding affinity to FRK (unknown origin) at 10 uM in presence of ATP relative to control	B	N[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425652	<	Inhibition	%	50.0	CHEMBL4223	Homo sapiens	INH	%	50.0
	13454659	CHEMBL2427785	Competitive binding affinity to FRK (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL4223	Homo sapiens	INH	%	50.0
	13871762	CHEMBL3100927	Inhibition of human PTK5 assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	92.0	CHEMBL4223	Homo sapiens	Activity	%	92.0
	14585307	CHEMBL3241823	Inhibition of human PTK5 assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	83.5	CHEMBL4223	Homo sapiens	Activity	%	83.5
	14722526	CHEMBL3293410	Inhibition of FRK (unknown origin) by TR-FRET-based Z'-LYTE assay	B	C[C@H]1Oc2cc(cnc2N)-c2c(nn(C)c2C#N)CN(C)C(=O)c2ccc(F)cc21		CHEMBL3286830	=	IC50	nM	53.0	CHEMBL4223	Homo sapiens	IC50	nM	53.0
	15018600	CHEMBL3362264	Inhibition of FRK (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	7.0	CHEMBL4223	Homo sapiens	INH	%	7.0
	15249282	CHEMBL3428312	Inhibition of human FRK/PTK5 using poly[Glu:Tyr] (4:1) peptide substrate at 1 uM by 33P Hotspot assay	B	CN1CCN(c2ccc(Nc3ncc(Cl)c(NC[C@H]4CCCO4)n3)cc2)CC1		CHEMBL3426891	=	Inhibition	%	41.3	CHEMBL4223	Homo sapiens	INH	%	41.3
	15622561	CHEMBL3588268	Inhibition of human recombinant Frk at 1 uM	B	Cc1cc2cn[nH]c2cc1-c1cccc2c(N)c(C(N)=O)nnc12		CHEMBL3586447	=	Inhibition	%	88.0	CHEMBL4223	Homo sapiens	INH	%	88.0
	15622565	CHEMBL3588281	Inhibition of human recombinant Frk	B	Cc1cc2cn[nH]c2cc1-c1cccc2c(N)c(C(N)=O)nnc12		CHEMBL3586447	=	IC50	nM	41.0	CHEMBL4223	Homo sapiens	IC50	nM	41.0
	15756978	CHEMBL3630505	Inhibition of FRK (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	98.95	CHEMBL4223	Homo sapiens	INH	%	98.95
	15757745	CHEMBL3630505	Inhibition of FRK (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	96.9	CHEMBL4223	Homo sapiens	INH	%	96.9
	15758724	CHEMBL3630505	Inhibition of FRK (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	54.5	CHEMBL4223	Homo sapiens	INH	%	54.5
	16413509	CHEMBL3743743	Inhibition of PTK5 (unknown origin)	B	O=C(O)C1CN(Cc2ccc(OCc3ccc(Cl)c(Cl)c3)cc2)C1		CHEMBL3741589	>	IC50	nM	10000.0	CHEMBL4223	Homo sapiens	IC50	uM	10.0
	16425273	CHEMBL3751111	Inhibition of Frk (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	-0.8	CHEMBL4223	Homo sapiens	INH	%	-0.8
	16431841	CHEMBL3748195	Inhibition of human FRK using poly[Glu:Tyr] (4:1) as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL4223	Homo sapiens	IC50	uM	10.0
	16450853	CHEMBL3762709	Inhibition of FRK (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	85.6	CHEMBL4223	Homo sapiens	INH	%	85.6
	16495204	CHEMBL3777746	Inhibition of N-terminal His6-tagged recombinant human PTK5 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	3.0	CHEMBL4223	Homo sapiens	Activity	%	3.0
	16496123	CHEMBL3777746	Inhibition of N-terminal His6-tagged recombinant human PTK5 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	0.0	CHEMBL4223	Homo sapiens	Activity	%	0.0
	16508913	CHEMBL3777746	Inhibition of N-terminal His6-tagged recombinant human PTK5 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	12.0	CHEMBL4223	Homo sapiens	Activity	%	12.0
	16593593	CHEMBL3811551	Inhibition of GST-tagged full length human recombinant FRK expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808884	<	Inhibition	%	40.0	CHEMBL4223	Homo sapiens	INH	%	40.0
	16593622	CHEMBL3810817	Inhibition of GST-tagged full length human recombinant FRK expressed in baculovirus using Fluorescein-Poly GT as substrate	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808884	=	IC50	nM	62.0	CHEMBL4223	Homo sapiens	IC50	nM	62.0
	16614484	CHEMBL3816682	Inhibition of human FRK at 1 uM using poly[Glu:Tyr] (4:1) as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1	Outside typical range	CHEMBL3815093	=	Inhibition	%	-24.0	CHEMBL4223	Homo sapiens	INH	%	-24.0
	16618210	CHEMBL3816344	Inhibition of full length recombinant human GST-tagged cytoplasmic FRK expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL4223	Homo sapiens	INH	%	50.0
	16739377	CHEMBL3857052	Inhibition of GST tagged recombinant full length human FRK expressed in baculovirus at 500 nM by Z'-LYTE assay	B	C[C@@H](Nc1ncnc2oc(-c3ccc(NCCN4CCCCC4)cc3)cc12)c1ccccc1		CHEMBL3891846	=	Inhibition	%	21.0	CHEMBL4223	Homo sapiens	INH	%	21.0
	16739378	CHEMBL3857052	Inhibition of GST tagged recombinant full length human FRK expressed in baculovirus at 500 nM by Z'-LYTE assay	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	16.0	CHEMBL4223	Homo sapiens	INH	%	16.0
	16739444	CHEMBL3857052	Inhibition of GST tagged recombinant full length human FRK expressed in baculovirus at 500 nM by Z'-LYTE assay	B	C[C@@H](Nc1ncnc2oc(-c3ccc(NCCN(C)C)cc3)cc12)c1ccccc1		CHEMBL3901622	=	Inhibition	%	31.0	CHEMBL4223	Homo sapiens	INH	%	31.0
Inactive	17903717	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903718	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903719	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903720	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903721	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903722	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Active	17903723	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	=	Kd	nM	390.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	390.0
Inactive	17903724	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903725	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903726	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903727	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903728	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903729	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903730	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903731	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903732	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903733	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903734	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903735	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903736	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903737	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903738	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Active	17903739	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	=	Kd	nM	627.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	627.0
Inactive	17903740	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903741	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903742	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903743	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903744	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903745	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Active	17903746	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	=	Kd	nM	10837.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	10837.0
Inactive	17903747	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903748	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903749	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903750	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903751	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903752	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903753	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Active	17903754	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	=	Kd	nM	736.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	736.0
Inactive	17903755	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903756	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903757	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903758	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903759	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903760	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903761	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903762	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903763	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903764	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903765	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903766	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903767	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903768	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Active	17903769	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	Kd	nM	94.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	94.0
Inactive	17903770	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903771	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903772	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903773	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903774	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903775	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903776	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903777	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903778	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903779	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903780	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903781	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903782	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903783	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903784	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903785	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903786	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903787	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903788	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903789	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Active	17903790	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	=	Kd	nM	1104.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	1104.0
Inactive	17903791	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17903792	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	=	Kd	nM	850.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	850.0
Active	17903793	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	=	Kd	nM	1207.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	1207.0
Inactive	17903794	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903795	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903796	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903797	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903798	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903799	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903800	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903801	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903802	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Active	17903803	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	=	Kd	nM	1.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	1.0
Inactive	17903804	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903805	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903806	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903807	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Active	17903808	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	=	Kd	nM	428.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	428.0
Inactive	17903809	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903810	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903811	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903812	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903813	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Active	17903814	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	=	Kd	nM	2330.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	2330.0
Inactive	17903815	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903816	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903817	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903818	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903819	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903820	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903821	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903822	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Active	17903823	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	=	Kd	nM	3023.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	3023.0
Inactive	17903824	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Active	17903825	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	=	Kd	nM	172.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	172.0
Inactive	17903826	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903827	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903828	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903829	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903830	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903831	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903832	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Active	17903833	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	=	Kd	nM	643.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	643.0
Inactive	17903834	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903835	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903836	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903837	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903838	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903839	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903840	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Active	17903841	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Kd	nM	145.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	145.0
Inactive	17903842	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903843	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903844	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903845	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903846	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903847	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Active	17903848	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	28.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	28.0
Inactive	17903849	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903850	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903851	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903852	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Active	17903853	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	=	Kd	nM	1548.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	1548.0
Inactive	17903854	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903855	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903856	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903857	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903858	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903859	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903860	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Active	17903861	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	Kd	nM	560.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	560.0
Active	17903862	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	=	Kd	nM	724.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	724.0
Active	17903863	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	=	Kd	nM	1864.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	1864.0
Inactive	17903864	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903865	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903866	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903867	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903868	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903869	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Active	17903870	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	=	Kd	nM	1630.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	1630.0
Inactive	17903871	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903872	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903873	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903874	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903875	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903876	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903877	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Active	17903878	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	=	Kd	nM	795.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	795.0
Inactive	17903879	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903880	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Active	17903881	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	27.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	27.0
Inactive	17903882	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903883	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903884	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903885	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Active	17903886	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	Kd	nM	589.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	589.0
Inactive	17903887	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Active	17903888	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	Kd	nM	560.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	560.0
Inactive	17903889	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903890	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903891	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903892	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903893	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903894	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903895	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903896	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Active	17903897	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	5.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	5.0
Inactive	17903898	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903899	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903900	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903901	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903902	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903903	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903904	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903905	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903906	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903907	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903908	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903909	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903910	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903911	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903912	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903913	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903914	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903915	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903916	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903917	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903918	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903919	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903920	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903921	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903922	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903923	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903924	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Active	17903925	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	=	Kd	nM	330.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	330.0
Inactive	17903926	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903927	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903928	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903929	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903930	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Active	17903931	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	=	Kd	nM	222.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	222.0
Inactive	17903932	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903933	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903934	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Active	17903935	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	Kd	nM	112.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	112.0
Inactive	17903936	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903937	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903938	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903939	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903940	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903941	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903942	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903943	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903944	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903945	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903946	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903947	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903948	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903949	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903950	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903951	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903952	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903953	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903954	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903955	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Active	17903956	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	=	Kd	nM	727.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	727.0
Inactive	17903957	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903958	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17903959	CHEMBL3991720	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL4223	Homo sapiens	Kd apparent	nM	30000.0
	18053019	CHEMBL4011866	Inhibition of FRK (unknown origin) at 0.1 uM pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP relative to control	B	COC(=O)C1=C(Nc2ccccc2Cl)O/C(=C\c2c[nH]c3ncccc23)C1=O		CHEMBL4089159	=	Inhibition	%	1.7	CHEMBL4223	Homo sapiens	INH	%	1.7
	18058137	CHEMBL4012745	Binding affinity to human FRK (215 to 503 residues) expressed in mammalian expression system at 1 uM by kinome scan assay relative to control	B	Cc1ncc(NC(=O)c2cccc(C(F)(F)F)c2)cc1-c1cnc(OC2CCOCC2)c(N2CCOCC2)c1		CHEMBL3962812	=	Activity	%	92.0	CHEMBL4223	Homo sapiens	Activity	%	92.0
	18114336	CHEMBL4025158	Inhibition of wild-type human partial length FRK (A215 to F503 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	84.0	CHEMBL4223	Homo sapiens	Activity	%	84.0
	18203682	CHEMBL4043969	Inhibition of wild-type human partial length FRK (A215 to F503 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	59.0	CHEMBL4223	Homo sapiens	Activity	%	59.0
	18253574	CHEMBL4055071	Inhibition of wild-type human partial length FRK (A215 to F503 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	89.0	CHEMBL4223	Homo sapiens	Activity	%	89.0
	18253575	CHEMBL4055071	Inhibition of wild-type human partial length FRK (A215 to F503 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	100.0	CHEMBL4223	Homo sapiens	Activity	%	100.0
	18255294	CHEMBL4055568	Binding affinity to partial length human FRK expressed in Escherichia coli BL21 by active-site-dependent competition assay	B	COc1n[nH]c2ncc(C#Cc3c(F)ccc(NS(=O)(=O)c4cccc(C#N)c4)c3F)cc12		CHEMBL4098896	=	Kd	nM	22.0	CHEMBL4223	Homo sapiens	Kd	nM	22.0
	18255304	CHEMBL4055578	Inhibition of partial length human FRK expressed in Escherichia coli BL21 assessed as remaining activity at 1 uM after 1 hr by KINOMEscan method	B	COc1n[nH]c2ncc(C#Cc3c(F)ccc(NS(=O)(=O)c4cccc(C#N)c4)c3F)cc12		CHEMBL4098896	=	Activity	%	1.9	CHEMBL4223	Homo sapiens	Activity	%	1.9
	18265868	CHEMBL4057318	Inhibition of FRK (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	31.3	CHEMBL4223	Homo sapiens	INH	%	31.3
	18266062	CHEMBL4057512	Inhibition of FRK (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	1.3	CHEMBL4223	Homo sapiens	INH	%	1.3
	18268035	CHEMBL4057960	Inhibition of FRK (unknown origin)	B	CC(C)C(=O)N1CCC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)C1		CHEMBL4069387	=	IC50	nM	472.0	CHEMBL4223	Homo sapiens	IC50	nM	472.0
	18268036	CHEMBL4057960	Inhibition of FRK (unknown origin)	B	CC(C)C(=O)N1CCO[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)C1		CHEMBL4075954	=	IC50	nM	706.0	CHEMBL4223	Homo sapiens	IC50	nM	706.0
	18268037	CHEMBL4057960	Inhibition of FRK (unknown origin)	B	COCC(=O)N1CCC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)C1		CHEMBL4076024	=	IC50	nM	151.0	CHEMBL4223	Homo sapiens	IC50	nM	151.0
	18268038	CHEMBL4057960	Inhibition of FRK (unknown origin)	B	COCC(=O)N1CCO[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)C1		CHEMBL4062498	=	IC50	nM	214.0	CHEMBL4223	Homo sapiens	IC50	nM	214.0
	18268039	CHEMBL4057960	Inhibition of FRK (unknown origin)	B	Nc1nccn2c([C@@H]3CCCN(C4CCOCC4)C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c12		CHEMBL4077588	=	IC50	nM	85.0	CHEMBL4223	Homo sapiens	IC50	nM	85.0
	18268040	CHEMBL4057960	Inhibition of FRK (unknown origin)	B	Nc1nccn2c([C@H]3CN(C4CCOCC4)CCO3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c12		CHEMBL4060757	=	IC50	nM	132.0	CHEMBL4223	Homo sapiens	IC50	nM	132.0
	18269006	CHEMBL4058136	Inhibition of recombinant human N-terminal His6-tagged FRK (218 to end residues) expressed in baculovirus Sf21 insect cells preincubated for 5 mins followed by substrate addition after 30 to 60 mins in presence of ATP by fluorescence assay	B	C=CS(=O)(=O)N1CCC[C@@H]1Cn1cc(-c2ccc3c(c2)OCO3)c2c(N)ncnc21		CHEMBL4095253	=	IC50	nM	510.3	CHEMBL4223	Homo sapiens	IC50	nM	510.3
	18274905	CHEMBL4118347	Inhibition of FRK in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled HEIKLPVK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384	=	Inhibition	%	39.2	CHEMBL4223	Homo sapiens	INH	%	39.2
	18274906	CHEMBL4118347	Inhibition of FRK in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled HEIKLPVK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl	Outside typical range	CHEMBL3884839	=	Inhibition	%	-12.9	CHEMBL4223	Homo sapiens	INH	%	-12.9
	18274907	CHEMBL4118347	Inhibition of FRK in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled HEIKLPVK probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Inhibition	%	-9.6	CHEMBL4223	Homo sapiens	INH	%	-9.6
	18282090	CHEMBL4120045	Inhibition of recombinant full length GST-tagged human FRK cytoplasmoic domain expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	14.4	CHEMBL4223	Homo sapiens	INH	%	14.4
	18282409	CHEMBL4120045	Inhibition of recombinant full length GST-tagged human FRK cytoplasmoic domain expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	19.7	CHEMBL4223	Homo sapiens	INH	%	19.7
	18282850	CHEMBL4120435	Inhibition of FRK (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	31.3	CHEMBL4223	Homo sapiens	INH	%	31.3
	18283070	CHEMBL4120655	Inhibition of FRK (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	3.3	CHEMBL4223	Homo sapiens	INH	%	3.3
	18283290	CHEMBL4120875	Inhibition of FRK (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	5.0	CHEMBL4223	Homo sapiens	INH	%	5.0
	18440224	CHEMBL4157048	Binding affinity to wild-type human partial length FRK (A215 to F503 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	84.0	CHEMBL4223	Homo sapiens	Activity	%	84.0
	18484180	CHEMBL4185827	Binding affinity to wild-type human partial length FRK (A215 to F503 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	95.0	CHEMBL4223	Homo sapiens	Activity	%	95.0
	18484664	CHEMBL4185827	Binding affinity to wild-type human partial length FRK (A215 to F503 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	100.0	CHEMBL4223	Homo sapiens	Activity	%	100.0
	18507630	CHEMBL4191161	Inhibition of recombinant human PTK5 (218 to end residues) at 1 uM using GGEEEEYFELVKKKK as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	94.0	CHEMBL4223	Homo sapiens	INH	%	94.0
	18653395	CHEMBL4230208	Inhibition of PTK5 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	95.0	CHEMBL4223	Homo sapiens	INH	%	95.0
	18653396	CHEMBL4230208	Inhibition of PTK5 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	18.0	CHEMBL4223	Homo sapiens	INH	%	18.0
	18655508	CHEMBL4230727	Binding affinity to wild-type human partial length FRK (A215 to F503 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	80.0	CHEMBL4223	Homo sapiens	Activity	%	80.0
	18751222	CHEMBL4263931	Inhibition of PTK5 (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	-2.0	CHEMBL4223	Homo sapiens	INH	%	-2.0
	18751587	CHEMBL4264316	Binding affinity to wild-type human partial length FRK (A215 to F503 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	96.0	CHEMBL4223	Homo sapiens	Activity	%	96.0
	18778953	CHEMBL4269643	Inhibition of human FRK using poly[Glu:Tyr] (4:1) as substrate at 1 uM by [gamma-33P]-ATP based assay relative to control	B	COc1cc2nccc(Nc3n[nH]c(C)c3C)c2cc1S(=O)(=O)C(C)(C)C		CHEMBL4293287	>	Inhibition	%	90.0	CHEMBL4223	Homo sapiens	INH	%	90.0
	18857982	CHEMBL4307828	Binding affinity to wild-type human partial length FRK (A215 to F503 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	100.0	CHEMBL4223	Homo sapiens	Activity	%	100.0
	18892956	CHEMBL4314922	Inhibition of human PTK5 (218 to end residues) using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	101.5	CHEMBL4223	Homo sapiens	Activity	%	101.5
	18919471	CHEMBL4322827	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged FRK (unknown origin) (223 to 505 residues) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr in presence of calmodulin by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	332.0	CHEMBL4223	Homo sapiens	Kd	nM	332.0
	18919659	CHEMBL4322827	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged FRK (unknown origin) (223 to 505 residues) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr in presence of calmodulin by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	=	Kd	nM	372.0	CHEMBL4223	Homo sapiens	Kd	nM	372.0
	18937947	CHEMBL4327700	Inhibition of human FRK assessed as residual activity at 1 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	97.4	CHEMBL4223	Homo sapiens	Activity	%	97.4
	18937948	CHEMBL4327700	Inhibition of human FRK assessed as residual activity at 1 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	98.24	CHEMBL4223	Homo sapiens	Activity	%	98.24
	18938544	CHEMBL4328064	Inhibition of human FRK assessed as residual activity at 100 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL4223	Homo sapiens	Activity	%	65.0
	18938922	CHEMBL4328428	Inhibition of human FRK using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	17.0	CHEMBL4223	Homo sapiens	IC50	10'-8M	1.7
	18958895	CHEMBL4333417	Binding affinity to wild-type human partial length FRK (A215 to F503 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	76.0	CHEMBL4223	Homo sapiens	Activity	%	76.0
	18964642	CHEMBL4335262	Inhibition of recombinant human PTK5 (218 to end residues) assessed as residual activity at 1 uM using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	92.0	CHEMBL4223	Homo sapiens	Activity	%	92.0
	18964643	CHEMBL4335262	Inhibition of recombinant human PTK5 (218 to end residues) assessed as residual activity at 1 uM using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	96.0	CHEMBL4223	Homo sapiens	Activity	%	96.0
	18972075	CHEMBL4337085	Inhibition of recombinant human PTK5 (218 to end residues) assessed as residual activity at 10 uM using GGEEEEYFELVKKKK as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	7.0	CHEMBL4223	Homo sapiens	Activity	%	7.0
	19021494	CHEMBL4347715	Inhibition of recombinant human FRK at 20 nM using Ulight-Poly GAT[EAY(1:1:1)] as substrate measured after 15 mins by LANCE method relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	8.0	CHEMBL4223	Homo sapiens	INH	%	8.0
	19021495	CHEMBL4347716	Inhibition of recombinant human FRK at 200 nM using Ulight-Poly GAT[EAY(1:1:1)] as substrate measured after 15 mins by LANCE method relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	11.0	CHEMBL4223	Homo sapiens	INH	%	11.0
Not Active	19040133	CHEMBL4351608	Inhibition of human PTK5 (218 to end residues) using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL4223	Homo sapiens	INH		
Active	19041120	CHEMBL4352381	Inhibition of human FRK at 10 uM using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL4223	Homo sapiens	INH		
	19059604	CHEMBL4357905	Binding affinity to wild-type human partial length FRK (A215 to F503 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	5.1	CHEMBL4223	Homo sapiens	Activity	%	5.1
	19063670	CHEMBL4359457	Binding affinity to wild-type human partial length FRK (A215 to F503 residues) expressed in bacterial expression system at 100 nM by Kinomescan method relative to control	B	CC(C)(C)c1cc(NC(=O)Cc2ccc(-n3cnc4cc(-c5ccc(S(C)(=O)=O)cc5)ccc43)cc2)no1		CHEMBL4473213	>	Activity	%	90.0	CHEMBL4223	Homo sapiens	Activity	%	90.0
	19090172	CHEMBL4365746	Inhibition of wild-type human partial length FRK (A215 to F503 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	94.0	CHEMBL4223	Homo sapiens	Activity	%	94.0
	19091937	CHEMBL4366411	Inhibition of human FRK at 100 nM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	8.7	CHEMBL4223	Homo sapiens	INH	%	8.7
	19118531	CHEMBL4372375	Inhibition of recombinant human N-terminal His6-tagged PTK5 (218 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM using JAK3tide as substrate in presence of [gamma-33P]-ATP or [gamma-32P]-ATP relative to control	B	Cc1cccc(Cn2nc(C)c3c(NC(=O)c4csc5c(N)ncnc45)cccc32)n1		CHEMBL4483816	=	Inhibition	%	19.0	CHEMBL4223	Homo sapiens	INH	%	19.0
	19144822	CHEMBL4377838	Inhibition of human PTK5 (218 to end residues) at 1 uM using GGEEEEYFELVKKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	15.0	CHEMBL4223	Homo sapiens	INH	%	15.0
	19148017	CHEMBL4379413	Inhibition of recombinant human PTK5 (218 to end residues) using GGEEEEYFELVKK as substrate incubated for 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL4223	Homo sapiens	IC50	uM	10.0
	19159432	CHEMBL4382536	Binding affinity to wild-type human partial length FRK (A215 to F503 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	5.9	CHEMBL4223	Homo sapiens	Activity	%	5.9
	19181038	CHEMBL4387249	Inhibition of recombinant full length human GST-tagged FRK expressed in baculovirus expression system at 0.1 uM using tyrosine-1 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	5.5	CHEMBL4223	Homo sapiens	INH	%	5.5
	19181264	CHEMBL4387249	Inhibition of recombinant full length human GST-tagged FRK expressed in baculovirus expression system at 0.1 uM using tyrosine-1 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	1.5	CHEMBL4223	Homo sapiens	INH	%	1.5
	19191575	CHEMBL4389255	Inhibition of wild-type human partial length FRK (A215 to F503 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	96.0	CHEMBL4223	Homo sapiens	INH	%	96.0
	19191918	CHEMBL4389732	Inhibition of wild-type human partial length FRK (A215 to F503 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	99.0	CHEMBL4223	Homo sapiens	INH	%	99.0
	19199868	CHEMBL4391358	Binding affinity to wild-type human partial length FRK (A215 to F503 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	99.0	CHEMBL4223	Homo sapiens	Activity	%	99.0
	19266433	CHEMBL4405383	Inhibition of wild-type human partial length FRK (A215 to F503 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL4223	Homo sapiens	INH	%	50.0
	19276106	CHEMBL4408109	Inhibition of recombinant human PTK5 (218 to end residues) at 1 uM using GGEEEEYFELVKKKK as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	10.0	CHEMBL4223	Homo sapiens	INH	%	10.0
	19306070	CHEMBL4414922	Inhibition of human FRK using poly[Glu:Tyr] (4:1) as substrate preincubated for 60 mins followed by [gamma-33P]-ATP addition and measured after 120 mins by filter binding method	A	C=CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1		CHEMBL3936761	=	IC50	nM	379.0	CHEMBL4223	Homo sapiens	IC50	nM	379.0
	19306071	CHEMBL4414922	Inhibition of human FRK using poly[Glu:Tyr] (4:1) as substrate preincubated for 60 mins followed by [gamma-33P]-ATP addition and measured after 120 mins by filter binding method	A	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	IC50	nM	79.0	CHEMBL4223	Homo sapiens	IC50	nM	79.0
	19334602	CHEMBL4419202	Binding affinity to FRK (unknown origin)	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	480.0	CHEMBL4223	Homo sapiens	Kd	nM	480.0
	19334603	CHEMBL4419202	Binding affinity to FRK (unknown origin)	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	440.0	CHEMBL4223	Homo sapiens	Kd	nM	440.0
	19334604	CHEMBL4419202	Binding affinity to FRK (unknown origin)	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	=	Kd	nM	190.0	CHEMBL4223	Homo sapiens	Kd	nM	190.0
	19334605	CHEMBL4419202	Binding affinity to FRK (unknown origin)	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	360.0	CHEMBL4223	Homo sapiens	Kd	nM	360.0
	19334606	CHEMBL4419202	Binding affinity to FRK (unknown origin)	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	=	Kd	nM	99.0	CHEMBL4223	Homo sapiens	Kd	nM	99.0
	19334607	CHEMBL4419202	Binding affinity to FRK (unknown origin)	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	0.31	CHEMBL4223	Homo sapiens	Kd	nM	0.31
	20598193	CHEMBL4602922	Inhibition of human FRK	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	<	IC50	nM	1000.0	CHEMBL4223	Homo sapiens	IC50	uM	1.0
	20600538	CHEMBL4603490	Inhibition of recombinant full length GST-tagged human FRK expressed in baculovirus expression system using tyrosine 1 as substrate after 1 hr in presence of ATP by ZYLTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL4223	Homo sapiens	IC50	uM	100.0
	22392062	CHEMBL4667157	Inhibition of recombinant human GST-tagged full length FRK expressed in baculovirus expression system using Tyr 01 as substrate at 10 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	5.0	CHEMBL4223	Homo sapiens	INH	%	5.0
	22423599	CHEMBL4674375	Inhibition of human FRK using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	83.14	CHEMBL4223	Homo sapiens	Activity	%	83.14
	22423600	CHEMBL4674375	Inhibition of human FRK using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	95.95	CHEMBL4223	Homo sapiens	Activity	%	95.95
	22823736	CHEMBL4717042	Inhibition of human FRK	B	C[C@H]1CC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)CN1C(=O)C1CC1		CHEMBL4103954	=	IC50	nM	111.0	CHEMBL4223	Homo sapiens	IC50	nM	111.0
	22823737	CHEMBL4717042	Inhibition of human FRK	B	CC1(C(=O)N2CCC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4F)c4c(N)nccn34)C2)COC1		CHEMBL4799627	=	IC50	nM	187.0	CHEMBL4223	Homo sapiens	IC50	nM	187.0
	22823738	CHEMBL4717042	Inhibition of human FRK	B	CC1(C(=O)N2CCC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)C2)COC1		CHEMBL4094125	=	IC50	nM	361.0	CHEMBL4223	Homo sapiens	IC50	nM	361.0
	22836234	CHEMBL4718861	Inhibition of recombinant human GST-tagged full length FRK expressed in baculovirus expression system at 500 nM using Tyr 01 peptide as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	16.0	CHEMBL4223	Homo sapiens	INH	%	16.0
	22836235	CHEMBL4718861	Inhibition of recombinant human GST-tagged full length FRK expressed in baculovirus expression system at 500 nM using Tyr 01 peptide as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	OCC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccccc1		CHEMBL4786776	=	Inhibition	%	14.0	CHEMBL4223	Homo sapiens	INH	%	14.0
	22836236	CHEMBL4718861	Inhibition of recombinant human GST-tagged full length FRK expressed in baculovirus expression system at 500 nM using Tyr 01 peptide as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	CN(C)CCNCc1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3[nH]2)cc1F		CHEMBL4748367	=	Inhibition	%	49.0	CHEMBL4223	Homo sapiens	INH	%	49.0
	22836237	CHEMBL4718861	Inhibition of recombinant human GST-tagged full length FRK expressed in baculovirus expression system at 500 nM using Tyr 01 peptide as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	CCOc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1		CHEMBL4776396	=	Inhibition	%	32.0	CHEMBL4223	Homo sapiens	INH	%	32.0
	22836238	CHEMBL4718861	Inhibition of recombinant human GST-tagged full length FRK expressed in baculovirus expression system at 500 nM using Tyr 01 peptide as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	COc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1		CHEMBL4783569	=	Inhibition	%	36.0	CHEMBL4223	Homo sapiens	INH	%	36.0
	22836239	CHEMBL4718861	Inhibition of recombinant human GST-tagged full length FRK expressed in baculovirus expression system at 500 nM using Tyr 01 peptide as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	OC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccccc1		CHEMBL4780286	=	Inhibition	%	33.0	CHEMBL4223	Homo sapiens	INH	%	33.0
	22843225	CHEMBL4720248	Inhibition of FRK (unknown origin)	B	C=CC(=O)N1CCC(Cn2cc(-c3ccc4c(c3)OCO4)c3c(N)ncnc32)CC1		CHEMBL4755698	=	IC50	nM	1129.3	CHEMBL4223	Homo sapiens	IC50	nM	1129.3
	22843226	CHEMBL4720248	Inhibition of FRK (unknown origin)	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	IC50	nM	29.2	CHEMBL4223	Homo sapiens	IC50	nM	29.2
	22843737	CHEMBL4720723	Inhibition of human FRK using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	4.56	CHEMBL4223	Homo sapiens	IC50	10^-9M	4.56
	22844088	CHEMBL4721074	Inhibition of human FRK assessed as residual activity using poly[Glu:Tyr] (4:1) as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	88.06	CHEMBL4223	Homo sapiens	Activity	%	88.06
	22844718	CHEMBL4721393	Inhibition of wild-type human partial length FRK (A215 to F503 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	90.6	CHEMBL4223	Homo sapiens	Activity	%	90.6
	22845480	CHEMBL4721761	Binding affinity to Nluc-tagged FRK (unknown origin) expressed in HeLa cells assessed as change in melting temperature incubated for 30 to 60 mins by NaLTSA assay	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	Delta Tm	degrees C	4.07	CHEMBL4223	Homo sapiens	deltaTm	degrees C	4.07
	22845500	CHEMBL4721781	Binding affinity to human FRK using poly[Glu:Tyr] (4:1) as substrate by radiometric hotspot kinase assay	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	IC50	nM	1.3	CHEMBL4223	Homo sapiens	IC50	nM	1.3
	22874824	CHEMBL4725515	Inhibition of human PTK5 assessed as remaining enzyme activity at 1 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	=	Activity	%	3.0	CHEMBL4223	Homo sapiens	Activity	%	3.0
	22874858	CHEMBL4725549	Inhibition of human PTK5 assessed as remaining enzyme activity at 0.1 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	=	Activity	%	18.0	CHEMBL4223	Homo sapiens	Activity	%	18.0
	22874884	CHEMBL4725575	Inhibition of human PTK5 assessed as remaining enzyme activity at 0.01 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	=	Activity	%	64.0	CHEMBL4223	Homo sapiens	Activity	%	64.0
	22882843	CHEMBL4727423	Inhibition of FRK (unknown origin)	B	Nc1nccn2c([C@@H]3CC[C@H]4COC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12		CHEMBL4749037	=	IC50	nM	46.0	CHEMBL4223	Homo sapiens	IC50	nM	46.0
	22882844	CHEMBL4727423	Inhibition of FRK (unknown origin)	B	Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12		CHEMBL4106978	=	IC50	nM	34.0	CHEMBL4223	Homo sapiens	IC50	nM	34.0
	22882845	CHEMBL4727423	Inhibition of FRK (unknown origin)	B	CC1(C)OC(=O)N2C[C@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)CC[C@H]21		CHEMBL4108687	=	IC50	nM	36.0	CHEMBL4223	Homo sapiens	IC50	nM	36.0
	22882846	CHEMBL4727423	Inhibition of FRK (unknown origin)	B	COc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2ccnc(N)c12		CHEMBL4114929	=	IC50	nM	154.0	CHEMBL4223	Homo sapiens	IC50	nM	154.0
	22882847	CHEMBL4727423	Inhibition of FRK (unknown origin)	B	Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3OC3CC3)c12		CHEMBL4107779	=	IC50	nM	530.0	CHEMBL4223	Homo sapiens	IC50	nM	530.0
	22950582	CHEMBL4766149	Inhibition of human recombinant PTK5 (218 to end residues) using GGEEEEYFELVKKKK as substrate incubated for 40 mins in presence of [gamma33P-ATP] by radiometric scintillation counting analysis	B	Cc1ccc(NC(=O)c2ccc(C)c(C(F)(F)F)c2)cc1C#Cc1nn([C@H]2CC[C@H](O)CC2)c2ncnc(N)c12		CHEMBL4798527	=	IC50	nM	19.0	CHEMBL4223	Homo sapiens	IC50	uM	0.019
	22952979	CHEMBL4766916	Inhibition of recombinant human PTK5 (218 to end residues) assessed as residual activity at 10 uM using GGEEEEYFELVKKKK as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	2.0	CHEMBL4223	Homo sapiens	Activity	%	2.0
	22953098	CHEMBL4767035	Inhibition of recombinant human PTK5 (218 to end residues) using GGEEEEYFELVKKKK as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	IC50	nM	51.0	CHEMBL4223	Homo sapiens	IC50	uM	0.051
	23122590	CHEMBL4804941	Inhibition of human FRK assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	92.0	CHEMBL4223	Homo sapiens	Activity	%	92.0
	23123285	CHEMBL4805529	Inhibition of human FRK assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	100.0	CHEMBL4223	Homo sapiens	Activity	%	100.0
	23123610	CHEMBL4805854	Inhibition of DNA-tagged human FRK assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	96.0	CHEMBL4223	Homo sapiens	Activity	%	96.0
	23124660	CHEMBL4806546	Inhibition of human FRK assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL4223	Homo sapiens	Activity	%	100.0
	23124661	CHEMBL4806546	Inhibition of human FRK assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	97.0	CHEMBL4223	Homo sapiens	Activity	%	97.0
	23128122	CHEMBL4807849	Inhibition of FRK (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	<	Activity	%	25.0	CHEMBL4223	Homo sapiens	Activity	%	25.0
	23128123	CHEMBL4807849	Inhibition of FRK (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	<	Activity	%	25.0	CHEMBL4223	Homo sapiens	Activity	%	25.0
	23128124	CHEMBL4807849	Inhibition of FRK (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Activity	%	25.0	CHEMBL4223	Homo sapiens	Activity	%	25.0
Not Active	23317425	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23317893	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	80.0	CHEMBL4223	Homo sapiens	% Control	%	80.0
Not Active	23318562	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23319043	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23319680	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23320155	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23320833	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23321301	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	92.0	CHEMBL4223	Homo sapiens	% Control	%	92.0
Not Active	23321931	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23322399	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	89.0	CHEMBL4223	Homo sapiens	% Control	%	89.0
Not Active	23323088	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23323556	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23324116	CHEMBL4880735	PTK5 (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	2.0	CHEMBL4223	Homo sapiens	% inhibition	%	2.0
Not Active	23324410	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23325045	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23325513	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	89.0	CHEMBL4223	Homo sapiens	% Control	%	89.0
Not Active	23326160	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	98.0	CHEMBL4223	Homo sapiens	% Control	%	98.0
Not Active	23326628	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	99.0	CHEMBL4223	Homo sapiens	% Control	%	99.0
Not Active	23327328	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23327796	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	99.0	CHEMBL4223	Homo sapiens	% Control	%	99.0
Not Active	23328383	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23328851	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	90.0	CHEMBL4223	Homo sapiens	% Control	%	90.0
Not Active	23329505	CHEMBL4881212	PTK5(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	109.0	CHEMBL4223	Homo sapiens	% residual kinase activity	%	109.0
Not Active	23329797	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23330265	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	95.0	CHEMBL4223	Homo sapiens	% Control	%	95.0
Not Active	23331021	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23331489	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23332076	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	59.1	CHEMBL4223	Homo sapiens	% Control	%	59.1
Not Active	23332542	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23333260	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23333899	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23334367	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23335346	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23335814	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	81.0	CHEMBL4223	Homo sapiens	% Control	%	81.0
Not Active	23336441	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	83.0	CHEMBL4223	Homo sapiens	% Control	%	83.0
Not Active	23336909	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23337605	CHEMBL4881976	FRK Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	94.5	CHEMBL4223	Homo sapiens	% Ctrl	%	94.5
Not Active	23337990	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	90.0	CHEMBL4223	Homo sapiens	% Control	%	90.0
Not Active	23338458	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23339070	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	80.0	CHEMBL4223	Homo sapiens	% Control	%	80.0
Not Active	23339538	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23340175	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	58.0	CHEMBL4223	Homo sapiens	% Control	%	58.0
Not Active	23340643	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23341300	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23341768	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	97.0	CHEMBL4223	Homo sapiens	% Control	%	97.0
Not Active	23342384	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23342852	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23343482	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23343950	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23344588	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23345161	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23345629	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23346206	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23346675	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23347280	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	82.2	CHEMBL4223	Homo sapiens	% Control	%	82.2
Not Active	23347766	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23348345	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23348813	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23349400	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23350018	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23350486	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23351091	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23351559	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23352056	CHEMBL4882747	FRK (PTK5) Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	7.133	CHEMBL4223	Homo sapiens	% Inhibition	%	7.1329
Not Active	23352583	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23353051	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23353933	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23354401	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23355133	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23355601	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23356237	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23356705	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23357314	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	77.0	CHEMBL4223	Homo sapiens	% Control	%	77.0
Not Active	23357961	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23358429	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	82.0	CHEMBL4223	Homo sapiens	% Control	%	82.0
Not Active	23359015	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	83.7	CHEMBL4223	Homo sapiens	% Control	%	83.7
Not Active	23359613	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	98.0	CHEMBL4223	Homo sapiens	% Control	%	98.0
Not Active	23360081	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23360666	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	83.0	CHEMBL4223	Homo sapiens	% Control	%	83.0
Not Active	23361134	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	62.0	CHEMBL4223	Homo sapiens	% Control	%	62.0
Not Active	23361707	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	98.0	CHEMBL4223	Homo sapiens	% Control	%	98.0
Not Active	23362243	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23362711	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23364353	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23364821	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23365560	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	96.0	CHEMBL4223	Homo sapiens	% Control	%	96.0
Not Active	23366103	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23366693	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23367161	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	77.0	CHEMBL4223	Homo sapiens	% Control	%	77.0
Not Active	23367580	CHEMBL4883933	FRK ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	111.0	CHEMBL4223	Homo sapiens	% Residual activity with Skepinone-L	%	111.0
Not Active	23368039	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	98.0	CHEMBL4223	Homo sapiens	% Control	%	98.0
Not Active	23368507	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	93.0	CHEMBL4223	Homo sapiens	% Control	%	93.0
Not Active	23369106	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	92.0	CHEMBL4223	Homo sapiens	% Control	%	92.0
Not Active	23369574	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	85.0	CHEMBL4223	Homo sapiens	% Control	%	85.0
Not Active	23370220	CHEMBL4884462	PTK5(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	91.0	CHEMBL4223	Homo sapiens	% residual kinase activity	%	91.0
Not Active	23370542	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23371010	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23371819	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	77.0	CHEMBL4223	Homo sapiens	% Control	%	77.0
Not Active	23372287	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	60.0	CHEMBL4223	Homo sapiens	% Control	%	60.0
	23372751	CHEMBL4884716	FRK(FRK1LGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL4223	Homo sapiens	pIC50		6.0
	23373160	CHEMBL4885007	FRK(FRK1LGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL4223	Homo sapiens	pIC50		6.0
	23373521	CHEMBL4885298	FRK(FRK1LGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL4223	Homo sapiens	pIC50		6.0
Not Active	23374986	CHEMBL4885979	Frk Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	5.5	CHEMBL4223	Homo sapiens	% Inhibition	%	5.5
Not Active	23375256	CHEMBL4886238	fyn-related kinase  Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1		CHEMBL2180408		Inhibition	%	-7.0	CHEMBL4223	Homo sapiens	% inhibition	%	-7.0
Not Active	23375714	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	73.0	CHEMBL4223	Homo sapiens	% Control	%	73.0
Not Active	23376182	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	73.0	CHEMBL4223	Homo sapiens	% Control	%	73.0
Not Active	23376759	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23377228	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23378087	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	94.0	CHEMBL4223	Homo sapiens	% Control	%	94.0
Not Active	23378555	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	95.0	CHEMBL4223	Homo sapiens	% Control	%	95.0
Not Active	23379722	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23380190	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	80.0	CHEMBL4223	Homo sapiens	% Control	%	80.0
Not Active	23380884	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23381532	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	68.0	CHEMBL4223	Homo sapiens	% Control	%	68.0
Not Active	23382000	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	81.0	CHEMBL4223	Homo sapiens	% Control	%	81.0
Not Active	23382624	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	100.0	CHEMBL4223	Homo sapiens	% Control	%	100.0
Not Active	23383092	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	93.0	CHEMBL4223	Homo sapiens	% Control	%	93.0
Not Active	23383801	CHEMBL4887436	FRK Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	92.0	CHEMBL4223	Homo sapiens	% Ctrl	%	92.0
Not Active	23384442	CHEMBL4888037	PTK5(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O	Outside typical range	CHEMBL4802045		Inhibition	%	-14.53	CHEMBL4223	Homo sapiens	% inhibition	%	-14.53
Not Active	23385007	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	80.0	CHEMBL4223	Homo sapiens	% Control	%	80.0
Not Active	23385474	CHEMBL4879731	KinomeScan assay: inhibition of FRK	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	91.0	CHEMBL4223	Homo sapiens	% Control	%	91.0
